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Abstract?
Biocatalytic?processes?are?advancing?because?of?their?high?selectivity?and?mild?operating?conditions,?in?
contrast? to?many? chemical? catalyzed?processes.?This? is?a? clear? advantage?and? frequently? results? in?
improved? environmental? performance.? Biocatalytic? processes? have? been? implemented? replacing?
traditional?chemical?catalysts?as?well?as?enabling?new?synthesis.?Regardless?of?the?process?routes,?the?
economic? feasibility? is? crucial? for? successful? industrial? implementation.? This? has? also? been?
demonstrated?by? implemented?biocatalytic?processes,?showing?a?clear?cost?advantage?compared? to?
the?chemical?alternative.?
One? family?of?enzymes?described? to?have?a? lot?of?potential? for? industrial?biocatalysis? is?cytochrome?
P450?monooxygenases.?The?main?motivation? for? this? statement? is? their? ability? to?hydroxylate?non?
activated? hydrocarbons? in? a? specific?manner,?using?molecular? oxygen? as? oxidant.? Containing?more?
than?26?000?enzymes,?this?family? includes?diverse?enzymes?from?all?kingdoms?of? life.?However,?their?
dependence? on? cofactor,? redox? partners? and? relatively? low? activity? and? stability? hinders? the?
development?of?efficient?processes.? In? this? thesis,?a?novel?systematic?approach?has?been?applied? to?
identify?bottlenecks?for?economically?feasible?whole?cell?P450?catalyzed?processes?to?direct?research?
and?enable?faster?implementation.?A?methodological?approach?was?introduced?by?reviewing?literature?
based?on?guidance?by?economic?metrics,?followed?by?cases?studies?to?confirm?the?initial?analysis.?The?
last? part? of? the? thesis? consists? of? an? economic? assessment? based? on? a? process? model? using?
experimentally?gained?knowledge,?including?a?sensitivity?analysis?of?the?biological?parameters?protein?
expression?and?enzyme?total?turnover.??
Case?studies?of?various?complexities?have?been?chosen?throughout?the?thesis.?The?first?case?study?was?
performed? using? a? P450? fusion? construct? expressed? in? the? well? explored? host? Escherichia? coli?
performing? ?hydroxylation?of?dodecanoic?acid.?This?system?represents?an?artificial?fusion?construct?in?
a? non?natural? P450? expressing? host.? The?main? limitations? in? this? case? were? identified? to? be? the?
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stability?and?activity?of?the?P450,?cofactor?regeneration?by?the?host?cell?and?substrate?inhibition.?The?
latter?was?partially?circumvented?by?the?introduction?of?substrate?in?solid?form.?The?second?case?study?
utilized? a? naturally? expressing? P450? host,? Bacillus?megaterium,? expressing? the? steroid? hydroxylase?
CYP106A2? for?15??hydroxylation?of?cyproterone?acetate.?The?catalytic?activity?of? the?overexpressed?
CYP106A2?was?dependent?on?the?natural?redox?partners?in?the?host?cell.?The?stability?of?the?P450?was?
also?here? identified?as?one?of?the? limitations?as?well?as?product? inhibition.?Product? inhibition?was? in?
this?case?addressed?by? introducing?a?modified???cyclodextrin,?yielding?98?%?conversion? in? the?gram?
scale.???
P450? catalyzed? whole? cell? processes? have? been? identified? suitable? for? production? of? high? value?
molecules.? The?main? limitations? have? been? shown? to? be? P450? stability? and? activity,? substrate? and?
product?inhibition?and?cofactor?regeneration?of?heterologous?expression?host.?Furthermore,?growing?
cells,? where? fermentation? and? biocatalysis? is? performed? in? one? step? is? shown? to? be? the? most?
economically?feasible?option.??
? ?
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Dansk?resumé?
Betydningen? af? biokatalytiske? processers? forøges? på? grund? af? deres? høje? selektivitet? og? milde?
reaktionsbetingelser?sammenlignet?med?mange?kemisk?katalyserede?processer.?Dette?er?en?åbenlys?
fordel,?hvilket?ofte?også?resulterer?i?en?reducering?af?miljøpåvirkningen.?Biokatalytiske?processer?bliver?
implementeret? for? at? erstatte? traditionelle? kemiske? katalysatorer? eller? for? at? åbne? op? for? nye?
synteseveje.? Den? økonomiske? rentabilitet? er,? uanset? processen,? afgørende? for? succesfuld?
implementering? på? industrielskala.? Dette? er? også? demonstreret? i? allerede? implementerede?
biokatalytiske? processer,? der? viser? en? klar? økonomisk? fordel? sammenlignet? med? de? kemiske?
alternativer.???
Cytochrome?P450?monooxygenases?er?en?familie?af?enzymer?der?har?et?stort?potentiale?for?industriel?
biokatalyse.?Den?primære?motivation?bag?dette?udsagn?er?denne?families?evne?til?at?hydroxylere?ikke?
aktiverede?kulbrinter?med?høj? specificitet? ved?brugen?af?molekylært?oxygen? som?oxidationsmiddel.?
Familien? indeholder? mere? end? 26? 000? mangfoldige? enzymer? fra? alle? livets? riger.? Udviklingen? af?
effektive? industrille?processer?besværliggøres?dog?af?enzymernes?afhængighed?af?co?faktor?og?redox?
partnere? samt? deres? relativt? lave? aktivitet? og? stabilitet.? I? denne? afhandling? er? en? ny? systematik?
fremgangsmåde? blevet? anvendt? til? at? identificere? flaskehalse? for? P450? katalyserede? processor? for?
hermed?at?guide?fremtidig?forskning?og?muliggøre?hurtigere?implementering?i?industrien.?En?metodisk?
fremgangsmåde? er? blevet? udviklet? ved? at? studere? videnskabeliglitteratur? omhandlende? styring? på?
baggrund? af? økonomiske? indikatorer.?Den? udviklede?metode? er?blevet? valideret? gennem? en? række?
relevante?eksempler.?Den?sidste?del?af?afhandlingen?består?af?en?økonomisk?evaluering?baseret?på?en?
procesmodel?samt?viden?opnået?gennem?eksperimenter,?dette?inkluderer?en?sensitivitetsanalyse?af?de?
biologiske?parametre?protein?ekspression?og?total?enzymomsætning.?????????????????????????
Igennem?hele?afhandlingen?er? relevante?eksempler?blevet?udvalgt?og?studeret.?Det? første?eksempel?
gjorde?brug?af?et?P450?fusionskonstrukt?udtrykt? i?den?velkendte?vært?Escherichia?coli,?hvori?enzymet?
blev? udnyttet? til? ??hydroxylering? af? dodekansyre.? Dette? system? repræsenterer? et? kunstigt?
fusionskonstrukt?udtrykt? i?en?vært?uden?naturlig? forekomst?af?P450.?P450?stabilitet?og?aktivitet,?co?
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faktor? regenerering? af? værtscellen,? samt? substratinhibering? blev? identificeret? som? de? største?
begrænsninger?i?dette?eksempel.?Substratinhiberingen?blev?til?dels?omgået?ved?at?tilføre?substrat?i?fast?
form.? I?det?andet?eksempel?blev?værten?Bacillus?megaterium,?der?naturligt?udtrykker?P450,?benyttet?
til?at?udtrykke?steroidhydroxylasen?CYP106A2?for?at?foretage?15??hydroxylation?af?cyproteronacetat.?
Den? katalytiske? aktivitet? af? the? overudtrykte? CYP106A2? var? afhængigt? af? værtens? naturlige?
redoxpartner.?I?dette?eksempel?blev?P450?stabilitet?også?identificeret?som?en?begrænsning,?men?også?
produktinhibering?viste?sig?at?være?begrænsende.?Produktinhiberingen?blev?i?dette?tilfælde?adresseret?
ved?at?introducere?et?modificeret???cyklodextrin,?resulterende?i?98?%?omdannelse?på?gram?skala.?
Hel?celles? P450? katalyserede? processer? er? blevet? identificeret? som? velegnede? til? produktion? af?
molekyler?af?høj?værdi.?Det?er?blevet?vist?af?de?primære?begrænsninger?er?P450?stabilitet?og?aktivitet,?
substrat?? og? produktinhibering? samt? værts? cellens? co?faktor? regenereringsevne.? Ydermere,? er? det?
blevet? vist? af? voksende? celler,? hvor? fermentering? og? biokatalyse? udføres? i? et? trin,? er? det? mest?
økonomisk?rentabel?alternativ.
? ?
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1 Introduction?
Background?1.1
Traditional? chemical? processes? are? based? on? oil? as? a? feedstock? and? also? include? harsh? reaction?
conditions? in?many? cases.? One? way? of? limiting? the? consumption? of? fossil? fuels? and? reducing? the?
emissions?of?greenhouse?gases?such?as?CO2? is?to? find?alternative?process?options.? ?More?sustainable?
options?gaining?ground?are?bioprocesses,?a?popular?term?including?both?biobased?processes?referring?
to? use? of? renewable? feedstocks,? fermentation? processes? and? biocatalytic? processes? utilizing? a?
renewable?enzymatic?catalyst.?The?terminology?applied?within?this?field?can?easily? lead?to?confusion,?
bio?based? processes? are? referring? to? the? feedstock? but? the? process? itself? could? be? a? biological? or?
chemical?process.?Within? the?bioprocesses? the?processes? could?be?divided? firstly? into? fermentation?
processes? producing? high?molecular?weight? products? such? as? enzymes? or? antibodies? and? secondly?
biocatalysis?where?an?enzyme? is?catalyzing?a?reaction,?which? is?the?type?of?process?dealt?with? in?this?
thesis.? It? should? however? be? noted? that? biocatalytic? processes? do? not? always? use? a? bio?based?
feedstock?and?could?also?include?fermentation.?Biocatalytic?processes?have?emerged?complementary?
to? or? replacing? traditional? chemical? processes.? These? processes? are? usually? performed? in? aqueous?
solutions?under?mild?conditions?(close?to?room?temperature,?neutral?pH,?atmospheric?pressure)?and?in?
this?way?are?generally?more?environmentally?friendly?compared?to?traditional?chemical?processes.??
Industrial?biocatalysis?1.2
Industrial?biocatalysis?(industrial?biotechnology?or?white?biotechnology)?is?the?biological?alternative?to?
traditional? chemical? synthesis.? Instead? of?metal? catalysts? such? as? Rh,? Ru,? Pd? and? Pt,? enzymes? are?
applied? to? catalyze? the? desired? reaction.? Enzymes? are? defined? as? proteins? capable? of? catalyzing?
chemical? changes? in? organic? compounds.? Enzymes? are? produced? via? fermentation,? where? a?
microorganism? is? cultivated? to? produce? the? enzyme? of? interest.? Commonly,? the?microorganism? is?
modified?to?overexpress?the?enzyme?and?the?enzyme?can?be?produced?either?intracellular?(inside?the?
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cell)?or?extracellular? (enzyme?exported?outside? the? cell).? In? recent? years?enormous?progress? in? the?
application? of? enzymes? for? industrial? chemistry? has? been? witnessed,? in? particular? in? the?
pharmaceutical? sector? (Wohlgemuth? 2010;?Woodley? 2008;? Bornscheuer? et? al.? 2012).? Enzymes? or?
rather?enzymatic?reactions?are?classified?according?to?the?type?of?reaction?performed?into?6?different?
classes? assigned? an? Enzyme? Commision? (EC)? number.? For? example,? potentially? important? types? of?
enzymes? for? industry?are?oxidoreductases? (EC?class?1)? including?cytochrome?P450?monooxygenases,?
transferases?(EC?2)?such?as?transaminases?and?hydrolases?(EC?3)? including? lipases.?Lipases?are?active?
and?highly?stable?enzymes?and?are?applied?for?e.g.?the?production?of?biodiesel,?a?low?value?chemical/?
fuel,?but?also? in?pharmaceutical?processes.?Transaminases?are?used? for?production?of?chiral?amines?
(high? value? pharmaceutical? intermediates)? (Savile? et? al.? 2010).? However,? one? class? of? enzymes?
commonly? described? to? have? a? lot? of? potential? for? industrial? biocatalysis? that? remains? particularly?
challenging?to? implement? is?the?enzyme?family?known?as?cytochrome?P450?monooxygenases?(P450s?
or? CYPs).? Cytochrome? P450s? perform? highly? interesting? chemistry? for? industry? but? their? biological?
characteristics?as?described?in?section?1.8?hinders?the?implementation.??
The? conditions? under? which? enzymatic? reactions? are? performed? in? nature? are? usually? at? low?
concentrations? and? controlled?by? inhibition?by? the?product.? This? is?nature’s?way?of? creating?highly?
efficient? catalysts? being? able? to? regulate? cellular? reactions? and? the? implication? is? that? the? KM,? the?
Michaelis?constant,? is?very? low,?describing?that?the?maximum?rate?of?which?an?enzymatic?reaction? is?
being? catalyzed? is? at? low? substrate? concentrations.? Under? physiological? conditions,? the? enzyme?
expression?is?also?upregulated?or?enzymes?broken?down?to?control?the?need?of?this?particular?catalytic?
reaction.?These?conditions?are?very?different? from? the?demands? for? industrial?application,?with?high?
demand?on?catalyst? stability?at?high?concentrations?of? substrate?and?product.?The? reason? for? these?
demands?are?so?that? it? is?possible?to?reach?efficient,?economical?feasible?processes.?Enzymes?can?be?
improved?to?function?better?under?desired?conditions?by?protein?engineering?through?rational?protein?
design,?where?new?mutants?are?created?by?site?directed?mutagenesis,?or?by?directed?evolution,?where?
large?mutant? libraries? are? created?by? random? changes? and?mutants? selected?by?desired?properties?
(Buchholz? et? al.? 2012).? This? has? also? been? implemented? for? P450s? aimed? at? improving? not? only?
selectivity? and? activity? (Seifert?et? al.?2011;? Furuya?et? al.?2012;?Malca?2012),?but?also? screening? for?
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P450s?performing?novel? reactions?or?engineering?P450s? to?perform?novel?reactions? (McIntosh?et?al.?
2014).?
Biocatalyst?formulation?1.3
Biocatalytic?processes?starts?with?a?fermentation?step,?where?the?biocatalyst?is?produced.?The?enzyme?
of? interest? is? typically? overexpressed? in? a? host? cell,? bacterial? or? fungal,? and? depending? on? the?
biocatalyst? formulation?the?process?structure?after?the? initial? fermentation?will?vary.?The?biocatalyst?
can? be? used? as? a?whole? cell,? growing? or? resting,? still?metabolically? active,? or? go? through? further?
formulation? steps.? These? steps? typically? consist? of? a? centrifugation/filtration? step? followed? by? cell?
disruption?(for?intracellular?enzymes)?and?purification?to?the?desired?purity.?The?enzyme?can?then?be?
applied? free,?soluble,? in? the?crudest? form?without?purification? (commonly?called?crude?cell?extract),?
purified?or? immobilized?(by?binding?to?a?carrier,?entrapment? in?matrices?or?by?cross?linking?(Sheldon?
2007)).? ? The? biocatalyst? can? also? be? purchased? in? the? desired? formulation,? and? then? the? initial?
fermentation?and?biocatalyst?processing?steps?are?excluded?from?the?biocatalytic?process.?
Economic?feasibility?1.4
Despite? the? many? advantages? of? biocatalytic? processes? compared? to? chemical? processes,? the?
economic? feasibility? is? of?major? importance? and? is?what?will? determine? if? a? process? finally?will? be?
implemented.? Although? environmental? assessments? are? of? increasing? importance,? the? economic?
assessment? is? still? the? key? factor? that? will? determine? the? fate? of? a? process.? To? guide? required?
biocatalyst? improvement? and? early? process? development,? economic?metrics? can? be? applied? (Table?
1.1).? The? concept? can?be? implemented? at? an? early? stage?of?process?development? to? guide? further?
development,?as?an? in?silico?engineering?approach? (Lima?Ramos?et?al.?2014).?The?metrics?applied? in?
this?thesis?are?reaction?yield,?final?product?concentration,?space?time?yield?(also?known?as?volumetric?
productivity)?and?biocatalyst?yield.?The?demands?on?these?metrics?depend?on?the?area?of?application?
(e.g?fuel?or?pharmaceuticals)?and?market?size.?The?demands?on?all?metrics,?individually?or?combined,?
reflects?different? costs?of? the?process.?However,? the?minimum? threshold?values? for?each? individual?
metrics?must?be?met?to?fulfill?the?demands?of?an?economical?feasible?process.?Reaction?yield?and?final?
product?concentration?can?be?applied?to?biocatalytic?processes?regardless?of?the?operating?mode?and?
23
4?
?
mainly?reflects?the?cost?contribution?from?down?stream?processing?(DSP).?The?difference?in?cost?of?the?
substrate?and?price?of? the?product?gives?a? first? indication?of?demands?on? the? reaction?yield.?Space?
time?yield,?or?productivity,?is?mainly?used?to?guide?the?development?of?growing?cell?processes,?which?
together?with?desired?amount?of?product?to?be?produced,?represents?the?cost?of?the?equipment.?For?a?
resting? cell? process,? this? is? also? of? importance? but? can? be?more? easily? controlled? by? the? catalyst?
concentration?applied? in?the?process.?Biocatalyst?yield? is?applied? to?resting?cell?processes?and?other?
processes?where? the? biocatalytic? reaction? is? performed? independent? from? the? initial? fermentation?
step,?and? reflects? the? cost?of? the?biocatalyst?production? (fermentation?and?biocatalyst?processing).?
Target? values? used? for? an? initial? analysis? of? a? potential? P450? catalyzed? whole?cell? process? are?
presented?in?Table?1.1?and?used?for?the?analyses?performed?in?Chapter?2.????
Table?1.1?Economic?metrics?to?guide?early?development?of?biocatalytic?processes.?
Metric? Mainly?applied?to? Unit? Target?value?
Reaction?yield? Growing?and?resting?cell?processes? %? >90
Final?product?concentration? Growing?and?resting?cell?processes? g/L? 20
Space?time?yield? Growing?cell?processes? g/L/h? 2
Biocatalyst?yield? Resting?cell?processes? g/g?cdw? 10
?
Cytochrome?P450?monooxygenases?1.5
Cytochrome?P450?monooxygenases?are?heme?containing?enzymes?found?in?all?kingdoms?of?life.?They?
are? a? diverse? group? of? enzymes? named? after? the? characteristic? peak? of? the? reduced? CO?bound?
complex?at?450?nm?and? include?more? than?26?000?enzymes? (Nelson?2009).?This?enormous?diversity?
also?implies?that?P450s?are?of?relevance?for?a?broad?range?of?research?fields,?not?least?because?of?their?
involvement? in? human? drug? metabolism? (Rendic? and? Guengerich? 2010;? Gillam? and? Hayes? 2013;?
Martinez?and?Rupashinghe?2013).?However,?in?this?thesis,?the?focus?has?been?on?P450s?with?potential?
for?synthetic?chemical?production?at?industrial?scale.?
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1.5.1 Classification?and?nomenclature?
P450s?are?as?mentioned?above?classified?under?oxidoreductases,?performing?oxidation?and?reduction?
reactions?(EC?1).?The?classification? is?further?divided? into?oxygenases?(introducing?oxygen?atoms? into?
their? substrates),? monooxygenases? (introduces? one? oxygen? atom? into? their? substrate),? external?
monooxygenases?and? finally?P450?monooxygenases? (Figure?1.1).?To?cover?all?P450s,? the?EC?number?
applied?is?1.14.X.Y.????
?
Figure?1.1?Classification?of?P450s?into?EC.?1.14.X.Y?
The?official?nomenclature?for?cytochrome?P450?monooxygenases?is?CYP?followed?by?an?Arabic?number?
representing? the? family? and? a? letter? representing? the? subfamily? and? a? final? Arabic? number?
representing?the?individual?gene?(Nelson?et?al.?1993).?Generally,?the?sequence?identity?within?a?family?
is?>40?%?and?within?mammalian?subfamilies?the?sequence?identity?is?>55?%.?
1.5.2 Chemical?reactions?catalyzed?by?P450s?
P450s? are? in? general? challenging? to? implement? in? industry? and? there? are? few? examples? of? the?
oxidation?of?non?natural?substrates.?Perhaps?surprisingly,?given?the?challenges,?the?scientific?literature?
reports? that? cytochrome? P450? monooxygenases? are? potentially? amongst? the? most? useful? of? all?
enzymes?to?exploit?as?industrial?biocatalysts?since?they?possess?the?ability?to?catalyze?the?oxidation?of?
non?activated? hydrocarbons? in? a? stereoselective? manner,? including? large? molecules? such? as? e.g.?
Oxidoreductases
Oxygenases?
Monooxygenases
External?
monooxygenases
P450?
monooxygenases
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steroids,?also?exemplified?in?Chapter?4?(De?Montellano?2005;?Julsing?et?al.?2008;?Schulz?et?al.?2012).?A?
general?reaction?scheme? is?shown? in?Scheme?1.1?and?examples?of?possible?reactions?types? in?Figure?
1.2,?selected? from?Sono?et?al.? (1996).?The?first?hydroxylation?can?also?enable?further?oxidations?and?
other? chemical? reactions? as? summarized? by? Bernhardt? and? Urlacher? (2014).?More? unusual? P450?
catalyzed? reactions?have? also?been? summarized? in? a? recent? review? (Guengerich? and?Munro?2013).?
Interestingly,? this? selective? chemistry? is? hard? to? achieve? by? conventional? chemical? routes? since?
heterogeneous? catalysis? and? organometallic? activation? suffer? from? side? reactions? and? other?
drawbacks? such? as? high? temperature? operation? (Labinger? 2004).? In? fact,? the? selectivity? of? these?
enzymes? far? outcompetes? their? chemical? counterparts,? but? it? is? their? productivity?which? has? been?
found? limiting.? The? lack? of? obvious? competing? chemical? processes? should,? therefore,? make? the?
biocatalytic? (P450?based)? processes? economically? interesting.? However,? for? products? without?
competitive? chemical? processes,? the?market? price? of? the? intended? products? can? be? a? challenge? to?
determine?and?will?be?further?elaborated?on?in?the?discussion?in?Chapter?6.?
?
Scheme?1.1?General?reaction?scheme?for?a?P450?catalyzed?reaction.?
?
?
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Figure?1.2?Example?of?reactions?performed?by?P450s.?A:?hydroxylation?of?hydrocarbons?exemplified?by?
activation? of? sp3? hybridized? carbons,? B:? epoxidation? of? carbon? carbon? double? bonds,? C:? aromatic?
hydroxylation,?D:?Dealkylation.?Reactions?selected?from?Sono?et?al.?(1996)?and?picture?modified?from?
O'Reilly?et?al.?(2011).?
1.5.3 Biological?characteristics?
The?main?biological?characteristics?of?cytochrome?P450?enzymes?are?the?heme?prosthetic?group,?the?
requirement? for? a? nicotinamide? cofactor? and? the? corresponding? electron? transfer? proteins?
(reductases).? ?P450s?are?mainly?dependent?on?NADPH,?although?NADH? is?also?used?by?some?classes.?
P450s?are?divided?into?classes?depending?on?the?nature?of?the?redox?partner.?The?catalytically?active?
complex?can?be?a?one?component?system,?where?the?redox?partner?is?fused?to?the?monooxygenase,?or?
two?or?three?components?(Figure?1.3).?P450s?have?been?divided?into?10?classes?dependent?upon?the?
electron?transport?chain?in?a?given?case?(Hannemann?et?al.?2007)?and?can?be?classified?into?one?(class?
VII,?VIII,?IX?and?X),?two?(class?II,?V?and?VI)?and?three?(class?I,?III?and?IV)?component?systems?(Urlacher?
and?Girhard?2012).?Furthermore,?P450s?can?be?soluble?or?membrane?bound?proteins,?the?latter?more?
common?among?mammalian?enzymes.??
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Figure?1.3? Illustration?of?A:?three?protein?systems? (e.g.?class? I),?B:?two?protein?systems? (e.g.?class? II)?
and?C:?one?protein?systems?(e.g.?class?VIII).?(Structures?based?on?PDB?code?1Q1R,?1PDX,?2ZWT;?1JAO,?
1F4U;?4DQK,?1BVY).?Picture?modified?from?Urlacher?and?Girhard?(2012).?
Additionally? to? the?biological? characteristics?described?above,? relatively? low?activity?and? stability?of?
P450s? makes? a? whole? cell? the? preferred? biocatalyst? formulation.? Whole?cell? systems? provide? a?
cofactor?regeneration?system,?possible?co?expression?of?redox?partners?and?a?protected?environment?
to? enhance? the? stability? of? the? biocatalyst.? Furthermore,? a? whole?cell? biocatalyst? is? considerably?
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cheaper?than?the?isolated?or?immobilized?enzyme,?if?the?extra?cost?for?catalyst?formulation?cannot?be?
justified?by?catalyst?recycle?(Tufvesson?et?al.?2011).?
Scope?of?the?thesis?1.6
The?main? goal? of? this? thesis? is? to? identify? and? address? bottlenecks? for?whole?cell? P450? catalyzed?
processes?to?enable?industrial?implementation.?Although?P450s?perform?challenging?chemistry?from?a?
traditional? chemical? perspective,? hydroxylation? of? non?activated? hydrocarbons,? there? are? many?
challenges?with?the?industrial?application?of?this?class?of?enzymes.?The?biological?nature?of?the?enzyme?
is?by?itself?associated?with?many?limitations?for?this?area?of?application.??
Layout?of?the?thesis?1.7
As?a? start?of? this? thesis,? the?potential?of?P450s? for?application? in?biocatalytic?processes?have?been?
summarized?with? the?basis?of?published? literature?and?demands?on?an?economical? feasible?process?
(Chapter? 2).? The? identified? limitations? have? then? been? experimentally? confirmed? using? two?model?
systems?(Chapters?3?and?4).?The?first?one? is?a?P450?(CYP153A)?fused?to?a?reductase?forming?a? larger?
protein?and?expressed?in?the?most?common?bacterial?host?used?in?research,?Escherichia?coli?(Chapter?
3).?The?second?model?system?used?consists?of?an?overexpressed?P450?(CYP106A2)?in?another?bacterial?
host,?Bacillus?megaterium?(Chapter?4).?The?gained?experiences?from?primarily?the?first?model?system?
(CYP153A?expressed?in?E.?coli)?were?subsequently?applied?to?a?third?model?system?and?the?knowledge?
was?transferred?to?Lonza?Chemie?AG?(Chapter?5?and?Appendix?1).?Based?on?this?work?a?process?model?
was?built? in? the?program?SuperPro?Designer? to?generate?a?cost?model?guiding? further?development?
(Chapter? 5).? The? thesis? is? finally? concluded? with? a? general? discussion,? conclusions? and?
recommendations?for?future?work.?
?
? ?
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2 Potential?of?P450?catalyzed?processes?
The? first? part? of? the? thesis? has? been? to? identify? opportunities? and? limitations? for?whole?cell? P450?
based?processes.?Published?literature?has?been?summarized?and?put?in?perspective?of?demands?on?an?
economically?feasible,?industrially?suitable?P450?catalyzed?whole?cell?process.?This?chapter?is?based?in?
large?part?on?our?review?paper?published?in?Applied?Microbiology?and?Biotechnology?(Paper?I).?
In? the? last? few? years? alone,? several? reviews? have? been? published? covering?many? aspects? of? the?
cytochrome?P450?family?and?their?potential? in?biotechnology,?and?the?chemical??and?pharmaceutical?
industry?(O'Reilly?et?al.?2011;?Urlacher?and?Girhard?2012;?Grogan?2011;?Julsing?et?al.?2008;?Jung?et?al.?
2011).? The?most? recent? review? by? Bernhardt? and?Urlacher? (2014)? is? an? excellent? summary? of? the?
progress?made?within?P450? research? for?biotechnological?applications.?Hence,? the?objective?of? this?
chapter?is?to?take?this?one?step?further?and?present?an?analysis?of?improvements?that?can?be?made?to?
whole?cell?cytochrome?P450?monooxygenases?systems,?using?both?biological?and?process?engineering?
tools,? to? enable? industrial? implementation? of? economically? feasible? P450? catalyzed? production? of?
chemicals?and?pharmaceuticals.?Important?steps?will?be?discussed?from?a?process?perspective?with?the?
intention?of?bridging? the?gap?between? the?extensive?molecular?biology? research?within? the? field?of?
P450s?and?future?process? implementation.?The? intention? is?to? identify?areas?where?more?research? is?
needed?and?to?guide?efforts?aimed?at?developing?a?process?for?this?group?of?catalysts,?which?has?more?
biological? than?chemical?challenges?compared?to?many?other?biocatalytic?processes.?This? is?done?by?
identifying?bottlenecks,?divided? into? catalyst,? reaction?or?process? related?parameters?preventing?us?
from?reaching?the?process?targets.?
Toward?processes?for?P450?based?systems?2.1
2.1.1 Whole?cell?processes?
In?whole?cell?processes,?the?host?plays?a?crucial?role?in?the?overall?process?structure?and?this?has?been?
emphasized? in? an? excellent? recent? review? by? Schrewe? and? co?workers? (Schrewe? et? al.? 2013).?
Exploration? of? recombinant? prokaryotic? and? eukaryotic? expression? systems? is? a? key? step? toward?
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industrial?implementation?of?such?biocatalysts.?However,?a?heterologous?recombinant?host?might?not?
be?superior?to?the?natural?P450?expression?host?and?high?expression? levels? in?the?natural?host?have?
been? suggested? to? improve? the? performance.? The? specific? activity? of? the? alkane?monooxygenase?
component?AlkB?was?e.g.? reported? to?be? five? to? six? times?higher? in? the?natural?host?P.?oleovorans?
compared?to?E.?coli?(Staijen?et?al.?2000).?Despite?the?possible?overexpression?in?E.?coli?(2?10?fold),?this?
did? not? compensate? for? the? lower? activity.? Indeed? those? processes?which? have? reached? industrial?
maturity? mainly? utilize? native? microorganisms? (Liese? et? al.? 2006).? There? are,? however,? some?
exceptions? such? as? the? impressive? synthetic? biology?work? of? an? entire? pathway,? including? P450s,?
leading? to? production? of? artemisinic? acid,? a? precursor? to? the? antimalarial? artemisinin,? by?
Saccharomyces?cerevisiae?with?a?product?concentration?of?25?g/L?(Paddon?et?al.?2013).?This?work?was?
funded?by?Bill?and?Melinda?Gates?Foundation?and?the?drug? is?being?sold?on?a?non?profit?basis.?Even?
though?the?result?is?very?inspiring,?for?commercial?products?in?general?the?development?cost?has?to?be?
accounted?for?in?the?overall?performance.?Another?engineered?pathway?including?several?P450s?from?
higher?eukaryotes?with?glucose/ethanol?as?a?substrate?in?Saccharomyces?cerevisiae?was?developed?for?
the?production?of?progesterone?and? later?hydrocortisone?(Szczebara?et?al.?2003;?Duport?et?al.?1998).?
The?reported?product?concentrations?are,?however,?in?the?mg/L?scale.?Metabolic?pathway?engineering?
has?also?been?applied? in?Escherichia?coli? for?production?of?precursors? in? the?synthesis?of?anticancer?
drug?taxol?where?a?plant?P450? is? involved? in?the?next?step?producing?taxadien?5??ol?(Ajikumar?et?al.?
2010).?However,?the?P450?catalyzed?reaction?was?shown?to?be?the?limiting?step?in?the?engineered?host?
and? a? titer? of? 60?mg/L?was? achieved.? Besides? native? hosts? such? as? Bacillus? sp.? (Bleif? et? al.? 2012),?
Pseudomonas?sp.? (Kuhn?et?al.?2012),?Streptomyces?sp.? (Park?et?al.?2003)?as?well?as?several?different?
yeast?strains?(Saccharomyces?cerevisiae?(Szczebara?et?al.?2003),?Schizosaccharomyces?pombe?(Dr?gan?
et?al.?2011),?Pichia?pastoris?(Kolar?et?al.?2007),?Yarrowia?lipolytica?(Nthangeni?et?al.?2004))?non?natural?
P450?expressing?hosts?exemplified?by?recombinant?E.?coli?have?been?used?as?expression?systems?for?
P450s?(Scheps?et?al.?2011;?Zhang?et?al.?2010).?E.?coli?lacks?intrinsic?P450?genes?and?heme?proteins,?and?
hence? might? require? addition? of? the? heme?precursor? (??aminolevulinic? acid),? whereas? the? yeast?
strains?to?varying?extent?have?their?own?P450?expression?systems?(as?well?as?an? internal?membrane?
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system)? simplifying? the?expression?of?eukaryotic?membrane?bound?P450s?even? though? this? can?be?
achieved?also?in?E.?coli?(Richardson?et?al.?1995).???
In? addition? to? selection?of? the?host? cell,? the?operating?mode? is? also? important? for? the?process? (as?
illustrated? in? Figure? 2.1).? Two? options? are? possible.? In? the? simpler? approach,? growing? cells? (where?
fermentation? and? biocatalysis? are? performed? simultaneously)? is? used.? Alternatively,? resting? cells?
(where?fermentation?and?biocatalysis?can?be?optimized?independently)?enables?different?possibilities?
for?process? improvement.?Previously,?the?choice?of?biocatalyst?form?from?a?process?perspective?was?
discussed,?and? it?was?concluded? that?decisions?need? to?be?made?on?a?case?by?case?basis? (Woodley?
2006;?Wohlgemuth?and?Woodley?2010).??
?
?
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Figure?2.1?a)?Fermentation?and?conversion?performed?in?one?step?with?growing?cells.?b)?Fermentation?
and? conversion?are? separated?by? centrifugation? (or? filtration)?enabling?optimum? conditions? for? the?
fermentation?and?conversion?and?use?of?the?cells?in?a?resting?state.?The?proposed?figures?assume?that?
the?product? is?present? in?the?media?or?buffer?and?not?associated?with?the?cells.?DSP?–?Downstream?
processing.?
2.1.2 Economic?metrics?
The?economic?potential?of?a?biocatalytic?process?can?be?described?using?metrics? (Lima?Ramos?et?al.?
2014;? Van? Dien? 2013).? Demands? on? reaction? yield? (g? product/g? substrate)? and? final? product?
concentration?(g/L)?can?be?applied?regardless?the?operating?mode.?Space?time?yield?(g?product/L/h)?is,?
however,?more? important? to? growing? cell? processes? in? line?with? fermentative? production? of? bulk?
chemicals? (Oudshoorn?et?al.?2010),?although?with?more? flexible? threshold?values?due? to? the?higher?
product?value.?Besides?the?final?product?concentration,? important?for?downstream?processing?(DSP),?
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the?cost?of?the?equipment?required?to?reach?desired?amounts?of?product? is?an? important?factor? in?a?
one?pot?growing?cell?process.?This?cost?is?best?translated?to?demands?on?space?time?yield.?For?scaling?
of?a?process,?the?space?time?yield?also?plays?a?role?in?a?resting?cell?process.?For?a?resting?cell?processes?
(and? for? processes? where? further? biocatalyst? processing? is? used)? biocatalyst? yield? (g? product/g?
catalyst)?is?applied?instead.?This?metric?represents?the?total?amount?of?product?that?can?be?produced?
by?the?catalyst,?similar?to?a?total?turnover?number.?The?biocatalyst?yield?reflects?the?cost?contribution?
of?the?catalyst?itself?and?the?target?value?is?influenced?by?the?final?cell?density?and?protein?expression?
of? the? fermentation?process.?Catalyst? recycle? is?one?approach? to? improve? the?biocatalyst?yield.?The?
requirements?for?all?metrics?are?dependent?upon?the?product?application?and?market?size.?The?value?
added?by?the?process?is?determined?by?the?selling?price?of?the?product?multiplied?by?the?reaction?yield?
minus?the?cost?of?the?substrate.?Before?considering?process?development,?a?reaction?yield?above?90?%?
is?recommended?to?be?able?to?reach?the?economic?targets.?The?reason?is?that?the?similar?properties?of?
substrate?and?product?make?DSP?difficult.?The?reaction?yield?is?determined?not?only?by?the?substrate?
concentration? but? also? by? the? specificity? of? the? enzyme.?Overoxidation? by? the? P450? of? interest? or?
other? pathways? in? the? cell? as?well? as? oxidation? by? other? P450s?will? influence? the? product? profile.?
Byproducts?will?strongly?contribute?to?more?challenging?DSP?due?to?very?similar?properties?of?many?
unwanted?byproducts?compared?to?the?target?molecule.?Although?a?reaction?yield?above?90?%?has?not?
been?achieved?for?all?whole?cell?processes?summarized?later?in?this?chapter,?there?are?examples?from?
a?resting?(Fujii?et?al.?2009)?and?growing?cell?process?(Kleser?et?al.?2012).?Furthermore,?it?is?important?to?
minimize?byproduct?formation?enabling?efficient?utilization?of?the?whole?cell?in?terms?of?e.g.?cofactor?
availability?(further?discussed?below).?Reasonable?target?values?for?product?concentration?is?above?20?
g/L? and? space?time? yield? around? 2? g/L/h? (growing? cells)? and? these? numbers? are? also? fulfilled? in?
successfully? implemented? industrial? biocatalytic? processes? (Straathof? et? al.? 2002;?Oudshoorn? et? al.?
2010;?Van?Dien?2013).?For?a?resting?cell?process,?with?potential?additional?biocatalyst?processing?step?
and? recycle,? a? target? value? for? the?biocatalyst? yield? for?pharmaceuticals?or?high? value? chemicals? is?
around? 10? g/g? cell? dry?weight? (g/g? cdw).? Each?metric? reflects? demands? on? different? steps? of? the?
process,?and?in?the?case?of?hydroxylation?reactions?by?P450s?the?required?reaction?yield?is?expected?to?
influence?the?DSP?cost?to?a?higher?extent?than?in?other?processes?due?to?very?similar?properties?of?the?
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substrate?and?product.?Typical?DSP?depends?on?the?product?localization,?if?the?product?is?accumulated?
inside?or?attached?to?the?cells?or?soluble?in?the?media,?determining?if?the?cells?need?to?be?separated?or?
disrupted.? Extraction? by? organic? solvents? and? further? purification? is? a? possible? scheme? and? also?
enables?the?DSP?to?be?retrofitted?to?an?existing?chemical?plant.??
In? Table? 2.1,? the? typical? parameters? relevant? for? whole?cell? P450? catalyzed? reactions,? divided? in?
biocatalyst? related? parameters,? substrate? and? product? related? parameters? and? process? related?
parameters,?are?shown?and?what?metric? they?primarily? influence.? It?should?be?emphasized? that? the?
targets?defined? for?each?metric?need? to?be? fulfilled? for?an?economical?viable?process.?Furthermore?
some? of? the? parameters? are? intrinsic? to? the? relevant? system? and? thereby? set? constraints? for? the?
process.?
? ?
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Table?2.1?Typical?biocatalytic?,?substrate?and?product??and?process?related?parameters?relevant?for?a?
whole?cell?P450?catalyzed?reaction?and?what?metric?they?primarily?influence.?a?The?toxicity?to?a?cell?is?
considered?to?be?irreversible?and?thereby?primarily?influence?biocatalyst?yield?and?final?product?
concentration?whereas?b?inhibition?to?the?enzyme?can?be?both?reversible?and?irreversable?and?can?
thereby?also?affect?the?space?time?yield.?Units?for?the?metrics:?c?total?amount?of?product?produced?per?
gram?cell?dry?weight?(g/g?cdw),?d?final?product?concentration?in?the?reaction?media?(g/L),?e?amount?of?
product?per?amount?of?substrate?(g/g),?f?amount?of?product?produced?per?volume?of?reaction?media?
per?time?(g/L/h).?
PARAMETER? METRIC?
Biocatalyst?
yieldc ??????????
(g/g?cdw)?
Final?product?
concentrationd?
(g/L)?
Reaction?
yielde??
(g/g)?
Space?time?
yieldf?(g/L/h)?
Biocatalyst?
related?
parameters?
Specific?
activity??
(U/g?cdw)?
Fermentation?cell?density??
(g?cdw/L)? ?? ?? ?? X?
Enzyme?expression??
(nmol/g?cdw)? X? ?? ?? ??
Enzyme?activity?(s?1)? ?? ?? ?? X?
Cofactor?regeneration?
(μmol/min/g?cdw)? ?? ?? ?? X?
Electron?transport?(s?1)? ?? ?? ?? X?
Coupling?efficiency?(%) X?
Stability?
Cell?(h)? X? X? ?? ??
Monooxygenase?(TTN?or?h)? X? X? ?? ??
Reductase?(TTN?or?h) X X ??
Cofactor?(TTN?or?h)? X? X? ?? ??
Substrate?and?product?related?
parameters?
Transport?across?membrane??
(μmol/min/g?cdw)? ?? X
Solubility?(g/L)? ?? X? ?? ??
Toxicitya?(g/L)?or?(g/g?cdw)? X? X? ?? ??
Inhibitionb?(g/L)?or??
(g/mol?P450)? X? X? ?? ?X?
Process?related?parameters?
Oxygen?(mol/L/h)? ?? ?? ?? X?
Transport?between?phases?
(g/L/h)? ?? ?? ?? X?
?
Economic? assessments? regarding? catalyst? production? for? application? in? processes? where? the?
biocatalytic?reaction?is?separated?from?the?fermentation?step?have?been?made?and?these?assumptions?
can? be? translated? to? biocatalyst? yield? targets? of? at? least? 10? g? product/g? dry? cell? weight? for?
pharmaceuticals? and? significantly? higher? numbers? for? lower? value? bulk? chemicals? (Tufvesson? et? al.?
37
18?
?
2011).?This?was?calculated?on?a?base?case?with?a?protein?expression?of?6.25?g/L?and?a?cell?titer?of?50?g?
cdw/L.?To?put?these?numbers?into?perspective?the?highest?reported?expression?of?functional?P450s?to?
our?knowledge?is?1.5?g/L?with?a?cell?titer?of?13?g?cdw/L?(Pflug?et?al.?2007).?To?reach?the?target?product?
concentration?of?20?g/L,?a?specific?activity?of?7?μmol?substrate?converted?per?gram?cell?dry?weight?per?
minute? (U/g? cdw)?would? be? required.? These? calculations? are? based? on? numbers? from? Pflug? et? al.?
(2007)?(13?g?cdw/L,?a?molecular?weight?of?the?substrate,?p?nitrophenoxydodecanoic?acid,?of?138?g/mol?
and?product?of?154?g/mol)? for?a?24?h?process?with?constant?activity.?Doing?similar?calculation? for?a?
growing?cell?process?based?on?a?space?time?yield?requirement?of?2?g/L/h,?the?required?specific?activity?
would?be?17?U/g?cdw.?Specific?activities?in?this?range?have?been?reported?and?are?not?unrealistic.?For?a?
resting?cell?process,?without?cell?recycling,?10?g/g?cdw?corresponds?to?45?U/g?cdw,?indicating?that?cell?
recycle?might?be?necessary?to?cover?the?extra?cost?contribution?from?the?biocatalyst?processing?step?
(filtration? or? centrifugation? and?washing? in? case? of? whole? cells).? However,? to? assume? a? constant?
activity?over?24?h?is?not?really?realistic?in?the?case?of?P450s.?Several?challenges?to?achieve?the?required?
targets?for?each?metric?can?be?expected?and?in?the?following?sections?this?will?be?discussed?along?with?
possible?solutions,?already?summarized? in?Table?2.2.?Table?2.1?and?Table?2.2?have?the?same?basis?to?
simplify?the?correlation?between?parameters?influencing?the?reaction?and?tools?to?improve?the?system?
in?order?to?reach?a?target?metric?in?the?end.?
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In? order? to? identify? and? summarize? where? the? P450? research? stands? in? relation? to? the? defined?
guidelines?above,?selected?growing?and?resting?whole?cell?processes?have?been?summarized?and?are?
presented? in? Figure? 2.2.? The? best?performance? among? the? processes,? in? relation? to? the? presented?
targets,? is? found?using? an?unspecified?P450? in? a? growing?natural?P450?expressing?mutant? strain?of?
Candida? tropicalis.? This? uncharacterized? P450? is? converting? n?tridecane? to? the? corresponding?
dicarboxylic? acid? in? a? batch? process?where? fermentation? and? conversion?were? separated? into? two?
steps,?although?in?the?same?fermenter?(Liu?et?al.?2004).?A?step?wise?addition?of?alkane?and?optimized?
pH?profile,?by?gradual?increase?during?the?production?phase,?were?applied?to?the?process.?The?process?
performance?is?in?the?same?order?of?magnitude?regarding?space?time?yield?and?product?concentration?
as?the?minimum?guideline?for?pharmaceutical?processes,?while?other?processes?are?almost?two?orders?
of?magnitude?behind.?As?can?be?seen? in?Figure?2.2,?the?resting?cell?processes?are?further?away?from?
the? target,? expressed? as? biocatalyst? yield,? compared? to? the? growing? cells? where? the? target? is?
represented?as?space?time?yield.?The?main?reason?for?this?is?that?the?catalyst?is?rarely?reused?in?P450?
catalyzed? processes,?which?would? be? required? to? cover? the? extra? cost? arising? from? the? additional?
biocatalyst? processing? step? (centrifugation? or? filtration).? In? lab? processes? cell? recycle? is? scarcely?
considered? and? as?mentioned,? in? industrially? implemented? processes,? growing? cells? has? been? the?
preferred?operating?mode.??
?
?
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Figure?2.2?Left:?Published?growing?P450?whole?cell?processes?presented?as?space?time?yield?vs?product?
concentrations.?Right:?Resting?P450?whole?cell?processes?presented? as?biocatalyst? yield? vs?product?
concentration.???represents?reac?ons?performed? in?bioreactors?and???represents?shake?flask?or?test?
tube?processes.? (Growing?cells? in? this? figure?defined?as?processes?performed? in?one?pot?and?space?
time?yields?calculated?on?entire?process?time.)?
A?whole?cell?system?is?a?complex?machinery?and?is?dependent?on?the?environment,?e.g.?the?availability?
of? cofactor? for? the? desired? biocatalytic? reaction? and? the? oxygen? consumption? by? the? resting? cell?
strongly?depends?on?the?state?of?the?cell.?Therefore,?it?is?hard?to?generalize?and?immediately?present?
required?parameters?that?need?to?be?fulfilled.?To?be?able?to?make?reasonable?calculations?and?guide?
the?catalyst?development?in?the?field,?some?assumptions?need?to?be?made?to?be?able?to?convert?e.g.?
specific?activity?(U/g?cdw)?to?a?space?time?yield?expressed?in?g/L/h.?Furthermore,?in?order?to?correlate?
activities?achieved?in?short?enzymatic?assays?(e.g.?using?p?nitrophenoxydodecanoic?acid)?to?reactions?
with? a? different? substrate? in? whole?cell? systems? is? not? straightforward? and? depends? on? several?
parameters.?In?the?case?of???pinene?oxyfunctionalization?by?a?BM3?quintiple?mutant,?the?in?vitro?assay?
above?showed?a?kcat?of?0.7?s?1?and?the?corresponding?value?for?the?non?natural?substrate???pinene?in?a?
whole?cell?with?heterologous? cofactor? regeneration?was?0.17,? representing?a? fourfold?difference? in?
favor?of?the?in?vitro?assay?(Schewe?et?al.?2008).?On?the?other?hand,?a?more?accurate?comparison?using?
the?same?substrate?in?vitro?and?in?vivo,?shows?the?opposite?trend?meaning?higher?specific?activities?for?
the?in?vivo?systems?(2.9?fold?for?(S)?limonene?hydroxylation?by?CYP153A6?and?3.9?fold?for?epoxidation?
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of?1?hexene?by?CYP102A1?F87V)?indicating?that?the? intact?cell?provides?a?better?environment?for?the?
enzyme?(Cornelissen?et?al.?2011;?Siriphongphaew?et?al.?2012).?
Improving? specific? activity? to? give? increased? space?time? yield? (g/L/h)? or?2.2
biocatalyst?yield?(g/g?biocatalyst)?
The?specific?activity,?expressed?as?U/g?cdw,?is?affecting?the?space?time?yield?(g/L/h)?for?a?growing?cell?
process?and?the?biocatalyst?yield?(g/g?cdw)?for?a?resting?cell?process.?There?are?two?main?factors?that?
contribute?to?the?specific?activity:?enzyme?expression?(mol?P450/g?cdw)?and?enzyme?activity,?kcat?(s?1,?
turnover? per? active? site? and? second).? However,? an? increased? enzyme? activity? in? vitro? does? not?
necessarily?translate?directly?to?corresponding?activity? in?vivo?due? to?the?many? factors? influencing?a?
P450?catalyzed?reaction?such?as?cofactor?supply,?electron?transport?and?proximity?and?stability?of?the?
catalytic?components.?
2.2.1 Fermentation?cell?density,?enzyme?expression?and?host?cell?physiology?
The? fermentation? performance? is,? as? discussed? earlier,? of? key? importance? for? the? economy?of? the?
process,?especially? in? the?case?of?resting?cells.?To? lower? the?cost?contribution?of? the?catalyst? it? is?of?
special?importance?to?reach?reasonable?cell?densities?in?the?fermentation?process.?When?the?guideline?
for?biocatalyst?yield?(g/g?cdw)?was?calculated?a?base?case?density?of?50?g?cdw/L?was?assumed?which?is?
reasonable?for?a?fed?batch?fermentation?process?(Tufvesson?et?al.?2011).?Overexpression?of?proteins?
constitutes?a?burden? to? the?host? cell?and? for?P450?expression,?heme?depletion?has?been? shown? to?
cause? a?major? stress? (Michener? et? al.? 2012).? In? a? reasonably? successful? fermentation? process,? an?
overexpressed?protein?content?of?12.5?%?of?the?cell?dry?weight?can?be?assumed?(Tufvesson?et?al.?2011)?
and?when? expressing? CYP102A1? in? E.? coli? similar? values? (11?%)?were? reported? (Pflug? et? al.? 2007).?
Dependent?on? the? requirement?of?overexpression?of?electron? transfer?proteins? in?a?given?case,? this?
gives?different?potential?for?expression?of?the?P450?itself?and?might?limit?the?total?potential?activity?of?
the?cell? (specific?activity).?This?has?been?exemplified?by?Schewe?and?coworkers?when?co?expressing?
glucose?facilitator?and?dehydrogenase?and?achieving?comparable?product?concentrations?with?half?the?
P450?expression?(Schewe?et?al.?2009).?
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Cell?physiology?has?in?several?cases?been?shown?to?have?a?crucial?impact?on?the?reaction?performance.?
By?changing? the?host?strain? from?P.?putida?GPo12? to?P.?putida?KT2440?and? the?carbon?source? from?
octane? to? citrate?a? six?fold? improved?productivity? (g/L/h)?was?achieved? in? the?hydroxylation?of? (S)?
limonene? to? (S)?perillyl?alcohol? (Cornelissen?et?al.?2011).?Further?work?on? the?same?system?showed?
the?importance?of?host?background?for?the?formation?of?byproducts?which?were?decreased?from?26?to?
8?%?by?changing?host?again?to?E.?coli?W3110?(Cornelissen?et?al.?2013).?Metabolic?engineering?of?the?
host?cell?can?also? influence? the?performance?of? the?whole?cell? system?as? indicated?by?an? improved?
product?per?glucose?yield? from?0.5?to?1.71? (mol/mol),?as?a?result?of?more?efficient?utilization?of?the?
cofactor?and? increased? specific?activity? from?9?U/g? cdw? to?26?U/g? cdw? in?a? resting? cell?biocatalytic?
conversion? of? propane? to? propanol? (Fasan? et? al.? 2011).? In? a? growing? NADPH? dependent? styrene?
epoxidation? on? the? other? hand,? the? cofactor? availability? limited? the? reaction? above? 21? U/g? cdw,?
probably? due? to? increased? consumption? of? glucose? by? stress? induced? processes? and?NADPH? being?
used? inefficiently?by? the?enzyme? (Bühler?et?al.?2008)? suggesting?metabolic?engineering? to? increase?
redox? biocatalysis.? This? supports? the? fact? that? synthesis? and? presence? of? active? NADPH? decrease?
growth?yields,?reduce?growth?rate?and?metabolic?activity?(Bühler?et?al.?2006).?
Direct?comparisons?of?growing?and?resting?processes?are?not?straight?forward.?First,?the?basis?of?the?
comparison? needs? to? be? determined,? e.g.? the? cost? driving?metric? in? a? specific? case? needs? to? be?
identified.?Second,?the?catalyst?concentration? in?a?growing?cell?process?will?vary?and? in?a?resting?cell?
process? the? chosen? catalyst? concentration? will? influence? space?time? yield? and? final? product?
concentration? and? is? an? important? factor? in? the? comparison.?Not?many? examples? can? be? found? in?
literature? where? direct? comparisons? based? on? process? performance? have? been? done? and? the?
operating?mode?has?a?big?influence?on?process?design?and?should?be?investigated?further.?Despite?this,?
in? an? attempt? to? compare? the? two? operating? modes,? E.? coli? overexpressing? NADPH? dependent?
cyclohexanone?monooxygenase? for?production?of? caprolactone?using?a? resting? cell?process? showed?
20?fold?higher?space?time?yields?(0.79?g/L/h?over?10?h)?compared?to?growing?cells,?although? it?could?
be?explained?by?different?cell?concentrations?and?the?specific?activity?of?the?growing?cells?were?higher?
than?the?resting?cells?(Walton?and?Stewart?2002;?Walton?and?Stewart?2004).?The?main?limitation?was?
shown?to?be?stability?of?the?monooxygenase?and?substrate?transport?across?the?cell?membrane.?It?was?
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also?shown?that?glucose?fed?non?growing?cells?were?not?limited?by?cofactor?regeneration?(intracellular?
NADPH?concentration?after?12?h?reaction?was?180?μM).?On?the?other?hand,?E.?coli?W3110?growing?in?
the?presence?of?yeast?extract?were?shown?to?be?more?resistant?to?n?octane?compared?to?resting?cells?
without?yeast?extract?and?this? lead?to?a?five?fold? increase?of?the?final?product?concentration?(Favre?
Bulle?and?Witholt?1992).? It?has?also?been?suggested? that?resting?cells?are?more?sensitive?to?product?
inhibition?compared?to?growing?cells?in?styrene?oxidation?(Julsing?et?al.?2012).???
2.2.2 Enzyme?activity?
The?highest? activity? reported? to?our? knowledge? is?363? s?1? reached?by? a?one? component?CYP102A1?
mutant? (Eiben?et?al.?2006).?However,?this?number? is?outstanding?and?reported?activities?above?1?s?1?
are?scarce?with?the?exception?of?BM3?and?P450cam?systems,?which?are?the?most?explored?P450s,?and?
a?few?other?one?component?systems?(P450nor?and?reductase?independent?eukaryotic?systems)(search?
on?BRENDA?2012?08)? (Scheer?et?al.?2011).? In?order? to? reach? the? lowest? target? for?pharmaceuticals,?
specified?above,?of?10?g?product/?g?dry?cell?weight,?assuming?an?expression?of?11?%?enzyme?per?g?cdw?
and?a?cell?density?of?13?g/L,?a?molecular?weight?of?the?enzyme?of?118?kDa?and?a?molecular?mass?of?the?
product?of?154?g/mol?(numbers?taken? from?Pflug?et?al.? (2007)),?the?required?turnover?number?for?a?
process? lasting?24?h? (without?cell? recycling)?would?be? less? than?1?s?1.?This? implies? that? the?activities?
reached?for?most?systems?are?in?the?range?of?activities?required?for?a?successful?industrial?process?and?
specially?the?P450?systems?in?four?families?(CYP102,?CYP101?and?P450nor?and?independent?eukaryotic?
systems).?The?enzyme?activity?can? furthermore?be? improved?by?directed?evolution?and?site?directed?
mutagenesis? and? the? extensive? work? done? with? the? most? explored? P450,? P450? BM3,? has? been?
summarized?up?to?June?2011?in?a?review?by?Whitehouse?and?colleagues?(Whitehouse?et?al.?2012).?In?
general,?these?techniques?have?evolved?extensively? in?recent?years?and?a?10?fold? (or?even?100?fold)?
improvement?of?the?enzyme?activity?is?reasonable?to?achieve?(Malca?2012;?Lewis?and?Arnold?2009).?To?
achieve?the?same? improved?performance?of?the?enzyme? in?a?whole?cell?system?as?achieved? in?vitro,?
the?enzyme?activity?would?have?to?be?the? limiting?factor.?However,?this? is,?according?to?calculations?
above,?not?the?case?as?long?as?the?assumed?stability?is?fulfilled?and,?therefore,?a?direct?translation?of?
rates?between?in?vitro?and?in?vivo?is?only?valid?when?no?other?limitations?are?present.?
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2.2.3 Cofactor?regeneration?
In?theory,?cofactor?regeneration?for?redox?catalysis?of?metabolically?active?cells?has?been?calculated?to?
be? in? the? range? of? 500?1000? U/g? cdw? (Duetz? et? al.? 2001;?Meyer? et? al.? 2006;? Blank? et? al.? 2008).?
However,? in? practice,? maximum? specific? activities? for? oxygenases? (although? not? P450?
monooxygenases)?achieved?in?whole?cells?are?around?200?U/g?cdw?(Bühler?and?Schmid?2004)?and?the?
cofactor?regeneration?has?in?several?cases?been?shown?to?limit?the?activity.?Cellular?processes?such?as?
increased? maintenance? demand? of? the? cell? under? biocatalytic? conditions? as? well? as? byproduct?
formation?and?uncoupling?(discussed?in?the?following?section)?can?be?part?of?the?explanation?why?the?
theoretical?value?has?not?been?reached.?Furthermore,?growing?cells? tend?to?utilize? the?cofactors? for?
better?growth? rather? than? the?desired?biocatalytic? reaction? implying? that? resting?cells?would?be? the?
better?operating?mode?from?this?point?of?view.?In?order?to?avoid?the?need?for?addition?of?the?required?
cofactor? in? stoichiometric? concentrations,? which? would? make? any? process? uneconomic,? several?
regeneration? approaches? have? been? developed.? Heterologous? coexpression? of? e.g.? glucose?
dehydrogenase?(NADPH),? improving?the?specific?activity?from?0.39?to?3.59?U/g?cdw?and?0.96?to?1.47?
U/g? cdw? respectively? (Schewe?et?al.?2008;?Siriphongphaew?et?al.?2012),?or?glycerol?dehydrogenase?
(NADH)? (Mouri? et? al.? 2006)? has? been? used? in? several? cases? to? improve? the? cofactor? regeneration.?
Another?approach? is? to?couple?permeabilized?cells,?expressing? the?enzymes?of? interest,?done? in? the?
case?with?NADPH?dependent?ketoreductase?and?glucose?dehydrogenase?used? for? the?production? in?
the?gram?per?liter?scale?with?specific?regeneration?activities?of?61?U/g?cdw?(Zhang?et?al.?2009).?Recent?
metabolic? engineering? approaches? for? better? NADPH? regeneration? during? glycolysis? have? been?
reviewed? by? Lee? and? co?workers,? in? the? best? cases? showing? a? 6?fold? improvement? of? catalytic?
performance? (final?product?concentration?or?specific?activity)? in?engineered?E.?coli? (Lee?et?al.?2013).?
Another?approach?to?tackle?the?dependence?of?the?more?expensive?and?less?stable?cofactor?NADPH?is?
to? change? the? cofactor? specificity? to? NADH.? This? was? done? by? site? directed? mutagenesis? for?
hydroxylation? of?myristic? acid? by? CYP102A1? (free? enzyme?with? cofactor? regeneration? by? formate?
dehydrogenase)? yielding? a? total? turnover?number?of?30?000? and? a? space?time? yield?of?153?mg/L/h?
(Maurer?et?al.?2005).??
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Aside? from? regeneration?of? the? cofactor?by? the?host? cell?and?heterologous?enzymatic? regeneration?
options,? non?enzymatic? options? to? regenerate? cofactors? and? direct? regeneration? of? the?
monooxygenase?active?site?have?been?reported?and?reviewed?(Hollmann?et?al.?2006).?NADPH?has?e.g.?
been? substituted?by? zinc?dust? and? cobalt(III)sepulchrate,? reaching?20?%?of? the? rate? achieved?using?
NADPH?in?vitro?for?hydroxylation?of?p?nitrophenoxydodecanoic?acid?(Schwaneberg?et?al.?2000).?In?the?
case?of?P450s?an?alternative?mechanism?for?the?reaction?is?the?use?of?the?peroxide?shunt?pathway?as?a?
source?of?both?electrons?and?oxygen,?which?was?exemplified?by?hydroxylation?of?naphthalene?by?a?
P450cam?mutant?showing?an?20?fold? improvement? in?activity?over? the?wild?type?enzyme? (Joo?et?al.?
1999).?Cumene?hydroperoxide?driven?dextromethorphan?demethylation?by?CYP2D6?resulted?in?210?%?
of?the?product?concentration?achieved?by?the?natural?cofactors?(NADPH/CPR)?after?1?h?in?vitro?assay,?
however,?with?decreased?stability?but?comparable?total?turnover?numbers?(Chefson?et?al.?2006).?The?
field?of?peroxide?driven?P450?catalysis? is?extensively?covered?with?patents?by?Arnold?and?co?workers?
(Cirino?and?Arnold?2008).?
2.2.4 Electron?transport?and?coupling?efficiency?
The?electron?transfer?from?the?cofactor?to?the?heme?active?site?is?in?many?cases?the?rate?limiting?step?
and?thereby?has?been?the?target?for?biocatalytic?improvement.?This?has?also?been?suggested?to?be?the?
reason?for?observing?equal?activity?in?an?overexpressed?engineered?system?as?in?the?native?host?with?a?
lower?enzyme? concentration? (Duetz?et? al.?2001).?Optimization?of? the? flux?of?electrons? is? crucial? to?
utilize?the?full?capacity?of?the?biocatalyst?to?the?targeted?reaction?and?the? importance?has?also?been?
emphasized?in?the?review?by?Bernhardt?and?Urlacher?(2014).?Approaches?with?fusion?constructs?have?
been?published?and?besides?constructs?with?the?reductase?domain?of?BM3,?the?reductase?domain?of?
CYP116B2? (P450RhF)? is?a?promising?alternative? (Bordeaux?et?al.?2011;?Robin?et?al.?2009).?This? field?
with?a? lot?of?potential?for?the?application?of?P450s?has?recently?been?reviewed? (Sadeghi?and?Gilardi?
2013).?The?length?and?also?structure?of?the?linker?within?the?fusion?constructs?have?been?shown?to?be?
important? for? electron? transport? (Munro? et? al.? 2007b;? Robin? et? al.? 2009).? Activity? can? also? be?
reconstituted?with?more?component?systems,?especially?for?eukaryotic?systems?with?unknown?redox?
partners,?even?though?the?redox?partners?are?commonly?known?for?eukaryotic?systems?in?contrast?to?
prokaryotic?ones.?The?choice?of?heterologous?redox?partners?is?firstly?determined?by?the?class?of?P450?
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but?has?proven?not? to?be? that? straight? forward?and?optimization?of? the?electron? transfer?has?been?
shown?to?be?beneficial?e.g.?by?a?modified?ferredoxin?(Bell?et?al.?2012).?Putidaredoxin?reductase?with?
putidaredoxin? (Kim? and? Ortiz? de?Montellano? 2009)? and? adrenodoxin? reductase?with? adrenodoxin?
(Zehentgruber?et?al.?2010a;?Hollmann?et?al.?2006;?Ewen?et?al.?2012;?Hakki?et?al.?2008)?have?been?the?
most? commonly? used? redox? partners? for? heterologous? expression.? Non?enzymatic? transfer? of?
electrons? to? the? heme?active? site? has? also? been? explored,? including? direct? chemical? reduction? or?
electrochemical?reduction?(Hlavica?2009)?as?well?as?light?driven?catalysis?exemplified?by?hydroxylation?
of?lauric?acid?by?P450?BM3?(Tran?et?al.?2013).?
The?catalytic?efficiency?is?amongst?others?affected?by?uncoupling,?when?reducing?equivalents?are?lost?
to?byproduct? formation?without?substrate?oxidation? (O'Reilly?et?al.?2011).?Uncoupling? is?affected?by?
the?physical?position?of?the?electron?transporting?chain?(i.e.?can?be?improved?by?the?design?of?fusion?
constructs)?but?especially?by?the?binding?of?the?substrate?in?the?active?site?and?is?therefore?a?particular?
challenge? for? efficient? catalysis? of? non?natural? substrates.? A? systematic? domain?based? directed?
evolution?strategy?was?used?to?engineer?P450?BM3?towards?the?non?natural?substrate?propane?(Fasan?
et?al.?2007).?This?resulted? in?total?turnover?number?of?45800?and? increased?coupling?efficiency?from?
17.4?to?98.2%?in?vitro.?
Improving?catalyst?stability?for?increased?biocatalyst?yield?(g/g?cdw)?and?final?2.3
product?concentration?(g/L)?
As?already?mentioned,?a?sufficient?stability?over?24?h?is?assumed?in?calculations?setting?a?threshold?for?
enzyme?activity.?If?the?stability?would?only?allow?for?an?8?h?reaction,?the?demand?on?all?rates?would?be?
three?times?higher.?This?forms?thereby?a?prerequisite?and? is?of?major? importance.? In?addition?to?the?
stability? of? the? host? cell,? the? stability? of? the?monooxygenase? and? also? the? corresponding? electron?
transport?proteins?are?critical?to?achieve?the?defined?process?targets.??As?stated?above,?a?supplement?
of?cofactors?gives?severe?economic?consequences?for?a?scaled?process?and?the?cofactor?regeneration?
is? one? of? the? motivations? for? a? whole?cell? process.? The? native? cofactor? regeneration? system? is,?
however,?not?adapted?to?the?activity?of?an?overexpressed?enzyme?and,?besides?the?regeneration,?the?
stability?of? cofactors? can? thereby?become? a? limitation? in? systems?with?high? turnover?numbers? and?
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stable?enzymes.? Total? turnover?numbers?of?up? to? 1300? for?NAD(P)+? and? 300? for?NAD+?have?been?
reached?in?an?in?vitro?P450?BM3?biphasic?system?using?formate?dehydrogenase?(Maurer?et?al.?2005).?
In? the? case? of? ketoreductase? with? a? glucose? dehydrogenase? cofactor? regeneration? approach? the?
overall? turnover?number? for?NADPH? recycling? reached?3400?with? a? specific? activity?of? 61?U/g? cdw?
(Zhang?et?al.?2009).?
When?uncoupling?occurs,?hydrogen?peroxide? is?produced?decreasing? the? stability?of? the?enzyme?by?
heme?degradation? (Cirino?and?Arnold?2003).?The? stability?of?P450?BM3? towards?hydrogen?peroxide?
has?been?explored?by?Arnold?and?co?workers?and?the?total?turnover?number?was?increased?11?fold?for?
a?hydrogen?peroxide? (5?mM)?driven?P450?BM3?heme?domain?by?protein?engineering?although? the?
enzyme?was? inactivated?within?5?min? in? the?presence?of?10?mM?hydrogen?peroxide?and? is? far? from?
industrially? suitable? (Cirino? and? Arnold? 2003).? Six? additional? rounds? of? directed? evolution? of? this?
enzyme? resulted? in? a? 250? times? longer? half?life? at? 57.5? °C? compared? to? the? holoenzyme? of? the?
wildtype? with? 50? %? remaining? activity? of? the? peroxide? driven? parent? (Salazar? et? al.? 2003).? The?
reductase?domain?of?CYP102A1? is?known?to?be?less?stable?than?the?monooxygenase?domain?(Munro?
et?al.?2007a).?When?the?reductase?domain?of?CYP102A1?was?replaced?with?the?more?stable?reductase?
domain?of?CYP102A3? the? stability?was? improved? (10?fold? longer?half?life?at?50? °C)?even? though? the?
activity?was?decreased?(Eiben?et?al.?2007).??
When?designing?a?whole?cell?biocatalytic?process?with?the?knowledge?that?solvents?most?probably?will?
be? used,? this? should? be? considered?when? choosing? the? host? and? screening? for? desired? enzymatic?
characteristics.? In?general,?Gram?negative?bacteria?are?known?to?be?more?solvent?tolerant?than?their?
Gram?positive?counterparts.?Variations?in?solvent?tolerance?can?be?explained?by?different?membrane?
composition?and?efflux?pumps?and?varies?not?only?between?different?bacterial?species?but?can?also?
vary?between?different?strains?of?the?same?species?(Ramos?et?al.?2002).??
The? stability? of? P450? BM3? in? the? presence? of? co?solvents? added? to? increase? the? solubility? of? the?
substrates? has? been? increased? by? directed? evolution? yielding? mutants? with? 10?fold? and? 6?fold?
increased?specific?activities?compared?to?the?parent?mutant?F87A?in?the?presence?of?2?%?THF?and?25?%?
DMSO? respectively? (Seng?Wong? et? al.? 2004).? The? improved? tolerance?was? also? seen? for? other? co?
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solvents?(acetone,?acetonitrile,?DMF?and?ethanol).?P450?BM3?mutants?have?also?been?constructed?by?
site?directed?mutagenesis?for?the?hydroxylation?of?cyclohexane?in?a?biphasic?system?containing?50?%?
cyclohexane?as?substrate?and?organic?phase?and?50?%?aqueous?buffer?(Maurer?et?al.?2005).?The?best?
double?mutant?was? shown? to?be?active? for?100?h?when? stabilized?by?catalase?and?BSA?with?a? total?
turnover?number?of?12?850.?Similarly,?octane?(used?as?substrate?and?second?phase)?and?myristic?acid?
in? dodecane? showed? total? turnover? numbers? of? 2? 200? and? 3? 300? demonstrating? applicability? of?
biphasic?reaction?systems.??
Immobilization?as?a?means?to? increase?the?stability?of?P450s?has?also?been?explored?although?to?be?
implemented? in? industry,?this?requires? improved?biocatalyst?yield?to?cover?the?additional?cost?added?
to?the?process.?Mainly?purified?enzymes?have?been?immobilized?and?in?this?case?cofactor?regeneration?
has? to?be? addressed.? Sol?gel?matrix? showed? to?be? the?best? amongst? several?matrices? tested?when?
immobilizing? BM3? mutants? with? immobilized? formate? dehydrogenase? for? cofactor? regeneration?
(Maurer?et?al.?2003).?The?storage?stability?was?improved?measured?as?the?half?life?at?25?°C?from?5?days?
(with?glycerol)?to?29?days.?Reusability?of?the?catalyst?was?also?shown.?The?immobilization?of?the?heme?
domain?of?BM3?on?mesopourous?molecular?sieves?using?hydrogen?peroxide?as?electron?and?oxygen?
source?was? also? investigated?by?Weber? and? co?workers? (Weber?et? al.?2010).?However,? the?activity?
towards?n?octane?was?only?twice?as?high?compared?to?the?free?enzyme?and?still?quite?low?reaching?in?
total?62?nmol?product?per?mg?P450.?A? fusion?protein?between?the?plant?CYP71B1?and? its?reductase?
showed?10?fold?improved?activity?compared?to?the?free?enzyme?when?immobilized?in?colloidal?liquid?
aphrons? (CLA)? (Lamb? et? al.? 1998).? Another? immobilization? approach,? taking? the? importance? of?
proximity?of?the?electron?transfer?chain?for?efficient?electron?transfer?into?close?consideration,?called?
PUPPET?where?P450cam,?putidaredoxin?and?putidaredoxin? reductase?where? fused? to?monomers?of?
proliferating?cell?nuclear?antigen? (PCNA)? forming?a? trimeric?ring?structure? (Hirakawa?and?Nagamune?
2010).? This? lead? to? an? increase? in? initial? activity? by? two? orders? of? magnitude? measured? by? O2?
consumption?and?NADH?consumption?compared? to? the?a?mixture?of? the? free?enzymes? leading? to?a?
specific?activity?of?500?min?1.??
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Cell?free?extracts?of?E.?coli?expressing?CYP105D1?immobilized?on?the?anion?exchange?resin?DE52?only?
showed?activities?of?one?third?to?half?of?the?free?enzyme?but?showed?activity?up?to?36?h?using?formate?
dehydrogenase? for? cofactor? regeneration? (Taylor? et? al.? 2000).? Flocculent? yeast? Saccharomyces?
diasticus? expressing? a? fused? P450? enzyme?was? immobilized?within? reticulated? polyurethane? foam?
biomass?particles?in?a?fluidized?bed?reactor?enabling?production?in?5?batch?cycles,?each?lasting?8?h?with?
higher?final?product?concentration?and?production?rate?than?freely?suspended?cells?(Liu?et?al.?1998).???
Even?though?the?stability?is?shown?to?be?increased?by?protein?engineering?and?immobilization,?from?a?
process?perspective,?it?is?important?that?the?stability?under?process?relevant?conditions?is?considered?
(agitation,?temperature,?concentration?of?reactants?etc.).?
Improving?substrate?and?product?related?parameters?2.4
The? biocatalyst? can? be? changed? and?modified? in? several?ways? as? discussed? above.? However,? the?
substrate? and? product? are? generally? fixed? and? challenges? associated? with? the? reactant(s)? and/or?
product(s)? needs? to? be? circumvented? by? other? means.? Typical? substrates? and? products? of? P450?
catalyzed? reactions?have?poor?water? solubility?which? is?a? challenge?when? the?whole?cell? catalyst? is?
present?in?the?aqueous?phase.?The?transport?of?the?poorly?water?soluble?substrate?can?limit?the?space?
time?yield?(g/L/h)? if? it? is? lower?than?the?reaction?rate?and?also? influences?the?product?concentration?
(g/L)?achievable.?Inhibition?and?toxicity?can?limit?the?final?product?concentration?(g/L)?and?biocatalyst?
yield? (g/g?cdw)?achievable.?Volatility?of?the?substrate?or?product?could?potentially? limit?the?reaction?
yield,?especially?considering?the?supply?of?gaseous?oxygen.?This? is,?however,?not?considered?to?be?a?
challenge?for?high?value?molecules?relevant?for?P450?catalyzed?processes?due?to?the? large?molecular?
weight?of?substrates?and?products?and?thereby?in?general?also?low?volatility.?
2.4.1 Transport?limitations?across?the?cell?membrane?
Dependent?upon?the?physical?properties?of?the?substrate,?transport?across?the?cell?membrane?has?in?
some?cases?been?shown?to?limit?the?reaction.?Three?different?mechanisms?of?hydrocarbon?uptake?by?
bacteria? have? been? described? in? the? scientific? literature:? uptake? from? aqueous? phase,? uptake? of?
solubilized?substrate?in?an?apolar?solvent?and?from?direct?contact?with?organic?droplets?(Schneider?et?
al.?1998).?The?membrane?needs?to?allow?transport?of?desired?compounds?but?still?be? intact?enough?
50
31?
?
not? to? affect? the? viability?of? the? cell.? In? general?whole?cell?biocatalysis? is? 1?2?orders?of?magnitude?
slower?than?isolated?enzymes?due?to?transport?limitations?across?the?cell?walls?and?membranes?(Chen?
2007).? Different? permeabilization? methods? (physical,? chemical? and? molecular? engineering?
approaches)? can? be? applied? depending? on? the? microorganism? (eukaryotic? or? prokaryotic,? Gram?
positive?or?Gram?negative)?and? characteristics?of? your? compound? (hydrophilic?or?hydrophobic)?and?
have?been? reviewed?previously? (Chen?2007).? ?Zehentgruber?and? co?workers?demonstrated? that? for?
steroid?transport?across?the?cell?membrane? in?fission?yeast?permeabilization?by?Tween?80? increased?
the?activity?by?50?%?but?hexadodecyl?trimethyl?ammonium?bromide?(CTAB)?extinguished?the?activity?
instead,?probably?due?to?toxicity?to?the?biocatalyst?(Zehentgruber?et?al.?2010b).?Microbial?engineering?
strategies? to? improve? the?uptake?of?hydrophobic? substrates?by?bacteria?was?applied? in? the? case?of?
dodecanoic?acid?methyl?ester?oxygenation?in?E.?coli?W3110?and?a?28?fold?increase?of?maximal?specific?
activity?was?achieved?by?co?expression?of?the?AlkL?membrane?protein?(Julsing?et?al.?2012).?Application?
of? a? biphasic? system? further? increased? the? activity? (62?fold).? However,? the? expression? of? AlkL?
decreased?the?stability?of?the?cell.?The?same?approach?has?been?taken?for?alkanes?(n?dodecane)?in?E.?
coli?GEC137?(Grant?et?al.?2011).?The?examples?above?are?applied?to?the?alkane?monooxygeanse?system?
from? Pseudomonas? putida? GPo1? and? not? a? P450.? Regarding? P450s,? the? fatty? acid? transport?
(pentadecanoic?acid)?was?improved?in?resting?E.?coli?K27?by?expression?of?the?same?gene?encoded?on?
pGEc47?from?Pseudomonas?oleovorans?from?0.7?U/g?cdw?to?1.3?U/g?cdw?(Schneider?et?al.?1998).?The?
productivity?was? further? improved? threefold? by? the? use? of? cell? free? extract,? although?NADPH?was?
added? in? this? case.? The? AlkL? transport? protein? was? also? applied? in? the? well?studied? limonene?
hydroxylation?by?CYP153A6?expressed? in?E.?coli?W3110? resulting? in?an? increased?hydroxylation? rate?
from?7.1?to?16.6?U/g?cdw?(Cornelissen?et?al.?2013).??
Change?of?the?heterologous?expression?host?can?also?improve?the?substrate?transport.?Utilization?of?B.?
megaterium?MS941? instead?of?E.?coli?avoided?the? inability?of?E.?coli?to?transport?acids?with?terpene?
structure?(Bleif?et?al.?2012).?Similarly,?hydroxylation?of?testosterone?and?diclofenac?by?human?P450s?
CYP3A4?and?CYP2C9? respectively?expressed? in?E.?coli? showed?higher? specific?activity? in? the? form?of?
isolated?membranes?compared?to?whole?cells?indicating?transport?limitation?(Vail?et?al.?2005).?Another?
option?to?circumvent?the?transport? limitation?across?the?cell?membrane? is?to?express?the?enzyme?by?
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surface?display.?CYP106A2? from?Bacillus?megaterium? (Schumacher?et?al.?2012)?and?human?CYP3A4?
(Schumacher? and? Jose? 2012)? was? expressed? on? the? outer? membrane? of? E.? coli? and? showed?
hydroxylation? of?deoxycorticosterone? and? testosterone,? respectively.? It? should,? however,?be? noted?
that? the? advantages? with? using? the? whole?cell? system? were? lost? and? cofactor? and? electron?
transporting?proteins?need?to?be?added?externally.?The?transport? limitations?can?also? imply?that?the?
product? is?accumulated? inside?the?cell? (Shimizu?et?al.?2003)?and?needs?to?be?recovered?through?cell?
lysis,?thereby?ruling?out?cell?recycle.?
2.4.2 Solubility?of?reactants?
Many?substrates?for?reactions?catalyzed?by?P450?have?limited?water?solubility.?For?example,?medium?
chain?alkanes?(C5?C16)?are?water?soluble?up?to?around?40?mg/L?and?likewise?fatty?acids?with?the?same?
chain?length?are?soluble?in?the?range?of?7?mg/L?to?19?g/L.?In?these?cases?the?transport?of?the?substrate?
to? the?water? phase? containing? the? catalyst? requires? an? immiscible? or?miscible? organic? solvent? to?
facilitate? faster? transport.? Two? phase? systems? with? immiscible? solvents? are? of? particular? interest?
(Schewe?et?al.?2009;?Cornelissen?et?al.?2011).?There?are?many?parameters?to?consider?when?choosing?a?
solvent:? availability? and? price,? the? biocompatibility? towards? the? enzymes? and? the? host,? low?water?
solubility,? substrate? and? product? capacity,? flammability,? low? emulsion? forming? tendency? and? in?
cofactor?dependent?reactions? low?NADPH?consumption? rate? (Schewe?et?al.?2009).?The?solvent?used?
also?needs?to?be?industrially?applicable,?environmentally?friendly?as?well?as?non?hazardous.?Generally,?
biocatalysis?is?better?in?organic?solvents?with?an?octanol/water?partition?coefficient?(logP)?greater?than?
4? (Laane? et? al.? 1987).? All? the? mentioned? criteria? lead? to? the? options? of? using? solvents? such? as?
hexadecane?and?bis(2?ethylhexyl)phthalate? like? in? the?case?of?styrene?oxidation? (Panke?et?al.?2000).?
Ethyl?oleate?was?applied?as?a?second?phase?in?1.5?L?bioreactors?to?circumvent?the?low?solubility?of?the?
substrate? in?the?case?of?progesterone?hydroxylation?by?CYP3A4?expressed? in?Y.? lipolytica,? increasing?
the? final? product? concentration? 5?fold? to? around? 230? μM? corresponding? to? 80?mg/L? (Braun? et? al.?
2012).?On?the?other?hand,?the?viscosity?of?phthalates?can?prevent?the?dispersion?of?the?substrate?and?
decrease? the?overall? activity?by?diffusion? limitations? as?well? as? the?oxygen? transfer? rate? at?a?given?
power? input? (Panke?et?al.?2002).?The?use?of? solvents?also?brings? the?concern?about? safety? into? the?
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picture,? especially? in? combination? with? high? oxygen? supply? and? to? address? this? explosive? proof?
reactors?have?been?designed?at?pilot?scale?(Schmid?et?al.?1998a).??
2.4.3 Inhibition?and?toxicity?
In?reactions?catalyzed?by?P450s?not?only?the?potential?solvent?but?also?the?substrate?and?product?are?
in?many? cases?hydrophobic?and? toxic? to? the? cells?and? inhibitory? to? the?enzyme.?The?host? selection?
should? be? done? carefully,? exemplified? by? B.? subtilis? 3C5N? showing? significantly? higher? tolerance?
towards? the? substrate?1?hexene? compared? to?E.? coli?DH5?? (Siriphongphaew?et? al.?2012).?An?efflux?
pump? knock?out? E.? coli,? enabling? heme? and? substrate? accumulation? inside? the? cell? improved? the?
stability? and? reaction?performance? (up? to?7? fold? increase?of?product? concentration)? in? the? case?of?
hydroxylation?of? compactin,? vitamin?D3? and? 4?cholesten? 3?one? (Fujii?et? al.? 2009).? In? a? study?of?10?
recombinant?P450s?belonging?to?CYP1,?CYP2?and?CYP3?families,?13?substrates?were?tested?of?which?6?
showed? substrate? inhibition? in? the? range? of? 5?24?μM? corresponding? to? 2?9?mg/L? (Lin? et? al.? 2001).?
Assuming? a? batch? process?with? no? engineering? solutions? applied,? the? tolerance?would? have? to? be?
improved?by?3?orders?of?magnitude.?Depending?on?the?chemical?properties?of?the?molecules?different?
approaches? can?be? taken.? Inhibition?by? the? substrate? can?be?overcome?by? in? situ? substrate? supply?
(ISSS)? using? continuous? supply? of? the? substrate? by? a? feeding? strategy? or? by? resins? or? solvents.?
Regarding?the?product? in?situ?product?removal?(ISPR)?can?be?applied?by?similar?approaches? (Lye?and?
Woodley? 1999;?Woodley? et? al.? 2008;? Dafoe? and? Daugulis? 2014).? Product? removal? by? resins? was?
applied?to?steroid?hydroxylation?by?CYP106A2?and?enabled?reuse?of?the?catalyst?(Zehentgruber?et?al.?
2010a).?Extractive? fermentation?with? isopropyl?myristate?was?applied? in?the?case?of?artemisinic?acid?
production?by?Saccharomyces?cerevisiae?reaching?a?product?concentration?of?25?g/L,?an?improvement?
by?10?g/L?due? to?change?of? feed?composition?and? introduction?of? the? second?phase? (Paddon?et?al.?
2013).?
Improving?space?time?yield?(g/L/h)?by?effective?reactor?operation?2.5
2.5.1 Transport?limitations?between?phases?in?a?two?phase?system?
Other? parameters? that? have? been? addressed? in? the? use? of? two?phase? systems? are? the?maximum?
transfer?rates?of?the?hydrophobic?compounds?between?the?organic?and?aqueous?phase.?The?transfer?
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rates?of?n?heptane,?n?octane?and?n?decane?to?the?aqueous?phase?were?determined?to?79,?64?and?18?
mmol/L/h?respectively?(Schmid?et?al.?1998b).?Calculated?in?g/L/h?these?numbers?are?in?the?same?order?
of?magnitude? (lowest? value? corresponding? to? 1.8? g/L/h)? as? the? target? space?time? yield? of? 2? g/L/h.?
However,?addition?of?the?surfactant?bis(2?ethylhexyl)?sulfosuccinate?sodium?salt?(AOT)?to?a?two?phase?
hexane/water?emulsion?increased?the?initial?rates?of?the?hydroxylation?of?camphor?by?P450cam?using?
yeast?alcohol?dehydrogenase?for?cofactor?regeneration,? indicating?transport? limitations?between?the?
phases?in?the?hexane?buffer?system?(Ryan?and?Clark?2008).?Total?turnover?numbers?achieved?for?the?
monooxygenase?was?28900?and?for?YADH?regenerating?NADH?11800.?
2.5.2 Oxygen?requirements?
Hydroxylations?by?P450s?require?equimolar?amounts?of?oxygen.?One?oxygen?atom?is?introduced?to?the?
substrate?and?one?is?reduced?to?water.?For?the?reaction?to?take?place?it?is?of?utmost?importance?that?
molecular?oxygen? is?available?and?that? it?can?be?supplied?at?a?sufficient?rate.?Even? though?potential?
oxygen? limitation? has? not? been? studied? to? a? large? extent?within? the? field? of? P450s,? intact? E.? coli?
expressing?recombinant?P450?for?the?hydroxylation?of?progesterone?has?been?suggested?to?be?limited?
by?molecular? oxygen? (Shet? et? al.? 1997).?Nevertheless,? this? study?was? conducted? in?milliliter? scale?
without?agitation,?and?the?P450?catalyzed?reaction?was?only?responsible?for?1.5?%?of?the?total?oxygen?
utilized?by?the?cell.?Already?1947,?resting?cells?without?nitrogen?source?were?suggested?to?consume?45?
%?of?what?cells?in?the?same?state?consumed?in?the?presence?of?nitrogen?source?(Armstrong?and?Fisher?
1947).?This?could?be?explained?by?the?higher?Km?of?oxygenases?(10?60?μM)?compare?to?the?electron?
transfer? chain? (1? μM)? meaning? that? at? low? oxygen? concentrations,? the? oxygen? will? be? used? for?
respiration? instead?of?the?catalytic?reaction?(Duetz?et?al.?2001).?Optimization?of?biomass?and?activity?
will?be?one?important?step?in?the?process?development?and?this?has?been?done?in?the?case?of?whole?
cell?Baeyer?Villiger?oxidation?(Baldwin?and?Woodley?2006).?This?is?illustrated?by?optimizing?the?height?
of?the?grey?area? in?Figure?2.3,?assuming?that?the?O2?supply? is?sufficient.?Besides?the?overall?reaction?
rate,? dissolved? oxygen? concentrations? can? also? effect? the? reaction? in? terms? of? regioselectivity?
(Schneider?et?al.?1998).?
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As?a? rule?of? thumb,?oxygen? transfer? rates? in? industrial? size? fermenters?are?100?mmol/L/h?and? that?
would? be? able? to? transfer? oxygen? to? 1670?U/L.? Assuming? a? product?with? 154? g/mol? in?molecular?
weight,? this?activity?corresponds? to?a?space?time?yield?of?15.4?g/L/h? if? the?supplied?oxygen? is?solely?
used?for?the?catalytic?reaction?(and?with?100?%?reaction?yield).?Keeping?the?target?for?space?time?yield?
in?mind,?2?g/L/h,?efficient?use?of?oxygen?is?required?since?13?%?of?supplied?oxygen?has?to?be?used?for?
the?reaction.?This? leaves?the?remaining?87?%?for?the?metabolism?or?growth?of?the?cell?and? it? is?clear?
that? there? is? no? room? for? poor? coupling? efficiency? consuming? oxygen?without? product? formation.?
Depending?on?the?specific?requirement?of?oxygen?of?the?resting?cell?the?oxygen?availability?also?set?the?
requirements?for?the?specific?activity?of?the?cell?and?thereby?also?on?enzyme?activity?and?expression?
levels.? The? oxygen? requirements? in? combination? with? solubility? issues? leading? to? high? oxygen?
pressures?and?solvents?in?combination?consist?of?a?safety?problem?as?discussed?above.??
?
Figure?2.3?Oxygen?demand?vs?biocatalyst?concentration? in?whole?cell?biocatalytic?oxidation?process.?
Dashed? line? represents? possible? O2? supply? from? industrial? sized? fermenters,? the? lower? solid? line?
represents?O2?requirements?for?cell?metabolism?and?the?higher?solid?line?the?total?O2?demand?for?cell?
metabolism?and?P450?catalyzed?reaction.?(Reconstructed?from?Baldwin?and?Woodley?(2006))?
There?are,?however,?alternatives? to? increase? the?oxygen? transfer? rate? to? the?aqueous?media? if? the?
specific? activity? per? g? cdw? and? catalyst? concentration? cannot? be? optimized? enough? in? relation? to?
oxygen?supply.?This?can?be?done?by? increased?oxygen?pressure? in? the?reactor?by?elevated?pressure,?
supply? of? pure? oxygen? instead? of? air,?modified? oxygen? supply? configuration? and? complete? reactor?
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configurations.? E.g.? the? use? of? a? bubble? column,?where? air? is? released? in? fine? bubbles? through? a?
sintered? glass? in? the? bottom? of? the? reactor? increased? the? activity? of? a? whole?cell? Baeyer?Villiger?
oxidation?reaction?(Hilker?et?al.?2004).?Another?example?is?bubble?free?aeration?using?membranes?of?
which? the?mass? transfer? characteristics?have? been?described? and? equations?presented? (Cote? et? al.?
1988).?The?technique?was?exemplified? in?a?biocatalytic?reaction?enabling?a?reduction?of?the?reactant?
feed?rate?with?one?third?while?still?keeping? the?same?reaction?rate? (Lynch?et?al.?1997).?A?circulation?
loop?with? a? glass? tube? containing? dead?end? hollow? gas?permeable? fibers? controlling? the? dissolved?
oxygen? tension? (DOT)?with? the?oxygen?pressure? inside? the? fibers?was?used? to?prevent? the? volatile?
substrate?fluorobenzene?from?evaporation.?
Perspectives?2.6
There? is?no?doubt? that?P450?monooxygenases?perform?excellent?chemistry?and?based?on? that?have?
huge?potential?within?white?biotechnology.?Despite?this?fact?and?that?lots?of?research?have?been?done?
within?the?field?not?many?industrial?processes?with?P450s?have?been?implemented.?P450s?are?a?good?
example? of?where? chemists,? biologists? and? chemical? engineers? need? to?work? together? in? order? to?
reach?industrial?implemented?processes?and?that?the?idea?of?process?development?and?identification?
of?bottlenecks?at?an?early?stage?can?help?to?direct?efforts.?In?order?to?improve?a?process?that?doesn’t?
meet? the? requirements? for? being? economically? viable? the? bottlenecks? first? need? to? be? identified.?
However,?it?is?not?easy?to?distinguish?between?parameters?that?at?first?glance?depend?on?each?other.?
The?biological?parameters?important?for?whole?cell?P450?catalyzed?reactions?are?summarized?in?Table?
2.3?and?numbers?achieved?for?P450?systems?are?presented.??
? ?
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Table?2.3?Status?of?biocatalyst?related?parameters.?Assumptions?made?throughout?the?text?and?also?in?
the?table?is?1)?Mw?(P450?BM3)?118?kDa,?2)?Mw?(substrate)?138?g/mol,?3)?Cell?density?13?g?cdw/L?.?
Stability?expressed?here?as?time?(h)?or?total?number?of?product?formed?per?enzyme?or?cofactor?(TTN).?
However,?following?Michaelis?Menten?kinetics,?reaction?rate?decreases?over?time?but?for?simplicity?
calculated?to?be?consistent?over?time.???
PARAMETER? Current?status? Reasonable?improvement?
Biocatalyst?
related?
parameters?
Specific?
activity?
(U/g?cdw)?
Enzyme?expression?
(nmol/L,?nmol/g?cdw)?
12500?nmol/L?(Pflug?et?al.?2007)?
943nmol/g?cdw? 10x?(Pflug?et?al.?2007)?
Enzyme?activity?(s?1)? >1?s?1(Whitehouse?et?al.?2012)? 20?100x?(Malca?2012;?Lewis?and?Arnold?2009)?
Cofactor?regeneration?
(U/g?cdw)?including?
electron?transport?(s?1)?
Calculated:?500?1000?U/g?cdw?(Duetz?et?al.?
2001;?Meyer?et?al.?2006;?Blank?et?al.?2008)?
6?10x?(Lee?et?al.?2013;?
Schewe?et?al.?2008)?
Oxygenases:?200?U/g?cdw?(Bühler?and?
Schmid?2004)? ?
P450:?26?U/?g?cdw?(Fasan?et?al.?2011)? ?
Coupling?efficiency?(%)? >98%?(Fasan?et?al.?2007)? 6x?(Fasan?et?al.?2007)?
Stability?
Cell?(h)? (resting?cell)?>90h?(Braun?et?al.?2012)? ?
Monooxygenase??
(TTN,?h)?
Reductase?(TTN,?h)?
(CYP102A1?mutants?w?various?substrates)?
2200?30000?(Maurer?et?al.?2005)?
10?20x?(Maurer?et?al.?
2005;?Eiben?et?al.?2007;?
Salazar?et?al.?2003)?
Cofactor?(TTN,?h)?
Ketoreductase?(NADPH)?3400?supporting?61?
U/g?cdw?(Schwaneberg?et?al.?2000)?
P450?(NADP+,?in?vitro)?280?1270?(Maurer?et?
al.?2005)
?
?
As?can?be?seen?in?the?table?the?prerequisites?of?successful?whole?cell?P450?biocatalytic??(Maurer?et?al.?
2005;? Eiben? et? al.? 2007;? Salazar? et? al.? 2003)? processes? are? sufficient? to? reach? target?metrics? (final?
product? concentration? and? space? time? yield? or? biocatalyst? yield)? when? parameters? are? analyzed?
individually.?However,?an?efficient?use?of?resources?available?is?required.??
In? Figure? 2.4? the? importance? of? the? weakest? chain? in? the? reaction? system? is? illustrated? and? the?
influence? it? has? on? the? economic? potential? illustrated? by? space?time? yield? and? final? product?
concentration.?The?biological?parameters?influencing?specific?activity?are?summarized?in?the?lower?left?
graph?in?the?figure?and?following?the?figure?clockwise?the?influence?of?these?parameters?on?economic?
metrics?are?presented.?The?specific?activity?in?combination?with?the?cell?concentration?determines?the?
space?time?yield,?which,?along?with?the?stability?of?the?cell,?influences?the?final?product?concentration.?
The? final?product?concentration?along?with?applied?catalyst?concentration?subsequently?determines?
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the? biocatalyst? yield? for? a? resting? cell? process? where? the? number? of? recycles? also? needs? to? be?
accounted?for.?What?also?can?be?seen?is?that?stability?of?the?system?plays?a?crucial?role,?and?once?again?
it?should?be?stressed?that?it?is?the?stability?under?process?relevant?conditions?that?matters.?
? ?
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Figure?2.4? Influence?of?the? typical?biological?parameters?presented? in?P450?whole?cell?processes?on?
economic? important? parameters? and? limitations.? Starting? in? the? lower? left? corner? the? rate? related?
parameters?are?listed?(enzyme?expression,?enzyme?turnover?number,?electron?transport?and?coupling?
efficiency)? influencing? the? specific? activity? that? in? the? upper? left? corner? together? with? the? cell?
concentration? results? in? the? space?time? yield.? The? space?time? yield? can? be? limited? by? the? possible?
oxygen? supply? by? the? reactor? and? the? transport? of? reactants? between? phases? or? across? the? cell?
membrane.?From?the?space?time?yield,?the?possible?final?product?concentration?is?determined?by?the?
stability? of? the? whole?cell? system? including? the? host? cell,? the? monooxygenase,? reductase? and?
cofactors,? shown? in? the? upper? right? corner.? The? lower? right? corner? illustrates? how? the? cell?
concentration? together?with? the? final?product? concentration?determines? the?biocatalyst? yield? for? a?
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resting?cell?process?where?the?number?of?recycles?also?needs?to?be?accounted?for.??Thick?lines?indicate?
the?limits?to?the?metrics.?
Guidelines?2.7
Biological? limitations? of? P450? catalyzed? whole? cell? reactions? have? previously? been? discussed? in?
individual? studies.? In? this? chapter,?quantitative? comparisons?of? individual?parameters? in? relation? to?
economic?metrics? to? guide? the? development? of? economically? feasible? processes? have? been?made.?
Recommendations?for?successful?development?of?P450?catalyzed?processes?for?synthetic?applications?
can?be?summarized?as?follows:??
General:?
? The?main? target? for?P450?catalyzed? reactions?are? recommended? to?be?high?value?molecules?
(fine?chemicals?and?pharmaceuticals),?complementary? to?existing?chemical? routes.?For? these?
high?value?products,?kcat?values?for?many?P450s?are?promising,?assuming?no?other?limitations.?
However,? if? the? process? is? aiming? for? production? of? low? range? bulk? chemicals? the? activity?
requirements?of?the?enzyme?increase?by?two?orders?of?magnitude?and?only?the?P450s?with?the?
highest?turnover?numbers?reported?so?far?would?be?sufficient.?
Biological:?
? The? stability?of? the? catalyst? is? crucial,?both? in? terms?of? cell,?enzyme?and? cofactor.? It? can?be?
concluded? that? turnover?numbers? in? the?higher?range?of?what?has?been?published?would?be?
enough?if?they?could?be?achieved?in?vivo?and?stable?over?24?h.?A?lower?stability,?meaning?that?
product? concentrations? and?biocatalyst? yields?need? to?be? reached? in? a? shorter? time,?would?
inevitably?translate?into?higher?demands?on?rates.??
? Carefully?selected?host?cell?systems?(e.g.?natural?P450?expressing?hosts)?for?a?robust?host?able?
to? handle? expression,? reactive? oxygen? species? and? simplify? transport? across?membrane? are?
recommended.?
? Cell? and? metabolic? engineering? to? various? extents,? (tuning? expression? especially? in?
multicomponent?systems,?balancing?of?redox?cofactors?and?energy?metabolites)?to?fully?utilize?
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the? potential? of? the? catalyst.?However,? this? approach? is? very? resource? demanding? and? the?
extent?of?the?work?needs?to?be?carefully?balanced?to?the?gain?expected.?Approaches?and?tools?
for? development? of? optimal? industrial? strains? have? recently? been? summarized? by?Van?Dien?
(2013).?
? The?coupling?efficiency?needs?to?be?maximized?to?utilize?available?cofactor?efficiently,?minimize?
toxic?byproducts?and?economical?use?of?oxygen?supplied.?
Process:?
? Product?localization?determines?product?recovery?and?if?cell?disruption?is?necessary?a?growing?
cell? process? is? favored? due? to? the? higher? economic? demands? on? the? resting? cell? process.?
Growing? or? resting? cells? needs? to? be? determined? on? a? case?by?case? basis? and? factors? like?
stability?and?product?profile?can?also?influence?the?decision.???
? Using? process? knowledge? and? constraints? gained? from? substrate? and? product? properties?
regarding?solubility,? toxicity?and? transport?should?be? taken? into?account?when?designing? the?
overall?process?from?the?beginning,?instead?of?designing?a?process?purely?based?on?the?P450?in?
mind?as?illustrated?in?Figure?2.5.?
?
?
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Figure?2.5?The?development?of?biocatalytic?P450?processes?needs? to?consider? the?overall?picture? to?
guide?efforts?and?thereby?enable?more?focused?process?development.?
?
? ?
62
43?
?
3 Case?study?I:?CYP153A?expressed?in?E.?coli?catalyzing?the???hydroxylation?
of?dodecanoic?acid?
The? model? system? chosen? for? the? first? case? study? represents? an? artificial? P450? fusion? construct?
expressed?in?a?naturally?non?P450?expressing?host?represented?by?E.?coli.?A?fusion?construct?consisting?
of?the?P450?heme?domain?and?the?electron?transporting?redox?partner?in?a?single?protein?is?favorable?
for? high? expression? levels? and? has,? in?many? cases,? been? suggested? as? a? promising? approach? for?
efficient? electron? transfer.? E.? coli? is? the?most? applied? organism? in? research? laboratories?with?well?
explored? genetics? and? is? easy? to? handle.? This?model? system?was? chosen? based? on? a? product?with?
commercial? interest? and? a? soluble? protein? with? reasonably? high? activity,? selectivity? and? coupling?
efficiency.?The?fusion?construct?was?created?and?characterized?in?Professor?Hauer’s?group,?University?
of? Stuttgart,? Germany,? who? also? kindly? supplied? the? plasmid.? The? CYP153A? heme? domain? from?
Marinobacter? aquaeolei? fused? to? the? reductase? domain? of? CYP102A1? from? Bacillus? megaterium?
expressed? in?E.?coli?was?applied?to?identify?the?bottlenecks?of?a?resting?whole?cell?catalyzed?process.?
This?was?done?by?characterization?of?the?biocatalyst?and?reaction?system.?The?P450?chimera?has?been?
shown?to?regioselectively?hydroxylate?fatty?acids?of?medium?chain?length.?Terminal?hydroxylated?fatty?
acids? can? be? used? in? the? field? of? high? end? polymers,? in? fine? chemicals? and? in? the? cosmetic? and?
fragrance?industry.?The?industrial?relevant?E.?coli?strain?HMS174?was?chosen?as?suitable?host?and?the?
fermentation? process? was? developed? in? Gerald? Striedners? lab,? BOKU,? Vienna,? Austria.? The? work?
presented?in?this?chapter?is?based?on?Paper?II.?
Introduction?3.1
The?complex?nature?of?P450s,?including?cofactor?dependence?and?the?requirement?of?redox?partners,?
is?associated?with?several?challenges?for?their?application?in?industrial?processes?(O'Reilly?et?al.?2011).?
Whole? cells? are? the? preferred? biocatalyst? formulation? since? they? provide? the? ability? to? regenerate?
cofactors,? mainly? via? the? pentose? phosphate? pathway,? the? tricarboxylic? acid? cycle? and? the?
transhydrogenases? system? (Lee? et? al.? 2013),? as?well? as? increased? stability?of? the? enzyme?due? to? a?
protected?environment.?In?the?previous?chapter,?challenges?for?P450?catalyzed?whole?cell?processes?to?
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reach?economic?feasibility?and?industrial?implementation?have?been?discussed.?Based?on?the?potential?
limitations?reported?for?whole?cell?processes,?here?a?strategic?approach?to?identify?the?bottlenecks?in?
a? P450? catalyzed? reaction? using? resting? cells? have? been? applied.? The? suggested? limitations? were?
described?to?be?substrate?and?product?related?inhibition?and?toxicity,?stability?(of?P450,?host?cell?and?
cofactor),? cofactor? regeneration? and? transport? limitation? between? phases? and? across? the? cell?
membrane?(Lundemo?and?Woodley?2015).?The?aim?of?this?chapter?is?to?validate?the?literature?based?
limitations?using?a?well?developed?model?system,? terminal?hydroxylation?of?medium?and? long?chain?
fatty?acids?by?a?P450?fusion?construct.?
Terminal? hydroxylated? fatty? acids? (??OHFAs)? and? ?,??dicarboxylic? acids? (?,??DCAs)? derived? from?
medium? and? long? chain? length? fatty? acids? are? key? intermediates? used? as? building? blocks? for? the?
synthesis?of?valuable?bioplastics,?and?precursors?of?high?end?polymers?in?the?chemical?industry?(Liu?et?
al.?2011).?Oxygenated? fatty? acids? can? additionally?be?used? in? the? cosmetics? area? for?production?of?
perfumes?and?for?pharmaceutical?applications?such?as?anticancer?agents.???OHFAs?and??,??DCAs?can?
be?produced?both?by?chemical?and?biological?routes.?Selective?oxidations?of?alkanes?by?the?chemical?
routes?suffer?from?poor?selectivity?(Labinger?2004).?A?promising?biological?alternative?is?the?biological?
route? catalyzed? by? P450s,? originating? both? from? eukaryotic? yeast? strains? and? bacterial? strains? as?
exemplified?below.?Significant?strain?engineering?was?applied?to?Candida?tropicalis?expressing?CYP52A.?
The?improved?host?reached?a?final?product?concentration?of?174?g/L?of?14?hydroxytetradecanoic?acid?
and? 6? g/L? of? 1,14?tetradecacanedioic? acid? after? 148? h? of? biotransformation? mainly? by? avoiding?
overoxidation?by?eliminating?the???oxidation?pathway?(Lu?et?al.?2010).??
Alternatively? to? the? yeast?CYP52,?one? family?of? enzymes? shown? to?hydroxylate? short? and?medium?
chain? fatty? acids? but? also? alkanes,?primary? alcohols,? and? limonene,? is? the? bacterial?CYP153? (Malca?
2012;? Scheps? et? al.? 2011;? Van? Beilen? et? al.? 2005;? Bordeaux? et? al.? 2011).? The? three? component?
CYP153A6? from?Mycobacterium? sp.? strain?HXN?1500,?was?expressed? in?E.?coli? resulting? in?6?g/L? (S)?
perillyl? alcohol? from? (S)?limonene? in? a? two?liquid? phase? system,? coexpressing? AlkL? for? improved?
substrate?transport?across?the?membrane?(Cornelissen?et?al.?2013).?The?side?product?formation?was?
reduced? to? 8? %? by? changing? host? from? P.? putida? to? E.? coli.? In? another? study,? the? same? three?
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component?CYP153?system?was?expressed?in?E.?coli?and?applied?for?production?of?octanol?in?a?resting?
cell? transformation? at?1?mL? scale? leading? to? a? final?product? concentration?of?8.7? g/L?of? after?24?h?
(Gudiminchi? et? al.? 2012).? Furthermore,? a? fusion? construct? with? CYP153A13a? fused? to? reductase?
domain?of?P450RhF?expressed? in?E.?coli?was?previously?demonstrated?to?hydroxylate?n?octane?to?1?
octanol?at?a?5?mL? scale,?however,?not?exceeding? the?product?concentration?above? (Bordeaux?et?al.?
2011).???
Within? this? subfamily,? CYP153A? from?Marinobacter? aquaeolei?was? shown? to? catalyze? the? terminal?
hydroxylation? of?medium? and? long? chain?length? fatty? acids? with? high? selectivity? (Malca? 2012).? A?
chimera?protein?was?constructed?consisting?of?the?heme?domain?of?CYP153A?from?M.aquaeolei?fused?
to? the? reductase? domain? of? CYP102A1? from? Bacillus? megaterium.? This? self?sufficient? chimera?
CYP153AM.aq.?CPRBM3? mutant? G307A? (termed? CPR2mut)? with? an? increased? activity? and? coupling?
efficiency? compared? to? the?wild?type,? is? a? soluble? protein?with?more? than? 95?%? ??regioselectivity?
towards? saturated? fatty?acids? in? the? range?of?C12:0?C14:0? (Malca?2012).?CPR2mut?was? recently?applied?
using?a?whole?cell?E.?coli?host?in?a?successful?biotransformation?producing?12?hydroxydodecanoic?acid?
methyl?ester?(Scheps?et?al.?2013).?The?methyl?ester?instead?of?the?fatty?acid?was?used?as?substrate?and?
applied?in?excess?as?a?second?liquid?phase?reaching?a?final?product?concentration?of?4?g/L.?
To? further? improve? the? economic? potential? of? terminal? hydroxylation? of?medium? and? long? chain?
length? fatty? acids? by? this? whole? cell? E.? coli? catalyst? a? better? understanding? of? the? limitations? is?
required.? This? study? focuses? on? the? characterization? of? the? artificial? fusion? construct? CPR2mut?
expressed?in?E.?coli?for?the?production?of?12?hydroxydodecanoic?acid?(Scheme?3.1).?This?is?done?with?
the?intention?to?identify?and?overcome?bottlenecks?of?the?reaction?system?preventing?this?whole?cell?
P450?catalyzed?process?from?reaching?economic?targets?by?studying?whole?cell?biotransformations,?in?
parallel?with?in?vitro?studies.?
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Scheme?3.1? ?hydroxylation?of?dodecanoic?acid?to?12?hydroxydodecanoic?acid?catalyzed?by?the?fusion?
construct?CPR2mut?(CYP153A?heme?domain?fused?to?the?reductase?domain?of?CYP102A1).??
Materials?and?methods?3.2
The? chosen?model? system? used? in? this? study? was? the? terminal? hydroxylation? of? dodecanoic? acid?
performed? by? CYP153A? G307A? from? Marinobacter? aquaeolei? fused? to? the? reductase? domain? of?
CYP102A1? from? Bacillus? megaterium? (termed? CPR2mut)? (Scheme? 3.1).? The? fusion? protein? was?
expressed?in?the?industrially?feasible?E.?coli?strain?HMS174?(DE3)?for?whole?cell?biotransformations,?in?
E.? coli? BL21(DE3)? for? enzyme? purification? and? in? a? knock?out? BL21? strain? for? the? beta? oxidation?
pathway?(?fadD)?for?product?inhibition?studies.?
3.2.1 Chemicals,?bacterial?strains?and?plasmids?
Yeast? extract? and? tryptone?were? purchased? from?Nordic? Biolabs? (Täby,? Sweden),? dodecanoic? acid?
from? Merck? KGaA? (Darmstadt,? Germany)? and? all? other? chemicals? were? from? Sigma?Aldrich?
(Schnelldorf,?Germany).?Plasmid?pET?28a(+)?(Novagen,?Madison,?WI,?USA)?and?L?rhamnose? inducible?
plasmid?pJOE4782.1?(kindly?provided?by?Dr.?Josef?Altenbuchner?(Stumpp?et?al.?2000))?with?the?fusion?
construct?CPR2mut?inserted?were?generated?at?the?ITB,?University?of?Stuttgart,?Germany.?E.?coli?strain?
HMS174?(DE3)?was?obtained?from?the?Striedner?lab?(BOKU,?Vienna,?Austria).?E.?coli?strain?BL21?(DE3)?
was?purchased? from?Novagen? (Madison,?WI,?USA)?and? the?BL21? (?? fadD)? (strain?with? knocked?out?
beta?oxidation?pathway)?was?kindly?provided?by?the?ITB,?University?of?Stuttgart,?Germany.?
66
47?
?
3.2.2 Fermentation?
A?seed?culture?with?LB?media?supplemented?with?kanamycin?(30?μg/mL)?was?inoculated?from?a??80?°C?
glycerol? stock? and? grown? at?37? °C,?180? rpm?until? late?exponential?phase? in? shake? flasks.? The? seed?
culture? was? used? to? inoculate? a? fermenter? with? 1? L? working? volume? (Infors? AG,? Bottmingen,?
Switzerland)?and?fermentation?was?performed?by?glucose?limited?fed?batch?with?a?growth?rate?of?0.1?
h?1? (Marisch? et? al.? 2013).? ? Fermentation? was? controlled? by? Iris? software? (Infors? AG,? Bottmingen,?
Switzerland)? and? feed?was? initiated?when? the? carbon? source? from? the?batch?media?was? depleted,?
indicated?by?a?pO2?spike.?Protein?expression?was?induced?by?0.5?μmol?IPTG?per?g?cdw?one?generation?
after?feed?start?and?the?process?continued?for?3?additional?generations.?Temperature?was?decreased?
at? the? time?of? induction? from?37? °C? to?30? °C,?pH?was?set? to?7.2?and?controlled?by?addition?of?14?%?
NH4OH?and?pO2?set?to?30?%?was?controlled?by?agitation.?Foam?was?controlled?by?addition?of?0.5?mL?
antifoam?204?(Sigma?Aldrich)?per?liter?media.?Cells?were?harvested?by?centrifugation?(4000xg,?25?min),?
washed?and?resuspended?in?100?mM?potassium?phosphate?buffer?pH?7.4,?supplemented?with?20?mM?
glucose?and?1?%?glycerol?and?stored?gently?shaking?in?4?°C?until?further?use.?
An?initial?seed?culture?was?also?used?to?inoculate?2?L?Erlenmeyer?shake?flasks?using?TB?medium?for?cell?
cultivation?and?protein?expression?aerobically?in?shaking?incubators?(Multitron,?Infors?HT,?Bottmingen,?
Switzerland).?Cells?were?grown?at?37?°C,?180?rpm?until?OD600?of?0.7?1?was?reached?before? induction?
and? protein? expression? at? 25? °C,? 180? rpm.? ? After? 16?20? h? of? protein? expression,? the? cells? were?
harvested?and?treated?as?described?above.??
3.2.3 Protein?purification?
The?cells?were?disrupted?using?an?EmulsiFlex?C5? (Avestin,?Mannheim,?Germany)?or?by?sonication?on?
ice?(3x2min,?1?minute?interval?(Heinemann,?Schwaebisch?Gmuend,?Germany)).?The?crude?cell?extracts?
suspended? in?50?mM?Tris?HCl?buffer?pH?7.4?were?centrifugated? (17?000? rpm,?45?min,?4? °C)?and? the?
supernatant? containing? the? soluble?P450?protein?was? recovered.?The?protein?was?purified?using?an?
Äkta?system?(GE?Healthcare?Biosciences,?Uppsala,?Sweden),?with?a?weak?anion?exchange?column?(30?
mL)?packed?with?Toyopearl?DEAE?650?M?(TOSOH,?Stuttgart,?Germany)?at?a?maximum?flow?rate?of?10?
mL/min.?The?binding?buffer?consisted?of?50?mM?Tris?HCl?buffer?(pH?7.4)?and?for?elution?a?step?gradient?
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of?50?mM?Tris?HCl?containing?1?M?NaCl?was?used.?The?protein?elution?was?detected?by?a?characteristic?
absorbance?at?418?nm,? in?addition?to? the? total?protein?detection?at?280?nm? (Sligar?et?al.?1979)?and?
eluted?at?a?concentration?of?250?mM?NaCl.?After?purification,?the?protein?was?concentrated?using?100?
kDa?cut?off?Vivaspin?tubes?(Sartorius,?Goettingen,?Germany)?and?aliquots?were?stored?at??20?°C?until?
further?use.??
3.2.4 In?vitro?substrate?and?product?inhibition?studies?
Substrate?and?product?inhibition?were?investigated?using?purified?enzyme?(0.5?μM?and?1?μM)?in?a?final?
volume?of?300?μL?in?eppendorf?tubes?with?50?mM?potassium?phosphate?buffer,?pH?7.4,?1?mM?NADPH?
cofactor? and? a? cofactor? regeneration? system? (5?mM? glucose?6?phosphate,? 1?mM?MgCl2,? 12? U/ml?
glucose?6?phosphate? dehydrogenase? from? Leuconostoc? mesenteroides).? For? substrate? inhibition?
studies? the? dodecanoic? acid? concentration? was? varied? between? 0.1? and? 2.5? mM.? The? product?
inhibition? experiments? were? performed? with? 1? mM? dodecanoic? acid? and? 0?2? mM? 12?
hydroxydodecanoic?acid.?The?substrate?and?product?were?dissolved?in?DMSO?prior?to?addition?and?the?
final?DMSO?concentration?was?kept?at?5?%?and?not?exceeding?the?water?solubility?limit.?The?reactions?
were?performed?at?30?°C,?700?rpm?stirring,?starting?with?the?addition?of?1?mM?NADPH.??
3.2.5 Resting?cell?biocatalytic?reactions?in?Erlenmeyer?flask??
Studies?of?parameters?believed?not?be? influenced?by? scale?were?performed? in? 100?mL? Erlenmeyer?
flasks?with?a?catalyst?concentration?of?50?g?cww/L.?Carbon?source?(20?mM?glucose?and?1?%?glycerol)?
was?added?at?time?point?0,?4?h?and?8?h?of?biotransformation.?Biocatalytic?reactions?were?performed?at?
30?°C?and?180?rpm.?
3.2.5.1 In?vivo?substrate?and?product?inhibition?studies?
In? vivo? substrate? and? product? inhibition? studies?were? performed? similarly? to? the? in? vitro? studies.?
Biotransformations?with?50?g?cww/L?resting?whole?cells? in?shake?flasks?were?used?and?various? initial?
substrate?concentrations?for?substrate?inhibition?studies?and?a?constant?substrate?concentration?with?
various? amounts? of? product? added? at? time? zero?were? applied? for? product? inhibition? studies.? The?
substrate?and?product?were?pre?dissolved?in?DMSO?and?5?%?of?DMSO?was?used?as?final?concentration.?
Inhibition?profiles?were?estimated?from?initial?reaction?rates.???
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3.2.5.2 Cofactor?limitation?
Cofactor?limitation?was?explored?by?addition?of?external?NADPH?in?stoichiometric?concentrations?(1.5?mM)?or?3?
mM?from?a?pre?dissolved?stock?in?100?mM?potassium?phosphate?buffer?(pH?7.4).?The?cofactor?was?confirmed?to?
be?taken?up?by?the?cell?by?monitoring?the?absorbance?by?NADPH?at?340?nm.??
3.2.5.3 Transport?limitation?
Transport? limitation?was? examined? by? different? permeabilization?methods? prior? to? the? biocatalytic?
reaction.?Both?mechanical? and? chemical?methods?were? applied.? Frozen? cells?were? spun?down? and?
pellet? frozen? in? ?20? °C?over?night.?Acetone? treated?cells?were? incubated?with?5?%?acetone?during?2?
minutes?while?vortexing.?Sonication?was?performed?during?1x2?minutes?(amplitude?60?%,?0.5?s?cycles)?
(UP400? S,? Hielscher? Ultrasonic? GmbH,? Teltow,? Germany).? Following? permeabilization? treatment?
(acetone?treatment?and?sonication)?cells?were?spun?down?and?the?pellet?was?resuspended?in?100?mM?
potassium?phosphate?buffer?pH?7.4.???
3.2.6 Resting?cell?biocatalytic?reactions?in?bioreactor?
To?expose? the?biocatalyst? to?more? industrial? relevant? conditions,? in? terms?of? stirring? and? aeration,?
biocatalytic? reactions?were? also? performed? in? a? stirred? tank? reactor? (Infors?Multifors? 2? (Infors?AG,?
Bottmingen,?Switzerland)).?Settings?controlled?via? Iris?software?were?pO2,? temperature?and?pH?with?
setpoints? 30?%? (controlled? by? stirrer),? 30? °C? and? 7.4? (controlled? by? 10?%? H3PO4? and? 5?M?NaOH)?
respectively.?Aeration?was?set?to?3.75?vvm.?Antifoam?204?was?added?according?to?need.??
3.2.7 Analytical?methods?
3.2.7.1 P450?determination??
The?concentration?of?correctly? folded?P450?was?measured?by?CO?differential?spectral?assay? (Omura?
and? Sato? 1964).? Samples? from? fermentations? and? biotransformations?were? stored? in? the? form? of?
frozen?cell?pellet?until?analyzed.?Cell?pellet?was?resuspended? in?2?mL?100?mM?potassium?phosphate?
buffer?and?a?spatula?tip?of?sodium?hydrosulfite?was?added?to?the?resuspension?and?incubated?on? ice?
for? 10?min.? The? resuspension?was? split? into? two? cuvettes,? of?which? one?was? treated?with? carbon?
monoxide?for?1?min?before?the?differential?spectra?was?measured?between?400?and?500?nm?(UV?1800,?
Shimadzu?Corporation,?Kyoto,?Japan).??
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3.2.7.2 Cell?dry?weight?determination??
Pellets? from? 1? mL? fermentation? or? biotransformation? samples? were? frozen? and,? after? thawing,?
resuspended?in?an?equal?volume?of?100?mM?potassium?phosphate?buffer,?pH?7.4?and?filtered?through?
preweighed?0.22?μm?PES?membrane? filter? (Frisenette,?Knebel,?Denmark)?by?application?of?vacuum.?
The?filters?were?dried?in?a?microwave?and?left?to?equilibrate?in?a?desiccator?before?weighing?both?prior?
to,?and?after,?application?of?the?sample.??
3.2.7.3 GC?analysis?
Reaction?progress?was?monitored?by?GC?FID?(Clarus?500?Gas?Chromatograph,?PerkinElmer,?Waltham,?
MA,? USA)? using? a? Elite?5? column? (PerkinElmer,? Waltham,? MA,? USA)? and? helium? as? carrier? gas.?
Alternatively,? the?mass? spectra?were? collected?on? a?GC?MS?QP?2010? instrument? (Shimadzu,? Japan)?
equipped?with?a?DB?5?MS?column? (30?m×0.25?mm×0.25??m)? (Agilent?Technologies,?Santa?Clara,?CA,?
USA)? with? helium? as? carrier? gas.?Mass? spectra? were? collected? using? ESI? (70? eV).? Samples? were?
prepared?by?extraction? in?twice?the?sample?volume?with?diethylether?or?tert?methyl?butyl?ether,?the?
organic?phase?pooled?and?centrifuged?and?then? left?to?evaporate?followed?by?resuspension? in?equal?
volumes? (60?μl)?tert?methyl?butyl?ether?and?N,O?bis(trimethylsilyl)trifluoroacetamide?containing?1?%?
trimethylchlorsilane?before?derivatization?(20?min,?70?°C).?Tridecanoic?acid?or?decanoic?acid?were?used?
as?an? internal?standard.?A? linear? temperature?gradient? from?180? °C? to?300? °C? (15?min)?was?applied?
after?1?minute?at?initial?conditions.?The?injection?volume?was?1?μL?and?a?split?ratio?of?20?was?used.?
Results?3.3
3.3.1 Catalyst?characterization?
To?identify?the?limitations?of?the?whole?cell?catalyzed???hydroxylation?of?dodecanoic?acid?by?CPR2mut?
expressed?in?E.?coli,?the?system?was?initially?characterized?at?small?scale?(shake?flasks).?This?part?of?the?
work?focused?on?the?limitations?identified?in?general?for?whole?cell?P450?catalyzed?reactions,?related?
to?the?catalyst?and?reaction.?The?potential?substrate?and?product?inhibition?was?examined?in?vitro?and?
in?vivo?to?identify?suitable?reaction?conditions.?Furthermore,?cofactor?regeneration?of?the?resting?host?
cell?and?potential?substrate?transport?limitations?across?the?cell?membrane?were?also?investigated.?
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3.3.1.1 Substrate?inhibition?studies?in?vitro?and?in?vivo?
To?determine?potential?substrate? inhibition?of? the?enzyme,? in?vitro? reactions?were?performed?using?
purified?CPR2mut? (1?μM)?and?different?concentrations?of?dodecanoic?acid? (0.1?2.5?mM),? starting? the?
reaction?with? the? addition? of? the? cofactor?NADPH.? Initial? rates?were? estimated? after? 2?minutes? of?
reaction? (Figure? 3.1).? At? higher? substrate? concentrations? (above? 1?mM),? the? initial? rate? decreases?
indicating?an? inhibitory?effect?of? the?substrate.? In?Figure?3.1,?a?reciprocal?plot?used? for?detection?of?
substrate?inhibition?is?displayed?(Cornish?Bowden?2012)?and?potential?kinetic?parameters?resulting?in?
the?dashed?line?in?Figure?3.1?are?Km?0.4,?vmax?0.25?and?Ksi?2.??
?
Figure?3.1?Left:?Substrate?dependence?of?initial?product?formation?rate?catalyzed?by?1?μM?of?purified?
CPR2mut.?Trendline? is? indicated?with?a?dashed? line.?Right:?Reciprocal?plot? for?detection?of? substrate?
inhibition? (Cornish?Bowden? 2012).? At? high? substrate? concentrations? deviations? from? the? linear?
dependence?(solid?line)?predicted?from?concentrations?lower?than?or?equal?to?1?mM?can?be?seen.??
?
To? investigate?whether? the?same?substrate? inhibition? trend?could?be?observed?using? the?whole?cell?
catalyst,?the?effect?of?increasing?substrate?concentrations?was?also?investigated?in?vivo,?using?resting?
cells.?Figure?3.2?illustrates?the?initial?reaction?rate?at?various?substrate?concentrations?in?the?range?of?
(0.5–5?mM)?using?50?g?cww/L.?The? initial?rate?was?estimated?after?1?h?of?biotransformation?in?shake?
flasks.?In?vivo?results?confirm?the?indicated?substrate?inhibition?in?vitro.?
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Figure?3.2:?Whole?cell?biotransformation?with?increasing?concentrations?of?dodecanoic?acid?(using?5?%?
DMSO).?Experiments?performed?in?shake?flasks?using?50?g?cww/L?in?duplicates?and?error?bars?are?1??.?
?
Substrate? inhibition?was? further? confirmed? in?bioreactors,?where? transformations?with? resting? cells?
were?performed?with?5,?10?and?15?mM? substrate? concentration.?The? lowest?concentration? (5?mM)?
displayed?95?%? conversion?within?1?h?of? reaction?whereas? the? transformation?performed?with? the?
highest?substrate?concentration?(15?mM)?did?not?show?any?conversion?during?the?22?h?reaction?course?
(Figure?3.3).? The? 5? and?10?mM?experiments?did?not? show? any? significant?difference? in? initial? rate.?
However,? when? 10? mM? of? substrate? was? applied,? the? reaction? rate? slowed? down? after? 50? %?
conversion? corresponding? to?5?mM?product? formed? and?did?not? reach? complete? conversion?which?
potentially? could? indicate? a? negative? effect?of? the? product? formed.? The? initial? rate? of? experiments?
performed? in?shake? flasks?and? in?stirred? tank? reactors? (Figure?3.2?and?Figure?3.3)?differs? in? favor?of?
reactor?experiment?and?this?has?also?been?observed?previously,?and?is?believed?to?be?due?to?enhanced?
mixing? in? the? stirred? tank? reactor? (Kiss? et? al.? 2015).? The? effect? in? this? case? could? alternatively? be?
attributed?to?the?cells?originating?from?different?fermentation?batches.??
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Figure?3.3?Conversions?for?transformation? in?bioreactor?with? increasing?substrate?concentrations? (5,?
10?and?15?mM).?Experimental?conditions:??50?g?cww/L,?100?mM?potassium?phosphate?buffer?pH?7.4.?
The?substrate?was?dissolved?in?DMSO?and?applied?using?a?final?DMSO?concentration?of?5?%?(v/v).?
3.3.1.2 Product?inhibition?studies?in?vitro?and?in?vivo?
To?evaluate? if? the? reason? for? the? slower?conversion? rate?after? reaching?high?product?concentration?
could? be? product? inhibition,? in? vitro? reactions?were? performed? using? a? constant? concentration? of?
substrate?(1?mM)?and?different? initial?concentrations?of?the?product?12?hydroxydodecanoic?acid?(0?2?
mM)? (Figure?3.4).?The?decreasing? initial? rate?at? increasing?product?concentrations? indicates?product?
inhibition? using? 1? μM? and? 0.5? μM? of? purified? enzyme.? No? reaction? took? place? at? product?
concentrations? above? 1? mM? and? 1.5? mM? for? enzyme? concentrations? of? 0.5? μM? and? 1? μM,?
respectively.? These? results? indicate? that? the? product? inhibition? is? dependent? on? the? biocatalyst?
concentration?and?not?only? the?absolute?product?concentration,? implying? that?with?a? lower?enzyme?
concentration? the? negative? effect? appears? at? lower? actual? concentrations? of? product.?Without? a?
detailed?mechanistic?investigation,?this?could?potentially?be?explained?by?an?irreversible?binding?of?the?
product?to?the?active?site?of?the?enzyme,?thereby?making?the?inhibition?or?inactivation?dependent?on?
the?ratio?of?product?and?enzyme.??
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Figure?3.4?Influence?of?increasing?initial?product?concentration?(0?2?mM)?on?initial?rates.?The?reaction?
was?performed?in?vitro?and?initiated?by?the?addition?of?1?mM?of?dodecanoic?acid.?The?substrate?was?
dissolved?in?DMSO?and?applied?using?a?final?DMSO?concentration?of?5?%?(v/v).?
Potential? product? inhibition? was? also? evaluated? in? vivo? using? resting? whole? cells? in? shake? flasks?
performing?biotransformations?of?1.5?mM?of? initial?dodecanoic?acid?as?substrate?(Figure?3.5).?The?E.?
coli? strain?BL21? (?fadD)?was?used? in?order? to?avoid?any? consumption?of? formed?product?by? the? ??
oxidation? pathway.?What? could? be? observed?was? that? the? rate? of? product? formation? after? 2? h? of?
reaction?decreases?with?increasing?concentration?of?product?at?time?point?0.?In?agreement?with?the?in?
vitro?results,?the?presence?of?the?product,?12?hydroxydodecanoic?acid,?is?inhibitory?also?to?the?whole?
cell?catalyst.?
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Figure?3.5?Product?inhibition?profile?in?vivo?after?2?h?biotransformation?using?1.5?mM?dodecanoic?acid?
and?increasing?initial?product?concentration?performed?in?shake?flasks.?The?substrate?was?dissolved?in?
DMSO?and?applied?using?a?final?DMSO?concentration?of?5?%?(v/v).??
3.3.1.3 Cofactor?regeneration?
?One? of? the? reasons? for? using? a?whole? cell? system? for? cofactor? requiring? catalysis? is? the? ability? of?
metabolically?active?cells?to?regenerate?nicotinamide?cofactors.?This?has?however?been?suggested?to?
be? a? potential? limitation? in? an? overexpressed? host? (Lundemo? and?Woodley? 2015;? Bernhardt? and?
Urlacher?2014;?Siriphongphaew?et?al.?2012).?We?investigated?the?potential?limitation?of?resting?E.?coli?
to? regenerate? sufficient? NADPH? for? the? desired? biocatalytic? reaction.? Resting? whole? cell?
biotransformation?was?performed?in?shake?flasks,?at?a?substrate?concentration?of?1.5?mM?(Figure?3.6).?
Different?amounts?of?NADPH?were?added?to?the?biotransformations?and?the?initial?rate?was?evaluated.?
The?highest? initial?rate?was?obtained?when?twice?the?stoichiometric?amounts?of?substrate?of?NADPH?
was?provided?(3?mM)? indicating?that?the?cofactor?regeneration?of?the?resting?cell? is?not?sufficient?to?
support?the?catalytic?reaction,?at?achieved?rates?and?with?current?coupling?efficiency.?
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Figure? 3.6? Influence? of? cofactor? addition? on? biotransformations?with? resting? cells? in? shake? flasks.?
Reaction?conditions:??1.5?mM?dodecanoic?acid?and?NADPH?cofactor?added?at?the?start?of?the?reaction.?
3.3.1.4 Substrate?transport?limitation?studies?
The? last? potential? limitation? related? to? the? biocatalyst? investigated? in? this? study? was? substrate?
transport? across? the? cell? membrane.? Different? permeabilization? techniques? (sonication,? acetone?
treatment? and? freezing/thawing)? were? applied? prior? to? resting? cell? biotransformations.? Progress?
curves?of? the?biotransformations?using?1.5?mM?dodecanoic? acid? are? shown? in? Figure?3.7?with? and?
without? stoichiometric? amounts?of?NADPH? added.? The?highest? final? concentration?was? reached?by?
intact?cells?with?and?without?additional?cofactor?added.?No?permeabilization?method?with?or?without?
the?addition?of?cofactor?increased?the?reaction?performance,?indication?that?the?reaction?is?not?limited?
by?substrate?transport?across?the?cell?membrane.??
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Figure? 3.7? Progress? curves? of? biotransformations? of? 1.5?mM? dodecanoic? acid? in? shake? flasks? after?
different?permeabilization?methods?of? the?cell?membrane.?The?experiments?were?performed? in? the?
presence? (left? figure)? as?well? as? in? the? absence? (right? figure)? of? stoichiometric? amount? of?NADPH?
cofactor?(1.5?mM)?supplemented?at?the?beginning?of?the?reaction.??
3.3.2 Process?development?
To?study?the?reaction?in?a?more?easily?controlled?environment?and?with?relevant?agitation?and?oxygen?
supply? further? transformations? processes?were? performed? in? a? bioreactor,?which? is? also? the? final?
intended?reactor?configuration?for?this?type?of?biotransformation?process.?
3.3.2.1 Operating?in?a?bioreactor?
Progress? curves? of? a? biotransformation? performed? in? a? 1? L? bioreactor? using? 5? mM? substrate?
concentration? is?shown? in?Figure?3.8.?Substrate? inhibition?was?shown?to?occur? in?vivo? in?shake? flask?
transformations? already? above?1?mM? substrate? concentration.?However,? the? inhibition? profile? and?
reaction?rate?was?shown?to?be?different?in?stirred?tank?reactors?compared?to?shake?flasks?as?already?
discussed.?What?also?could?be?detected?at?higher?substrate?concentration?was? the?overoxidation? to?
dicarboxylic?acid.?During? the? course?of? the? reaction,? the? influence?on? cell?viability?was? followed?by?
measuring?the?cell?dry?weight?and?the?enzyme?inactivation?was?monitored?spectrophotometrically?by?
the? absorbance? at? 450? nm? of? the? reduced? CO? bound? form? of? the? correctly? folded? heme? domain?
(Omura?and?Sato?1964)? (Figure?3.8).? It?can?be?seen? that? the?whole?cell? is? intact?during? the?reaction?
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course?but?50?%?of? the? correctly? folded?enzyme?has?been? lost? already? after?2?h.? This? implies? that?
increased?stability?of?the?P450?fusion?construct?is?essential?for?further?development?of?the?process.?
?
Figure?3.8?Left:?Progress?curve?of?biotransformation?performed?in?1?L?bioreactor.?Reaction?conditions:?
50? g? cww/L,? 100? mM? potassium? phosphate? buffer? pH? 7.4,? 30? °C,? pO2? 30? %,? initial? substrate?
concentration? 5? mM.? Right:? Cell? dry? weight? and? correctly? folded? P450? during? transformation?
performed?in?1?L?reactor.?
3.3.2.2 Media?supplements?
To?understand?the?preferred?reaction?conditions?and?mode?of?operation?further?experiments?with?and?
without?carbon?source?and?nitrogen?source?were?performed.??Supplemental?carbon?was?found?to?be?
critical? for? the?performance?of? the? resting? cells? (Figure?3.9),?most? likely?due? to? the? requirement?of?
carbon? source? for? cofactor? regeneration.? Addition? of? nitrogen? source? (ammonium? sulfate)? to? the?
resting?cell?reaction?performed?in?100?mM?phosphate?buffer?(pH?7.4)?did?not?show?any?effect?on?the?
catalytic?performance,?however,?the?cells?started?to?increase?in?density?measured?by?following?the?cell?
dry?weight?(Figure?3.9).?Based?on?these?results,?the?biocatalytic?reaction?could?also?be?performed?in?a?
growing?cell?format.?However,?this?was?not?investigated?further?in?this?study.?
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Figure?3.9?Left:?Comparison?of?resting?cell?biotransformations?with?and?without?carbon?and?nitrogen?
source?performed?in?shake?flasks.?Carbon?source?can?be?seen?to?be?required?to?regenerate?cofactors?
required? for? the? biocatalytic? reaction.? Right:? Addition? of? nitrogen? source? does? not? increase? the?
reaction?performance?and?enables?cell?growth?seen?by?increasing?biomass?concentration.?Data?from?a?
5?mM? transformation? performed? in? a? bioreactor.? A? positive? effect? on? the? stability? of? the? P450? is?
indicated? compared? to? the? resting? cell? reaction?without? nitrogen? source? seen? in? Figure? 3.8.? (N? –?
nitrogen)?
3.3.2.3 Substrate?supply?
Substrate? and? product? inhibition? together? with? poor? P450? stability? and? insufficient? cofactor?
regeneration? have? been? demonstrated? as? limitations? for? this? reaction? system.? Different? substrate?
feeding? strategies?were? used? as? a? simple? and? easily? implemented?method? to? avoid? the? substrate?
inhibition? and? potentially? increase? the? stability,? by? e.g.? eliminating? the? use? of? co?solvent.? The?
commonly?used?batch?process?with?substrate?applied?dissolved?in?DMSO?(to?a?final?concentration?of?5?
%)?was?compared?with?application?of?the?substrate?dodecanoic?acid?in?solid?form.?In?addition,?a?batch?
with? solid?application?of? substrate?using? cells?pre?treated?with?5?%?DMSO?and?a? fed?batch?process?
(loading?substrate?dissolved?in?DMSO)?were?evaluated.?The?best?conversion?of?substrate?and?the?best?
rate?of? reaction?were?achieved?by?application?of? substrate? in? solid? form? (Figure?3.10).?The? reduced?
performance?of? the?cells?pretreated?with?DMSO? indicates? that? the?negative?effect?of? the?co?solvent?
can? be? explained? by? damage? to? the? catalyst.? However,? the? difference? of? the? solid? application? of?
substrate? to? the? cells? pretreated?with?DMSO? and? the? traditional? batch? process? can?most? likely? be?
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explained? by? inhibition? by? the? substrate? and? product? present? in? the? aqueous? phase?when? the? co?
solvent?is?present.??
Figure?3.10?Biotransformation?reaction?performed?in?1L?bioreactor.?Reaction?conditions:?50?g?cww/L,?
100?mM?potassium?phosphate?buffer?pH?7.4,?30?°C,?pO2?30?%,? initial?substrate?concentration? in?the?
batch?10?mM.?
To? study? the? solubility? of? dodecanoic? acid? and? to? understand? the? positive? effect? of? the? solid?
application? of? the? substrate,? an? experiment?was? set? up? identical? to? the? biotransformation? in? the?
bioreactor,?with?the?exception?that?no?cells?were?added.?Samples?were?taken?during?the?same?time?
interval?as?during?the?biotransformation.?The?aqueous?solubility?under?these?conditions?was?shown?to?
be?approximately?1.5?mM?(Figure?3.11).?This?is?significantly?lower?than?the?final?product?concentration?
reached?when?solid?feed?was?applied.?The?reported?water?solubility?at?25?°C?of?dodecanoic?acid?and?
12?OH? dodecanoic? acid? is? 12.76?mg/L? (ChemSpider? b)? and? 278?mg/L? (ChemSpider? c)? respectively?
corresponding?to?64?μM?and?1.3?mM.?This?indicates?that?with?our?experimental?setup?higher?solubility?
was? reached.? The? achieved? product? concentration? implies? that? the? solubilization? of? the? substrate?
continues? during? the? reaction? course? and? that? the? rate? of? dissolution? is? not? limiting? the? rate? of?
reaction.??
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Figure?3.11?Solubility?of?10?mM?dodecanoic?acid?in?100?mM?potassium?phosphate?buffer?over?time.?
Discussion?3.4
In?order?to?reach?the?requirements?of?an?economically?feasible?biocatalytic?process?the?concentration?
of?product? (and? therefore? substrate)?need? to?be? increased? from?what? is?normally?used? in? research?
laboratories.? In? this? chapter? a? methodological? approach? has? been? used? to? identify? bottlenecks?
preventing? us? from? reaching? the? concentration? targets? for? an? economically? feasible? process.?
Theoretically?identified?limitations?defined?in?Chapter?2?have?been?the?basis?for?the?investigation.?The?
P450?chimera?consisting?of?the?heme?domain?of?CYP153A?from?Marinobacter?aquaeolei?fused?to?the?
reductase?domain?of?CYP102A1?has?been?well? studied.?The?heme?domain?was?modified?by?protein?
engineering? for? increased? activity? and? the? regioselectivity? of? the? enzyme? was? improved? towards?
terminal?hydroxylation?(Malca?2012).?By?creation?of?a?fusion?construct?the?best?prerequisites?for?high?
expression?levels,?efficient?electron?transport?with?a?coupling?efficiency?of?73?%?and?high?activity?have?
been?fulfilled?(Scheps?et?al.?2013).??
E.? coli?HMS174,? an? industrial? relevant? E.? coli? strain,? known? to? have? an? enhanced? plasmid? stability?
compared? to? BL21? was? used? as?model? host? in? this? study.? A? successful? fermentation? process? for?
expression?of?the?fusion?construct?has?been?established?yielding?9?000?nmol?P450/L?for?a?fermentation?
process?with?a?final?cell?density?of?25?g?cdw/L?based?on?Marisch?et?al.?(2013).??
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The?focus?of?the?biocatalytic?reaction?has?been?resting?cell?biotransformations,?to?be?able?to?separate?
the?reaction?from?growth.?This?mode?of?operation?allows?optimization?of?the?biocatalytic?reaction,?e.g.?
by? change? of? biomass? concentration? and? also? recycle? of? the? biocatalyst.? Limiting? parameters? are?
defined?as?substrate?and?product?inhibition?as?well?as?enzyme?stability?and?cofactor?regeneration.?The?
substrate? inhibition? has? been? addressed? here? with? improved? reaction? performance? using? solid?
application? of? substrate,? also? benefitting? from? the? avoidance? of? organic? co?solvent.? Furthermore,?
external? supplement? of? cofactor? was? shown? to? be? beneficial? for? the? biocatalytic? reaction? but? is?
obviously?no?economical?viable?option?to?improve?the?cofactor?availability.?The?cofactor?regeneration?
can?be?improved?by?coexpression?of?e.g.?dehydrogenase.?However,?the?consequence?of?lower?possible?
expression? levels?of? the?P450? is?not?desired.?A? first?approach? in? this?case?would?be? to? improve? the?
coupling? efficiency? even? further,? thereby? utilizing? the? cofactors?more? efficiently? and? probably? also?
increase? the? stability? of? the? P450? by?minimizing? the? production? of? reactive? oxygen? species.? The?
stability? of? the? P450? can? be? seen? to? be? a?major? issue? in? this? study? and? perhaps? one? of? the?most?
challenging?aspects?of?whole?cell?catalysis.?Protein?engineering? is? the?most?promising?alternative? to?
increase?the?stability?of?the?enzyme?(Cirino?and?Arnold?2003;?Salazar?et?al.?2003).??
Characterization? and? identification?of? the? limitations?of? a?biocatalytic?process? is?only? the? first? step?
towards? development? of? an? economical? feasible? process.? The? performance? also? needs? to? be?
translated? into? quantitative? targets? and? from? there? required? improvements? on? the? biocatalytic?
parameters?identified.?The?economic?targets,?from?Chapter?2,?are?presented?in?Figure?3.12.?Regardless?
of?the?mode?of?operation,?high?final?product?concentrations?(more?than?20?g/L)?are?required?to?avoid?
high?DSP?cost.?A?high?reaction?yield,?above?90?%,?is?also?irrespective?mode?of?operation.?For?a?resting?
cell?process,? requirements?on? a?biocatalyst? yield?of?10?g/g? cdw? and? for? a? growing? cell?process? the?
identified?requirements?on?space?time?yield? is?2?g/L/h.? In?Figure?3.12?data?from?the?first?8?h?of?a?10?
mM? batch? biotransformation? (results? also? shown? in? Figure? 3.3)? is? represented? in? relation? to? the?
targets? discussed? above.?With? the? introduction? of? solid? substrate,? the? final? product? concentration?
could?be?increased?179?%?(from?0.43?g/L?to?1.2?g/L)?compared?to?the?control,?where?the?substrate?was?
pre?dissolved? in? DMSO? using? the? same? batch? of? cells.? However,? the? biocatalytic? performance? of?
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different?batches?of?cells?was?shown?to?vary?and?the?economic?calculations?below?are?based?on?the?
process?presented?in?Figure?3.3,?where?the?substrate?was?supplied?pre?dissolved?in?DMSO.??
?
Figure?3.12?Metrics?reached?after?8?h?in?a?batch?process?using?10?mM?substrate?are?presented?along?
with?quantitative?targets?for?an?economically?feasible?process?(Lundemo?and?Woodley?2015).??
Recommendations?for?future?development?3.5
In? order? to? fulfill? the? required? targets? presented? in? Figure? 3.12? several? aspects? of? the? biocatalytic?
reaction? will? require? improvement.? The? reaction? yield? is? close? to? reaching? the? target? and? when?
concentrations?of?substrate?and?catalyst?are?optimized?it?will?likely?move?even?closer.??
The? final?product? concentration? can?be? improved?by? increased? catalyst? stability,? increased? catalyst?
concentration? or? by? increased? specific? activity? of? the? biocatalyst.? As? seen? in? Figure? 3.12,? a? total?
improvement?of?12x?of?these?parameters?would?be?required?to?reach?the?target.?An?increased?stability?
of?3x?to?24?h?instead?of?8?h?in?combination?with?2x?increase?in?both?catalyst?concentration?and?specific?
activity?would?lead?to?the?target?final?product?concentration?of?20?g/L.?
The?space?time?yield?can?be?applied?in?a?resting?cell?process?to?reflect?the?equipment?occupancy?even?
though?the?metric?is?of?more?importance?for?a?growing?cell?process.?In?a?resting?cell?process?the?space?
time? yield? can?be? improved?by? increasing? catalyst? concentration? and?by? increased? specific? activity.?
Unfortunately,? a? doubled? catalyst? concentration? and? 2x? increased? specific? activity? would? not? be?
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sufficient? to? reach? the? set? target,? the? specific? activity?would?have? to?be? improved?5x? instead.?This?
could?be?addressed?by?protein?engineering?but?the?cofactor?regeneration?will?probably?be?a?challenge.?
As? demonstrated? in? this? study,? the? cofactor? regeneration? is? a? limiting? factor? for? this? resting? cell?
process.?The?capacity?of?the?cell?needs?to?be?utilized?efficiently,?by?optimized?enzyme?expression?and?
high?coupling?efficiency?to?minimize?unproductive?consumption?of?cofactor.??
Even?with? the? summarized? improvements? above? the? biocatalyst? yield? only? reaches? 1.65? g/g? cdw,?
indicating?that?the?catalyst?in?this?case?would?have?to?be?recycled?6?times?in?order?to?reach?the?target.?
This?will?most?likely?be?challenging?since?more?than?50?%?of?the?correctly?folded?P450?is?lost?after?4?h?
of?the?reaction?and?indicates?that?the?P450?process?is?preferably?run?using?growing?cells?as?operating?
mode.?
The? use? of? solid? substrate? is? a? promising? approach? to? avoid? the? need? for? immiscible? solvent? that?
potentially?can?damage?the?catalyst?and?at?the?same?time?would?cause?the?product?to?precipitate?at?
higher?concentrations.? In?research? laboratories?this?might?be?a?practical? issue?for?analysis?but? in?the?
final?process?it?enables?simple?separation?of?the?product?from?the?broth.???????
Conclusions?3.6
Limitations? for? the? resting? cell? P450? process? of? ??hydroxylation? of? dodecanoic? acid,? catalyzed? by?
CYP153A?fused?to?the?reductase?domain?of?CYP102A1?expressed?in?E.?coli,?was?demonstrated?as?a?first?
step? towards? process? development.? Insufficient? stability? of? the? catalyst? is? the?main? hurdle? for? an?
economically?feasible?process.?Cofactor?regeneration?and?substrate?and?product?inhibition?also?needs?
to?be? addressed,? as?well? as?demands?on? increased? specific? activity?of? the? cell.?Application?of? solid?
substrate? is?a?promising?approach?to?address?the? low?stability?of?the?biocatalyst?as?well?as?substrate?
and? product? inhibition? by? the? avoidance? of? co?solvent,? thereby? lowering? the? amount? of? soluble?
substrate?and?product.?
? ?
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4 Case?study?II:?CYP106A2?expressed?in?Bacillus?megaterium?catalyzing?15??
hydroxylation?of?cyproterone?acetate?
The?model? system? chosen? for? the? second? case? study? represents? a? natural? P450? expressing? host,?
industrially?established,?and?a?multicomponent?P450.?The?overexpressed?P450,?CYP106A2?is?naturally?
expressed? in? Bacillus? megaterium? ATCC? 13368? and? was? in? this? study? overexpressed? in? Bacillus?
megaterium?MS941,?without?overexpressing? the? still?unknown? redox?partners.?CYP106A2?has?been?
characterized? in? Professor? Rita? Bernhardt’s? lab,? Saarland? University,? Germany? who? also? kindly?
provided?the?whole?cell?biocatalyst.?
CYP106A2? from?Bacillus?megaterium?ATCC?13368?was? first? identified?as?a?regio??and?stereoselective?
15??hydroxylase? of? 3?oxo??4?steroids.? Recently,? it? was? shown? that? besides? 3?oxo??4?steroids,? 3?
hydroxy??5?steroids?as?well?as?di?and?triterpenes?can?also?serve?as?substrates?for?this?biocatalyst.?It?is?
highly?selective?towards?the?15??position,?but?the?6?,?7?/?,?9?,?11??and?15??positions?have?also?been?
described? as? targets? for? hydroxylation.? Based? on? the? broad? substrate? spectrum? and? hydroxylating?
capacity,? it? is? an? excellent? candidate? for? the? production? of? human? drug? metabolites? and? drug?
precursors.??
In?this?work,?the?conversion?of?a?synthetic?testosterone?derivative,?cyproterone?acetate,?by?CYP106A2?
under? in? vitro? and? in? vivo? conditions? was? demonstrated.? Using? a? Bacillus?megaterium? whole?cell?
system?overexpressing?CYP106A2,?sufficient?amounts?of?product?for?structure?elucidation?by?nuclear?
magnetic? resonance? spectroscopy? were? obtained.? The? product? was? characterized? as? 15??
hydroxycyproterone? acetate,? the?main? human?metabolite.? Since? the? product? is? of? pharmaceutical?
interest,?the?aim?was?to? intensify?the?process?by? increasing?the?substrate?concentration?and?to?scale?
up? the? reaction? from? shake? flasks? to? bioreactors? to? demonstrate? an? efficient,? yet? green? and? cost?
effective?production.?Using?a?bench?top?bioreactor?and?the?recombinant?Bacillus?megaterium?system,?
both?a? fermentation?and?a? transformation?process?were? successfully? implemented.?To? improve? the?
yield?and?product? titers? for? future? industrial?application,? the?main?bottlenecks?of? the? reaction?were?
addressed.??
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This?chapter?is?based?in?large?part?on?our?paper?submitted?to?Microbial?Cell?Factories?(Paper?III).?
Introduction?4.1
P450s? represent? a? suitable? alternative? over? chemical? synthesis,? especially? in? the? hydroxylation? of?
steroidal? pharmaceuticals,? where? the? chemical? methods? are? either? time?? and? labor?intensive,?
expensive?and?complex?or?non?existent? (Donova?and?Egorova?2012).?Steroid?based?drugs?are?one?of?
the? largest?groups?of?marketed?pharmaceuticals? (Bureik?and?Bernhardt?2007).?There?are?about?300?
approved? steroid? drugs? to? date? and? their? number? is? constantly? growing? due? to? the? production? of?
diversely? functionalized?steroid?cores,?resulting? in?often?altered?therapeutic?activity? (Tong?and?Dong?
2009).? Thus,? steroid?hydroxylating? P450s? could? provide? an? alternative? for? the? production? of? drug?
precursors?and?human?drug?metabolites.??
?
The?bacterial?P450,?CYP106A2?from?Bacillus?megaterium?(B.?megaterium)?ATCC?13368,? is?one?of?the?
few?cloned?bacterial?steroid?hydroxylases?that?has?been?studied?in?detail?and?was?announced?to?be?a?
suitable?biocatalyst?for?the?production?of?hydroxysteroids?(Zehentgruber?et?al.?2010a).?CYP106A2,?also?
known?as?15??hydroxylase,?converts?mainly?3?oxo??4?steroids? (Lisurek?et?al.?2004;?Berg?et?al.?1976;?
Kiss? et? al.? 2014)? although? recent? studies? have? shown? that? it? can? perform? di?? and? triterpenoid?
hydroxylation?(Bleif?et?al.?2012;?Bleif?et?al.?2011;?Schmitz?et?al.?2012)?and?the?conversion?of?3?hydroxy?
?5?steroids?(Schmitz?et?al.?2014).?Moreover,?as?a?result?of?on?going?screening?of?a?natural?substrate?
library,?the?substrate?range?of?this?enzyme? is?constantly?extended.?However,?the?native?substrate?of?
CYP106A2,?and?thus? its?biological?function,?are?still?unknown.? Its?natural?electron?transfer?protein? is?
also?unknown,?yet? the?activity?was? successfully?demonstrated?using?megaredoxin?and?megaredoxin?
reductase?(Berg?et?al.?1976)?and?it?is?also?supported?by?the?bovine?adrenal?redox?partners?as?well?as?by?
putidaredoxin?and?putidaredoxin?reductase?(Hannemann?et?al.?2006;?Virus?et?al.?2006;?Zehentgruber?
et?al.?2010a).??
?
In?the?past?two?decades?CYP106A2?was?profoundly?investigated?as?a?biocatalyst,?applying?the?enzyme?
in?whole?cell? systems,? efficiently? using? both? E.? coli? (Hannemann? et? al.? 2006;? Zehentgruber? et? al.?
2010a)?and?B.?megaterium?as?expression?hosts?(Bleif?et?al.?2012;?Bleif?et?al.?2011;?Schmitz?et?al.?2012;?
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Schmitz?et?al.?2014).?Whole?cell?systems,?in?which?the?P450?is?expressed?by?a?microbial?host,?have?the?
advantage?of? stabilizing? the?enzyme?under?process? conditions? and?providing? cofactor? regeneration?
through?cellular?metabolism,?avoiding?the?need?for?the?expensive?NADPH?supply.??
?
Since?the?transport?of?hydrophobic?substances?across?the?outer?membrane?of?E.?coli?was?found?to?be?
limiting?(Zehentgruber?et?al.?2010a),?the?attention?was?shifted?to?the?gram?positive?B.?megaterium?as?
host.? This? spore?forming,? mainly? aerobic? bacterium? became? a? long?term? participant? of? the?
biotechnological? industry,?due? to? the? fact? that?even? the?wild?type? strains?are? capable?of?producing?
high?titers?of?proteins?of?industrial?interest?(Meinhardt?et?al.?1989;?Barg?et?al.?2005).?Further?attractive?
characteristics? include? the? ability? to? grow? on? a? variety? of? carbon? sources,? the? GRAS? status,? high?
plasmid? stability? and? the? lack? of? endotoxin? and? extracellular? protease? production.? These?
characteristics?make?this?organism?highly?favored?for?industrial?practice?(Vary?et?al.?2007).?
?
The?endogenous?CYP106A2?system?in?B.?megaterium?ATCC?13368?was?used?for?in?vivo?transformation?
of?the?diterpene?abietic?acid?producing?12??hydroxyabietic?acid?and?12???hydroxyabietic?acid?(Bleif?et?
al.?2011).?As?a?next?step,?the?CYP106A2?gene?was?overexpressed?in?combination?with?bovine?adrenal?
redox?partners?in?B.?megaterium?MS941?for?the?hydroxylation?of?11?keto???boswellic?acid?in?the?15??
position?(Bleif?et?al.?2012).?Another?triterpenoid,?dipterocarpol,?was?also?hydroxylated?by?CYP106A2?in?
B.?megaterium?ATCC? 13368? resulting? in? six? products? at? a? 1? L? scale? (Schmitz? et? al.? 2012).?Recently?
reported,? the? regioselective? hydroxylation? of? the? 3?hydroxy??5? steroid? dehydroepiandrosterone?
(DHEA)?was?achieved?by?CYP106A2?expressed?in?the?natural?host?B.?megaterium?ATCC?13368?and?the?
recombinant?B.?megaterium?MS941?(Schmitz?et?al.?2014).??
?
In?the?present?work,?the?conversion?of?a?synthetic?testosterone?derivative,?cyproterone?acetate?(CPA,?
6?Chloro?1?,2??dihydro?17?hydroxy?3?H?cyclopropa(1,2)?pregna?1,4,6?triene?3,20?dione?acetate),?was?
performed?using?a?recombinant?B.?megaterium?MS941?system?overexpressing?the?CYP106A2?enzyme.?
The?synthetic?antiandrogen,?CPA,?was?converted? to?15??hydroxy?cyproterone?acetate? (15??OH?CPA,?
15??hydroxy?6?Chloro?1?,2??dihydro?17?hydroxy?3?H?cyclopropa(1,2)?pregna?1,4,6?triene?3,20?dione?
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acetate)?(Scheme?4.1).?CPA?is?a?synthetic?derivative?of?17??hydroxyprogesterone,?an?anti?androgenic?
compound? with? additional? progestogen? and? antigonadotropic? properties? (Neumann? and? Toepert?
1986;? Frith? and? Phillipou? 1985).? It? has? antagonistic? properties? towards? the? androgen? receptor,?
although?it?can?also?act?as?its?partial?agonist.?It?is?generally?used?as?a?treatment?for?metastatic?prostate?
cancer?and?for?the?control?of?libido?in?severe?hypersexuality?and/or?sexual?deviation?in?males,?but?it?is?
also?applied?for?the?treatment?of?hirsutism?and?acne?in?female?patients?and?in?oral?contraceptive?pills.?
The?main?human?metabolite?of?CPA?in?both?plasma?and?urine?is?the?15??OH?CPA.?It?shows?only?10?%?
of?the?progestogenic?potency?of?CPA?but?retains?the?anti?androgen?activity?(Frith?and?Phillipou?1985).?
These? characteristics? imply? that? the?metabolite? is? potentially? a? better?option? for? the? treatment? of?
androgen?induced?problems,?particularly? in?male?patients.? In?1982,? the?B.?megaterium?ATCC?13368?
strain? was? already? proposed? for? the? bioconversion? of? 1?,2??methylene? steroids? into? their? 15??
hydroxy? derivatives,? in? order? to? produce? new? anti?androgenic? steroids? with? minor? progestogen?
activity?(Petzoldt?et?al.?1982).?According?to?our?knowledge,?1?mg?15??hydroxy?metabolite?costs?300?$,?
while?250?mg?of?the?original?compound?costs?199?$?(Santa?Cruz?Biotechnology,?http://www.scbt.com/,?
2014).?Although?detailed? information?about? the?production? is?missing,? the?price?difference?suggests?
an?expensive?procedure.??
?
Scheme?4.1?Cyproterone?acetate?conversion?to? its?main?human?metabolite?15??hydroxycyproterone?
acetate?by?CYP106A2.?
In?this?study,?process?development?of?the?CPA?bioconversion?in?shake?flasks?and?lab?scale?bioreactors,?
was? performed,? thus? providing? an? improved? model? for? a? greener? yet? cost?effective? large?scale?
production?of?the?15??hydroxy?metabolite.?The?reaction?was?successfully?carried?out?at?400?mL?scale,?
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although? to? further? improve? the? conversion? rate? the? bottlenecks? of? the? system? were? identified.?
Working? with? P450s? applied? in? whole?cell? systems,? the? following? difficulties? have? already? been?
recognized?(Bernhardt?and?Urlacher?2014;?Lundemo?and?Woodley?2015):??
? NADP(H)?depletion?
? low?substrate?and?product?solubility?
? problematic?uptake?of?the?substrate?and?efflux?of?the?product?
? substrate?or?product?inhibition/toxicity.??
To? find? the? bottleneck? of? the? current? system,? each? point?was? addressed? separately.? The? cofactor?
limitation?was? investigated?by?adding?NADPH? in?excess.? Issues?with? solubility,? toxicity?or? inhibition,?
related? to? substrate?or?product?were? investigated.? Subsequently? substrate? feeding? strategies?were?
evaluated?in?an?attempt?to?overcome?these?effects.?Moreover,?the?proposed?transport?restriction?was?
addressed?by?using?different?membrane?permeabilization?methods? (freeze?thawing,?ultrasonication,?
acetone? treatment).? 2?hydroxypropyl???cyclodextrin? (HP???CD)? was? also? applied? to? improve? the?
process?performance?since?it?was?previously?described?to?be?successful?as?a?solubilizing?agent?and?was?
used?for?improved?substrate?transport?across?the?cell?membrane.?By?identifying?the?limitations?of?the?
system,?the?aim?was?to?be?able?to? improve?the?economic?performance?of?the?process?by? increasing?
the?reaction?yield?at?higher?substrate?concentrations.?
?
Materials?and?methods?4.2
4.2.1 Reagents?and?chemicals?
All?used?chemicals?were?from?standard?sources?and?of?highest?grade?available.?Solvents?of?analytical?
grade?were?used?for?HPLC,?while?solvents?used?for?large?scale?extraction?were?of?reagent?grade.?CPA?
was?obtained?from?BIOTREND?Chemikalien?GmbH,?Köln,?Germany?(??98%?(HPLC)).?
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4.2.2 Bacterial?strains?and?plasmids?
The?in?vivo?conversions?were?performed?using?a?recombinant?B.?megaterium?MS941?strain,?a?variant?
of?DSM319,?lacking?the?major?extracellular?protease?gene?nprM?(Wittchen?and?Meinhardt?1995).?The?
host?organism?was? transformed?with? the?plasmid?pSMF2.1C? (CYP106A2?gene? introduced?within? the?
SpeI/MluI?sites)?by?a?polyethylene?glycol?mediated?technique?using?protoplasts?(Bleif?et?al.?2012;?Barg?
et?al.?2005).?As? control,? the?wild? type?B.?megaterium?MS941? strain?was?used? (lacking? the?pSMF2.1?
plasmid,?but?naturally?containing?cytochrome?P450?genes)?to?confirm?that?the?reaction?is?catalyzed?by?
the?CYP106A2?enzyme.?The?wild?type?strain?did?not?display?any?activity?towards?the?substrate? (data?
not? shown)? and? no? P450?was? detected? using? CO? difference? spectroscopy? (Omura? and? Sato? 1964),?
indicating? that? the?P450?expression?and?catalytic?activity? reported? is?assigned? to? the?overexpressed?
CYP106A2.????
4.2.3 Protein?expression,?purification?and?spectral?characterization?
The? expression? and? purification? of? the? CYP106A2? protein?was? performed? as? described? previously?
(Simgen?et?al.?2000;?Lisurek?et?al.?2004).?For? the? reconstituted? in?vitro?system,?a? truncated? form?of?
bovine? adrenodoxin? (Adx4?108)?was? used? in? combination?with? bovine? adrenodoxin?reductase? (AdR),?
their?expression?and?purification?was?completed?as?described?elsewhere?(Sagara?et?al.?1993;?Uhlmann?
et? al.?1992).? The? characteristics?of? the?purified?CYP106A2?were? analyzed?by?UV?visible? absorbance?
spectroscopy.? The? spectrum? was? recorded? in? a? range? of? 200? to? 700? nm? with? a? double? beam?
spectrophotometer? (UV?1800,? UV?2101? PC,? Shimadzu? Corporation,? Kyoto,? Japan)? and? analyzed?
constantly?during?the?purification?process?to?determine?the?Q?value?(A417/A280),?which?was?in?all?cases?
above?1.5,?suggesting?a?high?amount?of?correctly? folded,?active?P450s.?The?samples? taken? from? the?
bacterial?cultures?during?cultivation?or?conversion?were?spun?down?and?the?pellet?kept?frozen?at??20?
°C?until?measurement?when?the?samples?were?resuspended?in?100?mM?potassium?phosphate?buffer,?
pH?7.4.?The?concentration?of?the?purified?protein?and?the?protein?expressed?in?the?whole?cell?system?
was?determined?by?CO?difference?spectroscopy?according?to?the?method?of?Omura?and?Sato?(Omura?
and?Sato?1964),?using?an?extinction?coefficient?of?91?mM?1?cm?1.??
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4.2.4 Substrate?binding?assay??
The? substrate? binding? spectrum? was? investigated? using? a? double?beam? spectrophotometer? (UV?
2101PC,? Shimadzu,? Japan)? and? tandem? quartz? cuvettes.? The? analysis? took? place? in? 800? μL? total?
volume.? In? one? chamber,? a? cuvette? containing? 10? μM? solution? of? CYP106A2? in? 50?mM? potassium?
phosphate?buffer,?pH?7.4?was?placed.? In?the?other?chamber?a?cuvette?filled?with?buffer?was?used?as?
reference.?CPA?was?dissolved? in?DMSO?at?a?stock?concentration?of?10?mM.?The?enzyme?was?titrated?
with? the?substrate? in?a?concentration?range?of?5? to?150?μM.?After?each? titration?step? the?spectrum?
was?recorded?in?a?range?of?350?to?500?nm.??
4.2.5 In?vitro?conversions?and?enzyme?kinetics?
The?in?vitro?conversion?of?CPA?was?carried?out?with?a?reconstituted?system?in?a?final?volume?of?250?μL?
at?30?°C?for?30?min?in?50?mM?potassium?phosphate?buffer?(pH?7.4),?containing?20?%?(v/v)?glycerol.?The?
reconstituted?system?contained?bovine?AdR?(1?μM),?a?truncated?form?of?Adx4–108?(10?μM),?CYP106A2?
(0.5? μM),? a?NADPH?regenerating? system? [MgCl2? (1?mM),? glucose?6?phosphate? (5?mM),? glucose?6?
phosphate?dehydrogenase?(1?U),?and?NADPH?(0.1?μM)]?and?CPA?(200?μM).?The?reaction?was?started?
by?adding?NADPH?(1?mM)?and?incubated?at?30?°C.?The?assay?was?stopped?by?the?addition?of?250??L?of?
ethyl?acetate,?mixed?vigorously,?and?extracted?twice.?The?combined?organic?phases?were?evaporated?
and? the? residues? were? dissolved? in? the? HPLC?mobile? phase? (60:40%? ACN:H2O)? and? subjected? to?
analysis.?
?
Reaction?kinetics?of?CPA?and?CYP106A2?were?performed?for?2?min?as?described?above,?using?bovine?
AdR? (0.5? μM),? bovine?Adx4–108? (5? μM)? and? CYP106A2? (0.25?μM).? The? substrate? concentration?was?
varied? from?20?to?250?μM.?Kinetic?parameters?were?determined?by?plotting?the? initial?reaction?rate?
(nmol? product/nmol? P450/min)? against? the? substrate? concentration? (μM).? Each? reaction? was?
performed?six?times,?the?data?represents?the?mean?of?these?independent?results.?Data?were?fitted?by?
hyperbolic? regression? with? the? help? of? Origin? (OriginLab? Corporation,? Massachusetts,? USA).? The?
substrate?inhibition?studies?were?performed?using?a?20?mM?CPA?stock?solution?dissolved?in?DMSO?and?
added?in?a?final?concentration?of?200?to?1200?μM.?Studying?the?product?inhibition,?the?substrate?was?
added?in?a?final?concentration?of?400?μM,?while?the?purified?product?concentration?ranged?from?0?to?
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1200?μM.?The?reactions?took?place?for?60?minutes,?then?the?samples?were?extracted?and?subjected?to?
HPLC?analysis?as?described?above.?
4.2.6 Heterologous?expression?in?shake?flasks?
Pre?cultures?were? inoculated? from?a? ?80? °C?glycerol?stock,?using?25?mL?complex?TB?medium? (24?g/l?
yeast? extract,? 12? g/l? soytone,? 2.31? g/l? KH2PO4? and? 12.5? g/l? K2HPO4)? supplemented?with? 10?mg/L?
tetracycline?and?incubated?overnight,?at?150?rpm,?30?°C.?The?main?culture,?containing?250?mL?complex?
medium? (supplemented?with?the?corresponding?amount?of?tetracycline)?was? inoculated?with?1?%?of?
the?culture?volume?from?the?pre?culture.?The?main?culture?was?incubated?until?an?OD578?of?0.5,?when?
5?g/L?xylose?solution?was?added?to?induce?expression.?After?24?h?expression,?the?cells?were?harvested?
(4500?x?g?,?4?°C,?15?min),?the?cell?pellet?was?washed?and?resuspended?in?100?mM?potassium?phosphate?
buffer?(pH?7.4).?
4.2.7 Heterologous?expression?at?fermenter?scale?
The? fermentation?process?was?adapted? from?Korneli?and?coworkers? (Korneli?et?al.?2012)? .?A? ?80? °C?
glycerol?stock?was?used?to?inoculate?the?first?pre?culture?with?LB?medium?which?was?used?to?inoculate?
a?second?pre?culture?with?batch?medium?(3.52?g/L?KH2PO4,?6.62?g/L?Na2HPO4*2H2O,?0.3?g/L?MgSO4*7?
H2O,?25?g/L?(NH4)2SO4,?1?g/L?yeast?extract?and?trace?elements?as?described?(Korneli?et?al.?2012)).?The?
first?pre?culture?was?incubated?for?8?h?in?a?100?mL?shake?flask?with?10?mL?LB?medium?at?150?rpm,?37?
°C.? 100?mL? batch?medium? supplemented?with? 5? g/L? fructose?was? used? for? the? cultivation? of? the?
second?pre?culture?in?a?1?L?flask,?inoculated?from?the?first?pre?culture?to?an?OD600?of?0.1.?After?12?h?of?
cultivation,? it? served? as? inoculum? for? the? fermenter.? The? batch? medium? in? the? fermenter? was?
supplemented?with?15?g/L?fructose.?The?feed?medium?consisted?of?150?g/L? fructose,?5?g/L?D?xylose,?
9.9?g/L?KH2PO4,?14.98?g/L?Na2HPO4,?0.3?g/L?MgSO4*7H2O,?25?g/L? (NH4)2SO4.?All?media?preparations?
were?supplemented?with?10?mg/L?tetracycline.?The?fed?batch?fermentation?process?was?carried?out?in?
a?1?L?Infors?Multifors?fermentation?vessel?(Infors?HT,?Bottmingen,?Switzerland).?Initial?conditions?were?
set? to?37? °C,?pH?7.0,?aeration?0.5?Lpm,?pO2? setpoint?20?%?controlled?by? stirrer.?The? fermenter?was?
inoculated?to?a?final?OD600?of?0.7?and?induced?at?an?OD600?of?10?with?5?g/L?xylose.?The?induction?at?a?
higher?OD600?in?the?fermenter,?compared?to?shake?flask,?is?due?to?the?higher?possible?final?cell?density?
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utilizing? a? fed?batch? process.? At? the? time? of? induction,? the? temperature?was? decreased? to? 30? °C,?
aeration?was? increased? to?1?Lpm?and?a? linear? feed?was? initiated.?The?pH?was?controlled?during? the?
process?with? 5?M? NaOH? and? 1?M? H3PO4.? Cells?were? harvested? by? centrifugation? and?washed? by?
resuspension?in?100?mM?potassium?phosphate?buffer,?pH?7.4.?20?mM?fructose?was?added?to?the?cells?
for?direct?use?in?biotransformation?or?stored?at?4?°C,?gently?shaking,?at?a?cell?density?of?200?g/L?WCW.?
4.2.8 Bioconversion?in?shake?flasks??
The?small?scale?conversion?of?CPA?was?performed?with?resting?cells? in?a?15?mL?culture?volume?using?
100?mL?baffled?shake?flasks.?The?catalyst?concentration?was?100?g/L?WCW,?unless?otherwise?stated.?
To?obtain?sufficient?amount?of?product?(mg)?for?NMR?structure?characterization,?the?conversion?was?
scaled?up?to?50?mL,?using?300?mL?baffled?shake?flasks.?CPA?was?added?in?200?μM?final?concentration?
from?a?20?mM?DMSO? stock? solution.?The?use?of?DMSO?did?not?exceed?2?%?of? the?culture?volume.?
Every?4?h,?2?M?fructose?solution?was?added?as?carbon?source?in?a?final?concentration?of?20?mM.?250?μL?
samples?were?taken?at?indicated?time?points?to?monitor?the?conversion.?The?samples?were?extracted?
twice? using? 250?μL? ethyl? acetate,? the? organic? phases? collected? and? evaporated? to? dryness? for? the?
subsequent?analysis?by?reverse?phase?HPLC.?In?the?case?of?product?isolation,?the?reaction?was?stopped?
and?the?steroids?were?extracted?twice?by?ethyl?acetate.?The?organic?phase?was?dried?over?anhydrous?
MgSO4?and?concentrated?to?dryness?in?a?rotavapor?(Büchi?R?114).?The?yellowish?residue?was?dissolved?
in? the?mobile?phase?of? the?HPLC?and? filtered? through?a? sterile? syringe? filter? (Rotilabo? syringe? filter,?
0.22? ?m,? Carl? Roth? GmbH,? Karlsruhe,? Germany).? The? product? purification? was? completed? by?
preparative?HPLC,?according?to?its?retention?time.?The?collected?fractions?were?evaporated?to?dryness?
and?analyzed?by?NMR?spectroscopy.?The?in?vivo?substrate?and?product?inhibition?was?studied?in?shake?
flasks,?using?resting?cells,?as?described?for?the?in?vitro?studies.?
4.2.9 HPLC?analysis?
The?HPLC?analysis?was?performed?either?on?a?Jasco?system?consisting?of?a?Pu?980?HPLC?pump,?an?AS?
950? sampler,? a? UV?975? UV/Vis? detector,? and? an? LG?980–02? gradient? unit? (Jasco,? Gross?Umstadt,?
Germany)?or?on?a?Dionex?UltiMate?3000?HPLC?equipped?with?a?Photodiode?Array?Detector? (Dionex,?
Thermo?Scientific).?A?reversed?phase?ec?MN?Nucleodor?C18?(3?μM,?4.0x125?mm)?column?(Macherey?
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Nagel,?Betlehem,?PA,?USA)?was?used?and?kept?at?an?oven?temperature?of?40?°C.?An?isocratic?gradient?
of?acetonitrile:water?in?a?ratio?of?60:40?was?applied?using?a?flow?rate?of?0.8?mL/min.?UV?detection?of?
the? substrate? and? product? was? accomplished? at? 282? nm.? Product? isolation? was? performed? using?
preparative? reversed?phase?HPLC? (ec?MN?Nucleodur? C18?VP? (5? μM,? 8x250?mm),?Macherey?Nagel,?
Betlehem,? PA,? USA)?with? a? flow? rate? of? 2.5?mL/min.? The? results? are? presented? as? conversion?%,?
calculated? from?the?product?area?divided?by?the?sum?of?substrate?and?product?areas.?Regarding?the?
product?inhibition?experiments,?when?product?was?added?initially?to?the?system,?the?data?is?presented?
as? relative?conversion? (subtracting? the? initially?added?product)?or?calculated?back? to?concentrations?
from?conversions.?
4.2.10NMR?characterization?of?the?main?metabolite?
The?NMR?spectrum?was?recorded? in?CDCl3?with?a?Bruker?DRX?500?NMR?spectrometer?at?300?K.?The?
chemical?shifts?were?relative?to?TMS?using?the?standard???notation?in?parts?per?million.?The?1D?NMR?
(1H? and? 13C?NMR,?DEPT135)? and? the?2D?NMR? spectra? (gs?HH?COSY,?gs?NOESY,?gs?HSQCED,?and? gs?
HMBC)? were? recorded? using? the? BRUKER? pulse? program? library.? All? assignments? were? based? on?
extensive?NMR?spectral?evidence.?
?
The?main?product?(P1)?was?identified?as?15??hydroxy?cyproterone?acetate?(15??OH?CPA)?(3.4?mg).?In?
comparison?to?cyproterone?acetate?the?NMR?spectra?of?its?conversion?product?showed?signals?for?an?
additional?secondary?hydroxyl?group?(?H?4.50?ddd,?J=7.5,?6.0?and?2.0?Hz;??C?68.86).?Its?position?at?C?15?
could?be?deduced?by?vicinal?couplings?of?the?methine?proton?with?H?14? (?H?1.93?dd,? J=12.0?and?6.0?
Hz),?H?16??(?H?2.47?dd,?J=16.8?and?7.5?Hz)?and?H?16??(?H?3.03?dd,?J=16.8?and?2.0?Hz)?in?the?HHCOSY?
and?with?C?13?(?C?47.00)?and?C?17?(?C?96.11)?in?HMBC.?The???orientation?of?the?hydroxyl?was?obvious?
by? the?NOESY? effects? of?H?15? to?H?16?? and? to?H?9? (?H? 1.53?m)? and?H?14,? both? in??? position.? In?
addition,?the?coupling?constants?found?for?H?15??resembled?those?for?other?closely?related?steroids,?
e.g.? 15??hydroxy?11?deoxycortisol? (Kiss? et? al.? 2014).? Selected? ?H? NMR? data? of? 15??hydroxy?
cyproterone?acetate? could?be? found? in? the? literature? (Bhargava?et?al.?1977)?and?matched?with?our?
values.?1H?NMR?(CDCl3,?500?MHz):???0.89?ddd?(6.3?and?2x4.7?Hz,?cPr?Ha),?1.01?s?(3xH?18),?1.27?s?(3xH?
19),?1.29?ddd? (9.0,?7.8?and?4.7?Hz,?cPr?Hb),?1.53?m? (H?9),?1.62?m? (2H,?H?11??and?H?12?),?1.74?ddd?
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(2x7.8?and?6.3?Hz,?H?1),?1.93?dd?(12.0?and?6.0?Hz,?H?14),?1.98?m?(H?11?),?2.03?m?(H?2),?2.04?m?(H?12?),?
2.09?s?(3x?OCOCH3),?2.10?s?(3xH?21),?2.47?dd?(16.8?and?7.5?Hz,?H?16?),?2.73?ddd?(2x12.0?and?2.3?Hz,?H?
8),?3.03?dd?(16.8?and?2.0?Hz,?H?16?),?4.50?ddd?(7.5,?6.0?and?2.0?Hz,?H?15),?6.20?brs?(H?4),?6.44?d?(2.3?Hz,?
H?7).? 13C?NMR? (CDCl3,?125?MHz):? ??12.30? (CH2,? cPr),?16.95? (CH3,?C?18),?20.74? (CH2,?C?11),?21.11? (C,?
OCOCH3),? 22.86? (CH3,?C?19),? 25.24? (CH,?C?2),?26.12? (CH,?C?1),?26.35? (CH3,?C?21),?31.96? (CH2,?C?12),?
34.44?(CH,?C?8),?38.84?(C,?C?10),?43.13?(CH2,?C?16),?47.00?(C,?C?13),?47.98?(CH,?C?9),?52.80?(CH,?C?14),?
68.86?(CH,?C?15),?96.11?(C,?C?17),?120.47?(CH,?C?4),?130.45?(C,?C?6),?136.30?(CH,?C?7),?152.32?(C,?C?5),?
170.51?(C,?OCOCH3),?197.98?(C,?C?3),?202.84?(C,?C?20).??
4.2.11Transport?and?cofactor?dependence?
Transport?limitation?was?examined?by?different?cell?membrane?permeabilization?methods?prior?to?the?
biocatalytic?reaction.?Both?mechanical?and?chemical?methods?were?applied?(freeze?thawing,?acetone?
treatment? and? ultra?sonication).? Frozen? cells?were? spun? down? and? the? pellet?was? kept? at? ?20? °C?
overnight.? Acetone?treated? cells?were? incubated?with? 5?%? acetone? for? 2?minutes?while? vortexing,?
mechanical? disruption?was? performed? by? sonication? for? 2?minutes? (amplitude? 60?%,? 0.5? s? cycles)?
(UP400?S,?Hielscher?Ultrasonic?GmbH,?Teltow,?Germany).?Following? the?permeabilization? treatment?
(acetone? and? sonication)? cells?were? spun?down? and? the?pellet? resuspended? in?100?mM?potassium?
phosphate? buffer? pH? 7.4.? Cofactor? was? added? to? the? untreated? control? samples? and? to? the?
permeabilized?ones,?once?and?twice?stoichiometric?amounts?relative?to?substrate?concentration.??
4.2.12 Storage?stability?
To?examine? the?storage?stability?of? the?whole?cell?catalyst,? the? transformation?was?performed?with?
resting?cells?after?1,?3?and?7?days?of?storage.?The?cells?were?stored?at?4? °C,?gently?shaking?at?a?cell?
density?of?200?g/L?WCW?in?100?mM?potassium?phosphate?buffer,?pH?7.4.?20?mM?fructose?was?added?
as?carbon? source?at? the? time?of?harvest,?after?1?and?3?days?of? storage?and?also?at? the? start?of? the?
reactions.?
4.2.13 Cyclodextrin?
As?an?alternative?substrate?feeding?strategy,?the?substrate?was?pre?dissolved?in?a?45?%?(w/v)?solution?
of?HP???CD?in?sterile?filtered?MilliQ?water?and?stirred?overnight?using?a?magnetic?stirrer.?
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4.2.14Optical?density?and?cell?dry?weight?determination?
To? estimate? the? cell? concentration,? the? optical? density? at? 600? nm? (OD600)?was?monitored? and? the?
gravimetric? dry? cell? weight? (g/L? DCW)? was? determined.? Samples? collected? for? dry? cell? weight?
measurement?were?spun?down,?the?supernatant?was?discarded?and?the?pellet?was?kept?at??20?°C?until?
further?analysis.?Thereafter?the?pellets?were?thawed?and?resuspended? in?the?original?sample?volume?
using?100?mM?potassium?phosphate?buffer,?pH?7.4.?Dry? cell?weight?was?measured? in? triplicates?by?
filtering? the? samples? through? a? pre?weighed? 0.22? μm? PES? membrane? filter? (Frisenette,? Knebel,?
Denmark)? applying? vacuum.? The? filters?were?washed?with? buffer,? dried? in? a?microwave? oven? and?
weighed?after?equilibrating?to?room?temperature?in?a?desiccator.?
4.2.15Bioconversion?in?bioreactor?
Biocatalysis? in?bioreactors?was?performed? in?the?same?vessels?as?the?fermentation?(Infors?Multifors,?
Infors?HT,?Bottmingen,?Switzerland)? in?a?working?volume?of?400?ml.?Set?points?applied?were:?30? °C,?
aeration?1?Lpm,?pO2?30?%?controlled?by?agitation,?pH?7.2?controlled?with?5?M?NaOH?and?1M?H3PO4.?2?
M?stock?solution?of?fructose?was?added?at?time?point?0,?4?and?8?h?in?a?final?concentration?of?20?mM.?
CPA?was? dissolved? in?DMSO? and? added? in? a? final? concentration? of? 1?mM,? the?DMSO? content? not?
exceeding?2?%?of?the?total?volume.?For?an?accurate?comparison?of?growing?and?resting?cells?half?of?the?
fermentation? volume?was? removed? after? 16? h? and? this? fraction?was? harvested? by? centrifugation,?
washed?and? resuspended? in?100?mM?potassium?phosphate?buffer,?pH?7.4.?Resuspended?cells?were?
transferred? to? a? bioreactor,? simultaneously? to? the? still? growing? cells.? Fructose? and? xylose? were?
continuously? fed,? for? both? resting? and? growing? cells,? at? half? the? volumetric? rate? compared? to? the?
fermentation?due?to?half?the?volume.?
Results?4.3
4.3.1 Purification?and?spectral?characterization?of?CYP106A2?
The?CYP106A2?protein?was?expressed?and?purified?using?a?recombinant?E.?coli?C43?(DE3)?strain.?The?
UV?Vis?absorbance?spectra?recorded?from?250?to?700?nm?showed?the?characteristic?absorbance?peaks?
at?356,?417,?534,?567?nm? in? the?oxidized? form.? In? the? case?of? the? reduced? and? carbon?monoxide?
bound?form,?the?peak?at?450?nm?was?observed,?with?no?peak?indicating?inactive?P450?at?420?nm.?
96
77?
?
4.3.2 In?vitro?conversion,?reaction?kinetics?and?inhibition?studies?
Using?difference?spectroscopy,?the?binding?of?CPA?to?CYP106A2’s?active?site?was?studied?in?vitro.?CPA?
did?not?induce?any?spectral?shift,?indicating?that?the?steroid?does?not?contribute?to?the?replacement?of?
the? axial?water?molecule,? hindering? the? determination? of? the? dissociation? constant.? The? catalytic?
activity?of?CYP106A2?towards?CPA?was?first?tested?in?vitro.?The?activity?was?reconstituted?using?bovine?
adrenal? redox? partners? (Adx4?108? and? AdR)? proven? to? be? highly? efficient? electron? suppliers? for?
CYP106A2? (Ewen? et? al.? 2012;?Virus? et? al.? 2006).? The? CYP106A2?dependent? conversion? of? CPA?was?
analyzed?by?high?performance?liquid?chromatography?(HPLC)?and?resulted?in?one?main?product.?Using?
0.5?μM?CYP106A2?and?400?μM?substrate,?the?conversion?reached?48.2?±?2.8?%?in?60?minutes?(Fig.?4.1).?
?
?
Figure?4.1?HPLC?chromatogram?of?the? in?vitro?conversion?of?cyproterone?acetate?by?CYP106A2.?The?
reaction?was?performed?in?50?mM?potassium?phosphate?buffer?containing?20?%?glycerol?(pH?7.4)?at?30?
°C,?using?0.5?μM?CYP106A2,?10?μM?Adx4?108?and?1?μM?AdR.?The?reaction?was?stopped?and?extracted?
twice?by?ethyl?acetate?directly?after?the?addition?of?the?substrate?(grey?dotted?line,?0h)?and?after?1?h?
(black?line,?1?h).?Cyproterone?acetate?(400?μM)?was?converted?to?one?main?product?(P1).?
?
The? in?vitro?conversions?were?also?performed?with? increasing?substrate?concentrations?(50?μM? ??1.2?
mM)? to? study? the? potential? inhibitory? effect? of? the? substrate.? Using? 200? μM? or? higher? substrate?
concentrations,? the?product? concentration?never?exceeded?200?μM.?These? results? suggest? that? the?
enzyme? is? inhibited?above?a? certain?product? concentration,? regardless?of? the?amount?of? substrate,?
since?the?reaction?stops?after?150?to?200?μM?product?was?formed?(Fig.?4.2).??
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Figure?4.2? In?vitro?conversion?of?cyproterone?acetate?using? increasing?substrate?concentrations.?The?
reaction?was?performed?using?substrate?concentrations,?in?a?range?from?50?μM?to?1.2?mM?for?60?min.?
Each?bar? represents? the?mean? value?of? three? independent?measurements,?with? the? corresponding?
standard?deviation?indicated?by?the?error?bars.?
?
As?a?next?step,?the?Michaelis?Menten?parameters?for?the?CYP106A2?dependent?CPA?conversion?were?
determined.?The?catalytic?activity?of?the?CPA?conversion?showed?a?Vmax?of?61.65?±?2.56?nmol?product?
per?nmol?CYP106A2?per?minute?and?a?Km?of?103.14?±?11.99?μM?(Fig.?4.3).?
?
Figure?4.3?Determination?of?the?kinetic?parameters?for?the?cyproterone?acetate?conversion?catalyzed?
by?CYP106A2.?The?reaction?kinetics?were?performed?in?50?mM?potassium?phosphate?buffer?containing?
20?%?glycerol? (pH?7.4)?at?30? °C? for?2?min?using?0.5?μM?CYP106A2,?10?μM?Adx4?108?and?1?μM?AdR.?
Cyproterone?acetate?was?used? in?a?concentration?range?from?0?to?400?μM.?The?data?shown?are?the?
result?of?four?independent?measurements?(R2?>?0.98).?
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To? investigate?potential?product? inhibition,? in?vitro?product? inhibition?experiments?were?performed?
using? a? fixed? amount? of? substrate? with? increasing? initial? product? concentrations? (purified? by?
preparative?HPLC).?The?results?confirmed?the?assumption?that?the?product?used?in?200?μM?or?higher?
concentrations?strongly?inhibits?the?reaction.?Using?an?initial?15??OH?CPA?concentration?of?800?μM?or?
above,?less?than?half?the?conversion?could?be?observed?(21?%)?compared?to?the?control?sample?(47?%)?
containing?only?the?substrate?(400?μM)?(Fig.?4.4).?
?
Figure?4.4? In?vitro?conversion?of?cyproterone?acetate?using? increasing? initial?product?concentrations.?
The? reactions? were? performed? using? 400? μM? substrate? concentration? and? initial? product?
concentrations? ranging? from? 0? to? 1200? μM? for? 60?min.? The? data? represents? the?mean? of? three?
independent?measurements?with?the?corresponding?standard?deviation?shown?by?the?error?bars.?
4.3.3 In?vivo?conversion,?product?localization?and?catalyst?reusability?
Following? the? successful? conversion? of? cyproterone? acetate? by? the? CYP106A2?overexpressing? B.?
megaterium? strain? (Fig.?4.5),? the?product?of? the? reaction?was?purified?on?preparative?HPLC?and? its?
srtucture? was? identified? by? nuclear?magnetic? resonance? (NMR)? spectroscopy.? The? resulting?main?
product?(P1),?15??OH?CPA,?was?used?in?the?above?mentioned?in?vitro?as?well?as?in?the?in?vivo?product?
inhibition?studies.?The?whole?cell?catalyst?was? further?characterized?by?examining?the?substrate?and?
product?localization.?Both?substrate?and?product?were?shown?to?be?attached?to?the?cell?pellet?fraction?
(data?not?shown).?Adding?more?cells?after?4?h?of?conversion?did?not?improve?the?reaction?yield,?most?
likely? since? all? remaining? substrate?was? already? inside? or? attached? to? the? original? cells? (Fig.? 4.6).?
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However,? the? addition? of? 3? times?more? cells? (150? g/L?wet? cell?weight? (WCW))? and? 2? times?more?
substrate?(1?mM)?only?doubled?the?product?concentration?thereby?giving?a?lower?biocatalyst?yield.?
?
?
Figure?4.5?HPLC?chromatogram?of? the?cyproterone?acetate?conversion?using?B.?megaterium?MS941?
overexpressing? the? CYP106A2? enzyme.? The? reaction?was? performed?with? resting? cells? in? 100?mM?
potassium?phosphate?buffer?(pH?7.4)?at?30?°C,?150?rpm.?Cyproterone?acetate?(400?μM)?was?added?to?
the?cells?in?DMSO?solution?(2?%?v/v).?Samples?were?collected?directly?at?the?point?of?substrate?addition?
(grey?dotted?line)?and?after?2?h?(black?line).?The?substrate?was?converted?to?one?main?product?(P1).?
?
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Figure? 4.6? Effect? of? whole?cell? catalyst? addition,? with? and? without? additional? substrate,? on? 15??
hydroxycyproterone? acetate? production.? Reactions? were? performed? in? shake? flasks? with? 1? mM?
cyproterone?acetate?and?an?initial?catalyst?concentration?of?50?g/L?WCW.?After?4?h,?additional?150?g/L?
WCW?was?added?to?the?reaction?represented?with? ,?both?catalyst?and?substrate?(1?mM)?were?added?
to?the?reaction?represented?with???and?buffer?was?added?to?the?control?(?)?to?compensate?for?the?
change?in?volume.?
?
In?a? further?attempt? to? improve? the?biocatalyst? yield,? the? reusability?of? the?whole?cell? system?was?
investigated?to?decrease?the?cost?contribution?of?the?catalyst?and?increase?the?economic?potential?of?a?
resting? cell?process.?Removal?of? the?product?by? solvent?extraction?between?batches?was?explored.?
Washing?with?buffer?did?not?have?any?effect?on?the?product? in?the?cell?pellet? fraction.?Exposing?the?
cells?to?the?organic?solvent?ethyl?acetate?completely?destroyed?the?activity?of?the?cells.?Furthermore,?
washing?with?decanol?removed?the?product?from?the?cells,?but?at?the?same?time?damaged?the?catalyst?
resulting?in?around?30?%?relative?conversion?compared?to?the?first?batch?(Fig.?4.7).?
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Figure?4.7?Cell? recycling?by?product?extraction?using?decanol.??? represents? the? control?and??? the?
cells?washed?with?decanol?after?4?h.?Reactions?were?performed?with?resting?cells?in?shake?flasks,?using?
1?mM?cyproterone?acetate?and?an?initial?catalyst?concentration?of?100?g/L?WCW.?1?mM?substrate?was?
added?when?starting?each?reaction?but?only?to?the?washed?cells?at?4?h.?
4.3.4 Transport?and?cofactor?dependence?
The? potential? limitations? of? the?whole?cell? system? in? terms? of? substrate? transport? across? the? cell?
membrane? and? cofactor? regeneration? were? ruled? out? as? seen? in? Fig.? 4.8.? The? reactions? were?
performed?with?resting?whole?cells?in?shake?flasks?and?NADPH?was?added?in?1?mM?(stoichiometric?to?
substrate)? and? 2? mM? final? concentrations.? The? influence? of? cofactor? addition? and? the? cell?
permeabilization?methods?(sonication,?acetone?treatment?or?freeze?thawing)?on?the?reaction?rate?was?
investigated.?The?initial?rates?measured?in?these?experiments?did?not?show?any?significant?difference?
(data?not?shown).?In?addition,?Figure?4.8?shows?that?no?significant?difference?was?observed?in?the?final?
product? concentration? either,? regardless? of? permeabilization? treatment? or? external? addition? of?
cofactor.? The? cofactor? is? assumed? to? pass? the? cell? membrane? and? enter? the? cell,? similarily? to?
observations? in?E.?coli?where? this?was?monitored?by?a?decreasing?absorbance?of?the?supernatant?at?
340?nm.?The?results?demonstrate?that?the?cofactor?regeneration?of?the?host?B.?megaterium?MS941?is?
sufficient?to?support?the?observed?biocatalytic?reaction?rates?and?that?the?natural?redox?partners?are?
sufficiently?expressed?to?transport?electrons?from?the?cofactor?to?the?active?site?of?the?overexpressed?
P450.? The? substrate? transport? that? has? been? shown? to? limit? a? CYP106A2?catalyzed? steroid?
transformation? in?E.?coli?(Zehentgruber?et?al.?2010a)?was?not? limiting?the?reaction?studied?here? in?B.?
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megaterium,? according? to? the? tested?permeabilization?methods,? emphasizing? the? suitability?of? this?
whole?cell?catalyst.?
?
Figure? 4.8? Effect? of? different? cell? permeabilization? methods? and? cofactor? addition? on? 15??
hydroxycyproterone?acetate?production.?White?bars?represent?the?results?without?cofactor?addition,?
grey?bars?have?1?mM?NADPH?and?the?black?bar?have?2?mM?NADPH?added.?All?reactions?were?run?using?
1?mM?cyproterone?acetate,?2?%?DMSO?and?100?g/L?WCW?cells? from? the?same? fermentation?batch.?
Error?bars?are?1?.?
4.3.5 In?vivo?substrate?and?product?inhibition?
The? influence?of? increasing?substrate?and?product?concentrations?on? the? reaction?performance?was?
also?investigated?in?vivo?with?the?recombinant?B.?megaterium?MS941?strain?overexpressing?CYP106A2.?
The? substrate? inhibition? studies?were?performed?within?a? concentration? range?of?50?μM? to?1?mM.?
When?using?up?to?200?μM?substrate?concentration,?complete?conversion?of?the?substrate?took?place?
already? within? 2? h,? while? at? higher? substrate? concentrations? the? conversion? stopped? at? an?
approximate?product?concentration?of?300?μM?(70?%?conversion? in?the?case?of?400?μM?and?27?%? in?
the?case?of?1000?μM?CPA)?(Fig.?4.9),?showing?a?similar?trend?as?the?in?vitro?experiments.?
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Figure? 4.9? In? vivo? conversions? performed? in? shake? flasks?with? increasing? substrate? concentrations?
using?resting?cells.?The?reactions?were?performed?in?100?mM?potassium?phosphate?buffer?(pH?7.4)?at?
30?°C,?150?rpm,?with?a?substrate?concentration?ranging?from?50?μM?to?1?mM.?
4.3.6 Product?removal?strategies?
To?remove?the?product?and?push?the?reaction?equilibrium?in?the?forward?direction,?thereby?enhancing?
the? reaction?performance,? the?use?of? two?water?immiscible? solvents,?diisononylphtalate? (C26H42O4)?
and? hexadecane? (C16H34)? (selected? to? be? compatible?with? the?whole?cell? catalyst? and?with? oxygen?
requiring?reactions)?was?investigated.?However,?solubilization?of?the?substrate?in?these?solvents,?prior?
to? addition? to? the? aqueous?phase? containing? the?whole?cell? catalyst,?did?not? improve? the? reaction?
performance.?The?hydrophobicity?of?the?substrate?hinders?the?partitioning?to?the?aqueous?phase?and?
thereby? hampers? the? catalytic? reaction? (results? not? shown).? The? negative? results? could? also? be?
explained?by?analytical?difficulties?and?problems?with?homogenous?sampling?in?a?solid?liquid?2?phase?
system.?
?
Another?approach?to?maintain?a?low?concentration?of?the?dissolved?product? in?the?aqueous?phase? is?
to?avoid?the?use?of?a?miscible?co?solvent?and?instead?apply?feed?of?the?solid?substrate.?This?approach?
requires? that? the? rate? of? solubilization? of? the? substrate? into? the? aqueous?phase? is? faster? than? the?
reaction?rate?so?that?it?does?not?limit?the?observed?reaction.?However,?this?method?was?not?successful?
either,?most?likely?due?to?the?low?solubility?and?rate?of?dissolution?of?the?substrate.??
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A? third? approach? was? to? pre?solubilize? the? substrate? in? an? aqueous? solution? of? HP???CD?
((C6H9O5)7(C3H7O)4.5),? in?order?to?take?advantage?of? its?multiple?effects.?Cyclodextrin? (CD),?especially?
the? derivatized? forms,? have? been? shown? to? be? useful? in? enhancing? steroid? conversions? by? e.g.?
increasing?the?cell?wall?permeability,?stimulating?cell?growth?and?efficiently?solubilizing??hydrophobic?
substrates?(Donova?and?Egorova?2012).?The?complexation?of???CD?with?substrate?and/or?product?also?
leads? to? lower? amounts? of? free? dissolved? species? and? thereby? lower? inhibitory? effects? of? either?
substrate?or?product?on?the?catalyst,?as?suggested?previously?for?steroid?biotransformations?(Roglic?et?
al.?2007;?Singer?et?al.?1991).?Using?CD?solubilized?CPA,? the? transformations?were?performed? first? in?
shake? flasks?with?1?mM? final?concentration?of? the? substrate.?As?a?control,? the?conversion?was?also?
performed?with?the?substrate?dissolved? in?dimethyl?sulfoxide?(DMSO).?The?CPA?was?added?from?the?
45?%?CD?solution,?not?exceeding?5?%?of?the?reaction?volume.?During?the?conversion,?250?μl?reaction?
samples?were? taken? at? the? indicated? time?points? and? the?product/substrate? ratio?was? analyzed?by?
HPLC.?Despite?the?slow?initial?rate,?a?higher?conversion?was?reached?within?4?h?using?CD?as?solubilizing?
agent,? compared? to? the? control.?After? 24?h,? the? conversion?with?CD? showed? 38? ±? 0.05?%?product?
formation,?while?the?control?could?only?reach?27?±?4.6?%?(Fig?4.10).?Given?the? improved?conversion,?
the?same?strategy?was?applied?in?the?bioreactor?(Figure?4.11).?98?%?conversion?of?1?mM?substrate?was?
achieved?on?a?400?mL?scale?compared?to?a?final?conversion?of?55?%?for?the?control?without?CD.?
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Figure? 4.10? In? vivo? cyproterone? acetate? conversion? in? shake? flasks,? using? 2?hydroxypropyl???
cyclodextrin?and?DMSO?for?substrate?solubilization.?The?reactions?were?carried?out?with?resting?cells,?
in?100?mM?potassium?phosphate?buffer?(pH?7.4)?at?30?°C,?150?rpm.?The?substrate?was?pre?dissolved?
either?in?a?45?%?CD?solution?mixed?overnight?(?)?or?in?DMSO?(?)?with?a?final?concentration?of?1?mM.?
?
?
Figure? 4.11? In? vivo? cyproterone? acetate? conversion? in? bioreactor,? using? 2?hydroxypropyl???
cyclodextrin? and?DMSO? for? substrate? solubilization.?The? reactions?were? carried?out? in?400?ml? final?
volume?with?resting?cells?resuspended?in?100?mM?potassium?phosphate?buffer?(pH?7.4)?at?30?°C.?The?
substrate?was?either?pre?dissolved,?in?a?45?%?CD?solution?mixed?overnight?(?)?or?in?DMSO?(?)?with?a?
final?concentration?of?1?mM.?
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4.3.7 Influence?of?reaction?mixing?
In? this? study,? catalyst?dependent?parameters,?believed? to?be? independent?of? the?used? scale,?were?
investigated? in? shake? flasks.? Shake? flask? experiments? are? commonly?used? in? research? laboratories,?
providing? a? simple? and? fast? tool? to? demonstrate? the? proof? of? concept.? However,? for? process?
development? and? scale?up? studies,? a? more? controlled? environment? and? a? more? easily? scalable?
configuration? is? preferred.?When? comparing? batch? transformations? between? bioreactor? and? shake?
flasks?under?identical?conditions,?the?former?showed?faster?initial?rates?(Fig.?4.12).?This?result?indicates?
that?increased?mixing?enhances?the?reaction?rate,?most?likely?due?to?increased?mass?transfer?of?poorly?
water?soluble? substrate?but?also?due? to? the? increased?aeration.?These? results?also? suggest? that? for?
processes? targeting? scale?up? and? industrial? implementation,? process? development? should? be?
performed?with?the?intended?final?reactor?configuration,?in?this?case?a?stirred?tank?reactor?instead?of?
shake?flasks.?This?especially?concerns?reactions?involving?species?with?low?water?solubility?and?gaseous?
components?(e.g.?oxygen).??
?
Figure?4.12?Comparison?of?1?mM?cyproterone?acetate?transformation? in?bioreactor?and?shake?flask.?
The?reactions?were?carried?out?using?the?same?batch?of?cells,?in?a?resting?cell?format?(100?g/L?WCW),?
and? the? substrate?was?added?dissolved? in?DMSO.?The? initial? rate?of? the? reaction?performed? in? the?
bioreactor?(?)?showed?a?higher?initial?rate?compared?to?the?reaction?performed?in?shake?flasks?(?),?
although?the?reaction?in?the?shake?flask?resulted?in?a?higher?final?conversion.?
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4.3.8 Catalyst?stability?
The? stability?of? a?biocatalyst? is? crucial? for? the?economic?potential?of? a?biocatalytic?process.? In? this?
study?we?examined?the?storage?stability,?due?to?practical?reasons,?and?more?importantly,?the?stability?
under?process?conditions,?under?which?the?relevant?information?is?collected.?The?dry?cell?weight?and?
the?correctly?folded?P450?were?monitored?during?the?process?and?it?was?found?that?the?cells?remained?
intact? but? the? stability? of? the? CYP106A2? was? limited.? One? third? of? the? correctly? folded? P450? is?
degraded?after?4?h?of?the?reaction?and?more?than?50?%?is?lost?after?24?h?(Fig.?4.13).??
?
Figure? 4.13? Stability? of? the?whole?cell? catalyst? under? process? conditions.? Reaction? performed?with?
resting?cells?in?the?bioreactor?at?1?mM?cyproterone?acetate?concentration?and?a?cell?density?of?100?g/L?
WCW.? Samples?were? collected?at? the? indicated? time?points.?The?dry? cell?weight? (?)?and? the?P450?
content?(?)?were?measured.?
?
The?storage?stability?of?the?catalyst?was?determined?by?running?resting?cell?biotransformations?with?
cells?previously?resuspended?in?buffer?and?stored?gently?shaken?at?4?°C.?No?significant?loss?in?reaction?
performance?was? found?over?7?days?of?storage? (data?not?shown).?The?stability?of?the?catalyst?could?
potentially?also?be?affected?by? the?mode?of?operation.?However,?no?significant?difference?was?seen?
between?growing?and?resting?cells?in?terms?of?conversion,?whole?cell?stability?or?P450?stability.?
Discussion?4.4
Even? though? in? the?past?decade? significant?progress?was?made? to?develop?efficient?biocatalysts? for?
steroid?transformations,?there?is?still?a?great?demand?for?greener?and?cost?efficient?routes?for?valuable?
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steroid? production? (Donova? and? Egorova? 2012).? Microbial? steroid? transformations,? using?
heterologously? expressed? cytochrome? P450? enzymes? are? considered? to? be? a? promising? approach,?
since? the? regio??and?stereospecific?hydroxylations?are?known? to?be?challenging? for?synthetic?steroid?
chemistry,?suffering?from? low?predictability?and?specificity?(Bernhardt?and?Urlacher?2014).?However,?
in?most? cases? the? reactions? performed? at? analytical? scale? are? not? directly? applicable? for? industrial?
practice.?For?an? industrial?process,?the?economic?feasibility?needs?to?be?considered.?For?guidance,?at?
the?current?stage?of?process?development,?targets?for?economic?metrics?such?as?space?time?yield?(for?
a?growing?cell?process),? final?product?concentration?and?biocatalyst?yield? (for?a?resting?cell?process)?
can?be?used.?For?high?value?products?or?pharmaceuticals,?such?as?the?15??OH?CPA,?target?values?for?
product? concentration? of? 20? g/L,? a? space?time? yield? of? 2? g/L/h? (for? a? growing? cell? process)? and? a?
biocatalyst?yield?of?10?g?product/g?dry?cell?weight? (DCW)? (for?a?resting?cell?process)?can?be?used?as?
reference,? as? identified? in? Chapter? 2.? These? targets? can? only? be? achieved? using? higher? substrate?
concentrations,? and? problems? associated?with? higher? concentrations? such? as? low? solubility? of? the?
substrate,?potential?substrate?or?product?inhibition?and?toxicity?most?likely?will?arise.?
?
Hannemann? and? co?workers? converted? 11?deoxycorticosterone? to? 15??hydroxy?11?
deoxycorticosterone?using?CYP106A2,?functionally?expressed?with?bovine?adrenal?redox?partners?in?a?
growing?whole? cell? E.? coli? host.? According? to? our? calculations,? the?molar? substrate? concentration?
applied? in? this? study? (0.5?mM)? could? result? in? a?maximal? final? product? concentration? of? 0.17? g/L.?
Furthermore,?since?the?substrate?was?not?fully?converted?after?24?h,?the?reported?space?time?yield?of?
0.33?g/L/d? is?misleading? (Hannemann?et?al.?2006).?However,?the? focus?of?the?study?was?to?design?a?
whole?cell?catalyst?and?demonstrate?the?applicability?of?a?screening?assay.?The?whole?cell?system?was?
then?further? improved?by?the?coexpression?of?a?cofactor?regeneration?system?and?used?for?the?15??
hydroxylation?of?progesterone?and?testosterone?(Zehentgruber?et?al.?2010a).?This?system?was?shown?
to?be? limited?by? substrate? transport? across? the? cell?membrane? and? solubility?of? the? substrate?was?
shown?to?be?crucial?for?the?reaction?performance.?The?productivity?was?reported?to?be?5.5?g/L/d?using?
0.5?mM? initial?substrate?concentration?and?a? lyophilized?cell?extract?on?a?20?mL?scale.?The?reported?
productivity?in?this?case?is?also?misleading?since?it?was?extrapolated?from?a?30?min?reaction,?the?96?%?
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conversion?can?be?translated?to?a?final?product?concentration?of?0.15?g/L.?In?the?same?study?growing?
cells?showed?25?%?selectivity? towards? the?15??position,?considerably? lower? than?resting?cells.?More?
recently,? DHEA? was? regioselectively? hydroxylated? to? 7??OH?DHEA? by? CYP106A2? expressed? in? B.?
megaterium? (Schmitz? et? al.? 2014).? A? benchmark? 0.44? g/L? total? final? product? concentration? was?
obtained?upon?addition?of?1.5?mM?substrate?in?a?repeated?batch?mode,?yielding?6?different?products?
in?12?h,?which?is?the?highest?reported?concentration?of?the?studies?above.?The?selectivity?towards?the?
7??position?was?improved?from?0.7?to?0.9?by?changing?host?from?B.?megaterium?strain?ATCC?13368?to?
MS941.?The?bottlenecks?of?the?reaction?were?discussed?but?never?investigated.??
?
In? the? current? study,? a? systematic? approach? was? taken? to? identify? catalyst?? and? reaction?related?
limitations? to? enable? an? efficient? process? with? defined? targets? based? on? economic? guidance.? By?
addressing?the?identified?limitations?we?managed?to?improve?the?process?performance.?This?is?a?novel?
approach? compared? to? previous? studies? on? steroid? hydroxylation? by? CYP106A2.? The? regio?? and?
stereoselective? 15??oxidation? of? CPA? was? demonstrated,? in? shake? flasks? and? laboratory? scale?
bioreactors.? CYP106A2? was? overexpressed? in? B.? megaterium? MS941? and? proved? to? be? a? robust?
catalyst? for? the? synthetic? biotransformation? of? CPA.? The? B.?megaterium? host? offers? a? protective?
environment? for? the?enzyme,?enhancing? its?stability,?besides? the?cofactor? regeneration?provided?by?
the? cellular?metabolism,?which,? according? to? our? studies,?was? shown? to? be? sufficient? to? not? limit?
catalysis.? The? substrate? transport? across? the?membrane? of? the? B.?megaterium?whole?cell? catalyst?
turned?out?not?to?be?a?limiting?factor?either,?as?was?described?in?the?case?of?steroid?hydroxylation?by?
E.?coli?(Zehentgruber?et?al.?2010a).?In?contrast,?the?low?overall?solubility?of?the?reactants,?the?limited?
stability?of?the?P450,?in?combination?with?product?inhibition,?are?suggested?to?be?the?main?bottlenecks?
of?this?system.??
?
The?low?solubility?of?substrate? is?a?common?challenge?to?many?P450?catalyzed?reactions.?In?the?case?
of?CPA?the?solubility? is?reported?to?be?0.64?mg/L? (ChemSpider?d)?and?34?mg/L? for?the?hydroxylated?
product? (ChemSpider? a).? However,? this? should? be? put? in? perspective? to? the? aimed? final? product?
concentration? of? 20? g/L.? Low? steroid? solubility? is? usually? solved? by? the? application? of? a? water?
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immiscible?co?solvent?but?this?approach?has?limitations?at?higher?concentrations?when?the?co?solvent?
can?damage?the?biocatalyst?(Laane?et?al.?1987).?This?can?partly?be?circumvented?by?the?application?of?
CDs.?These?cyclic?oligosaccharides?are?used?in?e.g.?drug?delivery?(Davis?and?Brewster?2004)?and?have?
also?been?applied?in?P450?catalyzed?reactions,?mainly?as?a?solubilizing?agent?and?to?improve?substrate?
transport?across?the?cell?membrane,?however?at?limited?substrate?concentrations?(50?mg/L)?(Roglic?et?
al.? 2007).? The? effects? of? HP???CD? on? steroid? dehydrogenation? of? the? gram?positive? bacteria?
Arthrobacter?simplex?was? investigated?by?Shen?et?al.? (2014).?Cells?pretreated?with?HP???CD?showed?
double? the? initial? rate? and? reached? final? conversion? 1? h? faster? compared? to? the?non?treated? cells,?
although?in?the?end?both?reached?the?same?concentration.?This?was?shown?to?be?the?result?of?the?cell?
membrane?permeabilization? by? altered? lipid? and?protein?profiles?of? the?membrane.?CDs? have? also?
been? applied? in? other? fermentation? and? biotransformation? processes? to? avoid? toxic? and? inhibitory?
effects?of?the?substrate?or?product,?as?summarized?by?Singh?et?al.?(2002).?In?the?current?study,?using?
HP???CD,?98?%?conversion?of?1?mM?CPA?regio??and?stereoselectively?within?8?h?was?achieved,?resulting?
in? 0.43? g/L? product.? This?matches? the? literature? benchmark? for? steroid? conversion? by? CYP106A2?
(Schmitz?et?al.?2014),?yet?the?8?h?conversion?time? improves?their?space?time?yield?by?31?%.?This?new?
approach?of?bottleneck?identification,?takes?P450?catalyzed?reactions?one?step?further?towards?higher?
product? titers? and? economic? viability.? In? our? system,? the? time?dependent? product? inhibition? was?
shown? to? limit? final?achievable?product? concentrations?at?higher? substrate? concentrations,? thereby?
decreasing?the?reaction?yield.?By?overcoming?this?problem,?the?main?effect?of?CD?was?believed?to?be?
the?complexation?of?the?product,?thereby?pulling?it?out?of?the?hydrophilic?environment?present?in?the?
cell?and?pushing?the?equilibrium?towards?the?product?formation.??
??
Conclusions?4.5
Ultimately,?with?the?help?of?HP???CD,?a?nearly?complete?conversion?and?a?product?formation?of?0.43?
g/L?at?a?400?mL? scale?was?achieved,?getting?closer? to? industrial?process? requirements?and?a? future?
large?scale? application.?However,? in? order? to? fully? exploit? the? potential? of? the? CD? process,? further?
optimization? studies? should? be? performed.? Using? CD? to? circumvent? the? identified? bottlenecks? of?
solubility? and? product? inhibition,? the? stability? of? the? P450? is? still? a? challenge? for? an? economically?
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feasible?process.?Considering?that?the?stability?of?the?enzyme?will?make?cell?recycling?difficult,?and?that?
no?significant?differences?could?be?found?between?a?growing?and?resting?cell?process,?the?preferred?
operating?mode?for?further?process?development?would?be?growing?cells.?As?stated?above,?the?targets?
for?an?economically? feasible?growing?cell?process?are?a? final?product?concentration?of?20?g/L?and?a?
space?time? yield? of? 2? g/L/h? (Lundemo? and? Woodley? 2015).? Although? a? successful? process?
development?towards?the?suggested?values?by?addressing?the?limitations?was?performed,?there?is?still?
room?for?improvement.? ?
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5 Cost?assessment?of?P450?catalyzed?whole?cell?processes?
As?a? last?part?of? the? thesis,? the?knowledge?gained? from? the?already?presented?model? systems?and?
especially?from?the?first?(Chapter?3),?where?E.coli?was?applied?as?microbial?host,?was?applied?to?a?third?
model? system?with? the?main? intention? to? perform? an? economic? assessment? by? construction? of? a?
process? model.? The? most? explored? P450,? CYP102A1? from? Bacillus? megaterium,? a? natural? fusion?
construct,?was?used?as?basis?for?this?study.?A?double?mutant,?constructed?by?Michael?Ringle,?Lonza?AG,?
Switzerland,?shown?to?hydroxylate?4?ethylphenol?to?4?ethylcatechol?was?expressed?in?the?same?E.?coli?
strain?as?applied?in?Chapter?3?and?the?whole?cell?biocatalytic?process?was?studied?in?2.5?L?fermenters?
in?parallel?to?shake?flasks.?
Economical?feasibility?is?of?key?importance?for?all?production?processes,?regardless?of?their?design?and?
catalyst.? Biocatalytic? processes? are? known? to? be? highly? selective? and? in? general? environmentally?
friendly?due?to?the?mild?conditions?under?which?the?processes?can?be?performed.?Here,?an?economical?
assessment? based? on? a? process?model? of? a?whole? cell? P450? catalyzed? process? is? presented.? The?
enzyme?expression?and?enzyme?total?turnover?have?been?varied?with?values?taken?from?experiments?
performed? on? a? 2.5? L? scale? as? starting? point.? Furthermore,? these? whole? cell? processes? can? be?
performed?in?different?operating?modes,?which?have?also?been?evaluated.?????
The?aim?of?this?study?was?to?enable?economic?assessment?of?P450?catalyzed?whole?cell?processes.?The?
economic? assessment? can? also? be? used? to? confirm? the? analysis? made? in? Chapter? 2.? The? work?
presented?in?this?chapter?is?the?result?of?an?external?stay?at?Lonza?AG,?Visp,?Switzerland?and?based?on?
Paper?IV.?
Introduction?5.1
Chemical? process? design? has? traditionally? been? based? on? economic? viability? utilizing? models? of?
different?complexity.?In?recent?years,?the?ecological?(hazardous?substances?and?environmental?impact?
judged? by? e.g.? a? life? cycle? assessment? (LCA))? and? social? (environmental,? health? and? safety? (EHS))?
performance? has? also? been? included? in? the? design? (Ouattara? et? al.? 2012;? Albrecht? et? al.? 2010).?
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Frameworks? including? process? models? at? various? stages? of? the? process? design? can? be? used? for?
screening?of?synthesis?routes?and?process?options?with?the?information?available?at?that?development?
stage? (Albrecht? et? al.? 2010).? This? includes? comparisons? of? e.g.? a? chemical? synthesis? route? with?
biologically?mediated? synthesis? (Adlercreutz?et?al.?2010;? Johnston?et?al.?1987;?Kuhn?et?al.?2010).? In?
general,? biotechnological? processes? have? the? advantage? of? being? highly? regio? and? stereo? selective?
circumventing?the?need?for?protection?and?deprotection?steps?and?the?need?for?advanced?methods?in?
downstream?processing? (DSP).?Furthermore,? the? cost?distribution?may?differ?between? the? chemical?
and?biochemical?processes?and?therefore?assessments?needs?to?be?made?on?a?case?by?case?basis.?E.g.?
dilute?water? streams?and? capital? cost?are?perhaps? the?biggest? challenges? for?biocatalytic?processes?
whereas?the?raw?material?costs?including?the?catalyst?cost?is?dominating?in?a?chemical?process?(Kuhn?
et?al.?2010).? In? fermentation?processes?the?dominating?cost? items?have?been?described?to?be? labor,?
capital?cost?and?raw?materials?(Datar?1986;?Harrison?and?Gibson?1984).??The?cost?contribution?of?raw?
materials?also?depends?on?the?type?of?product,?generally?increasing?with?decreasing?product?value?and?
can?be?in?the?range?of?70?%?for?bulk?chemicals?(Harrison?and?Gibson?1984).?Regardless?of?the?different?
benefits? of? the? processes,? economic? profitability? is? the? key? parameter? determining? the? fate? of? a?
process.?All?major?chemical?and?pharmaceutical?companies?use?various?tools?for?process?improvement?
and?including?tools?for?economic?assessments?(Bode?et?al.?2011;?Harrison?and?Gibson?1984).?However,?
standard?costing? tools? for?biocatalytic?processes?are?not?well?established?and? the? sensitivity?of? this?
type?of?information?also?hinders?the?development.?In?the?scientific?literature?there?is?even?more?room?
for?exploration?of?the?field?of?economic?and?environmental?process?assessments,?although?it?has?been?
initiated?(Lima?Ramos?et?al.?2014).?An?assessment? is?beneficial?when?scaling?up?and?can?also?help?to?
identify?bottlenecks?in?a?process?and?help?to?identify?components?that?are?the?main?cost?contributors?
and?needs? to? be?optimized? or? improved? (Harrison? and?Gibson? 1984;? Kuhn? et? al.? 2010).?At? a?basic?
research?stage?the?cost?for?the?required?improvements?can?also?be?weighed?against?the?development?
cost?and?likelihood?of?improving?the?parameter?to?the?target?value?and?thereby?guide?research?efforts?
(Riet?1986).?This?has?been?done?in?general?for?fermentation?processes,?where?the?product?of?interest?
is?produced?during?fermentation?e.g.?as?secondary?metabolite?(Riet?1986).??
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In?this?study?a?process?model?is?used?to?guide?the?development?of?whole?cell?P450?catalyzed?reactions?
by? correlating? the? final?production? cost?with?biological?parameters? such?as?enzyme?expression?and?
enzyme? total? turnover.?Cytochrome?P450?monooxygenases? is? a?group?of?enzymes? able? to?perform?
hydroxylation? of? non?activated? hydrocarbons? including? aromatics? (Bernhardt? and? Urlacher? 2014;?
O'Reilly?et?al.?2011;?Urlacher?and?Girhard?2012).?However,?only?a?few?industrial?P450?processes?have?
been? implemented? so? far.?This? can?be?explained?by? the?many? challenges? in?making?P450? catalyzed?
processes? economically? feasible,? in? particular? limited? stability? and? low? activity? of? the? enzyme?
(Lundemo? and?Woodley?2015).? Furthermore,? the?need? for? stoichiometric? amounts?of?nicotinamide?
cofactor? and? redox? partners? transporting? electrons? from? the? cofactor? to? the? active? site? of? the?
monooxygenase?urge? the?use?of?metabolically?active?whole? cell? catalysts.?Metabolically?active? cells?
require?that?the?cell?is?used?for?the?catalytic?reaction?in?close?connection?with?an?initial?fermentation?
step.?Two?operating?modes?can?be?applied:?growing?cells?where?the?biocatalytic?reaction?is?performed?
simultaneously? to? the? fermentation? or? resting? cells?where? the? cells? are? harvested? after? the? initial?
fermentation?by? filtration?or? centrifugation?and? resuspended? in?buffer? for? the?biocatalytic? reaction?
step.?In?the?latter?case?the?biocatalytic?step?can?be?optimized?to?a?greater?extent?compared?to?growing?
cells?and?also?allows?recycling?of?the?catalyst,?if?the?product?localization?and?DSP?permits.?In?this?study?
an?economical? assessment?of? a?P450? catalyzed?process?has?been?made?based?on? a?process?model?
enabling? construction?of?mass?balances?over? the? entire?process?with? the? aim? to?put? the?biological?
parameters? (protein? expression? and? enzyme? total? turnover)? in? relation? to? the? actual? cost? for?
production.?Furthermore,?the?operating?mode?is?evaluated?as?well.?
Methodology?5.2
5.2.1 Approach?
Process? flow?sheets?were?built? in? the?process?modeling?and?evaluation?software?SuperPro?Designer?
(Intelligen?Inc,?Boston,?MA)?(SPD).?The?flowsheets?were?based?on?experimental?data?collected?at?a?2.5?
L?scale?(Appendix?1)?and?scalability?has?been?assumed.?Based?on?the?process?model,? including?mass?
balances,?economic?assessments?of?the?process?was?made.?The?economic?analysis?was?based?on?the?
unit?production?cost?taken?from?the?economic?evaluation?report?generated?in?the?software.?
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5.2.2 Model?
The? cost? calculations?have?been?done?with? the?assumption?of?an?existing?multi?purpose?plant.?The?
quantities?of?the?type?of?products?produced?by?P450?catalyzed?processes?are?not?assumed?to?be?large?
enough? to?make?a?dedicated?plant? suitable.?The?operating? costs?have?been?adjusted?with?a? facility?
dependent? cost? based? on? equipment? usage.? The? SPD? default? value? of? 100? $/h? has? been? applied.?
Throughout? the? process,? labor? is? calculated? on? the? assumption? that? the? process? requires? 1?man?
hour/hour.? All? procedures? include? a? cleaning? in? place? (CIP)? procedure? after? each? batch? and? the?
fermentation? includes? a? sterilization? in? place? (SIP)? procedure? prior? to? each? batch.? Inoculum?
preparation?and?waste?treatment?costs?have?not?been?included?in?the?assessment.?
The?basis?for?the?model?has?been?a?CYP102A1?double?mutant?expressed? in?Escherichia?coli?HMS174?
catalyzing?the?hydroxylation?of?4?ethylphenol?to?4?ehtylcatechol?(Scheme?5.1).?????
?
Scheme?5.1?Model? reaction?used?as?a?base?case? in? this? study,?hydroxylation?of?4?ethylphenol? to?4?
ethylcatechol.?
5.2.3 Base?case:?Resting?cell?process?
A?base?case?was?set?up?using?SuperPro?Designer.?The?process? is?divided? in?three?parts,?fermentation?
followed?by?biocatalysis?and?finally?DSP?(Figure?5.1).??
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Figure?5.1?SuperPro?Designer?flowsheet?of?the?resting?cell?process?used?for?economic?assessment.??
The?model?is?based?on?experimental?data?from?the?hydroxylation?of?4?ethylphenol?to?4?ethylcatechol?
by? a? CYP102A1? double?mutant? expressed? in? E.? coli? HMS174.? The? data? for? the? fermentation? and?
transformation?were? collected? from?experiments? run?on?a?2.5? L? scale? (Appendix?1).?The?process? is?
assumed? to? be? run? in? a? fermentation? plant? with? two? 50? m3? fermenters? and? a?
microfiltration/diafiltration?unit.?The? first? two?DSP?operations?are?also?assumed? to?be?performed? in?
the? fermentation? plant?while? further? purification? is? expected? to? be? performed? in? a?multi?purpose?
chemical?plant.? This? assumption? is?based?on? the?potential? to? collect?product? streams? from? several?
fermentation?batches?and?run?further?DSP?in?a?semi?continuous?mode?(Riet?1986).?The?process?model?
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and?analyses?up? to?a?concentrated?organic?product? stream?can?be?applied? to?many?P450?catalyzed?
processes,?since?the?majority?of?the?catalyzed?products?are?hydrophobic?and?a?concentration?step? is?
preferred? in? the? initial?DSP? to?minimize? the? volumes? to?be? treated.? From? this?point? it? is,?however,?
more?difficult? to?generalize?and? the? last?DSP?steps,? including?purification,?would?vary?depending?on?
the? product.? Furthermore,? a? concentrated? organic? product? stream? is? directly? comparable? to? a?
corresponding?stream?from?a?potential?competing?chemical?process?for?products?where?this?would?be?
the?target?of?the?cost?assessment.?
Other?fixed?process?parameters?have?been?summarized?in?Table?5.1?and?are?further?discussed?below.??
Table?5.1?Fixed?process?parameters??
Part?of?process? Parameter? State?and?motivation?
Fermentation? Duration? and? final?
cell?concentration.?
P450? expression? has? been? shown? to? be? optimal? at? a?
growth? rate? of? 0.1? h?1? and? a? feed? phase? lasting? 4?
generations.?
Diafiltration? Area? 131?m2?
Duration? 24?h?
Biocatalysis? Cell?density? Identical? to? fermentation? to? fully? utilize? the? capacity? of?
the?fermenter?where?the?biocatalytic?step?is?performed.?
Duration? The?stability?of? the?P450? is?assumed? to? limit? the?process?
to?8?h.?
DSP? Product?localization? Products?assumed?to?be?present?in?or?attached?to?the?cell?
membrane,? cell? separation? therefore? excluded.? This?
assumption?also?excludes?cell?recycle.?
?
5.2.3.1 Fermentation?
The? fermentation? process?was? run? as? batch?with? semi?defined?media? followed? by? fed?batch?with?
minimal?media?(Marisch?et?al.?2013).?The?batch?phase?was?assumed?to?last?for?12?h?followed?by?a?fed?
batch? phase? with? a? fixed? growth? rate? of? 0.1? h?1? yielding? a? final? cell? density? of? 33? g? cdw/L.? The?
fermentation?process?was?run?in?total?for?40?h?and?for?simplistic?reasons?this?is?shown?as?one?process?
with?one? inlet?media? stream?dependent?on? the?volume?and?one? stream?dependent?on? the?desired?
final?biomass?concentration.?The?duration?of?the?fermentation?process?and?biomass?concentration?has?
in?this?case?not?been?varied.?
118
99?
?
5.2.3.2 Diafiltration?
The? cells? are? harvested? and? reaction? media? changed? by? diafiltration.? Four? volumes? of? 100? mM?
potassium?phosphate?buffer?is?used?and?the?cell?concentration?is?kept?constant,?although?it?potentially?
could?be?changed.?Assumed?filter?area?is?131?m2.??
5.2.3.3 Biocatalysis?
The?base?case?biocatalytic?reaction?is?based?on?values?from?experiments?performed?at?2.5?L?scale?and?
presented? in? Appendix? 1.? Substrate? is? fed? based? on? the? P450? content? in? the? inlet? stream? (1? g?
substrate/g? P450? in? the? base? case,? corresponding? to? 10?mM? final? substrate? concentration).? The?
assumption? that? differs? from? the? results? in? the? supplementary? information? is? that? an? improved?
reaction?yield?of?90?%?is?assumed.?The?substrate?stream?consists?of?10?%?substrate?in?DMSO?and?the?
transformation?is?performed?during?8?h?at?30?°C.?The?substrate,?4?ethylphenol,?is?estimated?to?a?cost?
of?one?tenth?of?the?catalogue?price?in?SigmaAldrich?(4.9?$/kg).?The?metabolic?activity?of?the?cells?was?
retained? by? feeding? carbon? source? (glucose/glycerol?mixture)? on? a?mass? basis? dependent? on? the?
biomass?in?the?inlet?stream?to?the?transformation?step?(7?g?stock?mixture/g?cdw).??
5.2.3.4 Downstream?processing?
The?downstream?processing?is?the?part?of?the?process?that?will?vary?most?dependent?on?the?reaction?
system.? In? the? base? case? the? hydrophobic? product? is? assumed? to? be? present? attached? to? the? cell?
membrane?and? therefore?a?mixer?settler?extraction? is?chosen,? followed?by? thin? film?evaporation? to?
concentrate?the?organic?phase?containing?the?product.?This?also?implies?that?cell?recycle?has?not?been?
considered.?The?chosen?DSP?will?result?in?a?stream?for?further?purification?comparable?with?a?stream?
from?an?alternative?chemical?synthesis?route?so?that?the?two?competing?routes?until?this?point?can?be?
compared.??
The?product?will?first?be?extracted?using?an?equal?volume?organic?solvent,?in?this?case?ethyl?acetate?(40?
000?L/batch),? in?a?mixer?settler?extraction?with?a?batch?duration?of?6?h.?Extraction?and?evaporation?
data? has? been? assumed? using? the? properties? naphthalene? and? naphthol? found? in? the? Designer?
database?in?SuperPro?Designer.?Partition?coefficients?have?been?assumed?to?be?the?same?as?the?logP?
(octanol/water)?due?to?missing?experimental?data?for?ethyl?acetate.??
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The?organic?product?stream?will?then?be?concentrated?by?thin? film?evaporation.?The?unit?procedure?
has?been?specified?to?99?%?(molar)?feed?vaporization?in?6?h.?The?solvent?in?the?evaporated?stream?is?
assumed? to? be? recycled? to? 90?%? of? a? cost? of? 1.3? times? the? cost? of? energy? for? evaporation? of? the?
solvent.?This?is?represented?in?the?SuperPro?Designer?flowsheet?as?a?component?split?(Figure?5.1).????
5.2.3.5 Sensitivity?analysis?of?the?resting?cell?process?
The?parameters?presented?in?Table?5.2?have?been?varied?in?the?process?model?in?SPD.?As?a?base?case,?
a?yearly?production?of?5? tonnes?has?been?assumed,?an?enzyme?expression?of?0.05?g/g? cdw?and?an?
enzyme?total?turnover?of?1?g?substrate/g?enzyme.??
Table?5.2?Variable?parameters?and?practical?limitations.?Bold?numbers?indicate?the?chosen?base?case?
values.?
Part?of?process? Variable? Numbers? Motivation?
Fermentation? Enzyme?expression? 0.01,?0.05,?0.125?g/g?cdw Base?case?reached?for?the?
model?system?(1100?nmol/L).?
Maximum?value?chosen?due?to?
limitations?of?overexpression?
(Tufvesson?et?al.?2011).?
Biocatalysis? Enzyme?total?turnover? 0.1,?1,?5?g?substrate/g?
enzyme?
1?g?s/g?corresponds?to?a?
substrate?concentration?of?10?
mM?in?the?base?case.?
?
5.2.4 Annual?production?
The? target? annual? production? has? been? set? to? 5? tonnes/annum,? a? reasonable? number? for?
pharmaceutical?chemicals?(Lima?Ramos?et?al.?2014).?The?process?has?been?scaled? in?such?a?way?that?
the? number? of? batches? has? been? decreased? instead? of? the? size? of? the? equipment? or? any? other?
alternative.?However,?for?the?lower?numbers?in?the?sensitivity?analysis,?the?target?production?cannot?
be? met? within? one? year? and? therefore? the? production? cost? during? one? year? has? been? used?
(corresponding? to? a?production?of?1? tonnes/annum? in? the? case?of? low?enzyme?expression? and?0.7?
tonnes/annum?in?the?case?of?low?enzyme?total?turnover).?
120
101?
?
5.2.5 Influence?of?DSP?
As?mentioned?above,?the?DSP?after?a?concentrated?product?stream?will?vary?between?products?and?is?
therefore?not?considered? in?more?detail.?The?desired?purity?of? the? final?product?will?also?determine?
required?purification?and? further?contribute? to?the?cost.?To?see? the?overall?picture?a?remaining?DSP?
cost?of?2x?and?10x?the?initial?extraction?and?evaporation?has?been?considered.?
5.2.6 Alternative?operating?mode:?Growing?cells?
For? the? growing? cell? process,? the? biocatalytic? reaction? is? assumed? to? proceed? in? the? fermentation?
vessel? for? 8? h? directly? following? the? fermentation? process?with? carbon? source? fed? similarly? to? the?
resting?cell?process.?
Results?and?discussion?5.3
5.3.1 Sensitivity?analysis?
5.3.1.1 Enzyme?expression?
Already?when? looking? at? the? axis? of? the? figures? below,? it? can? be? concluded? that? it? is? high? value?
molecules? that? are? relevant? for? this? type?of?processes.?Approximate?market? value? for?a?high? value?
chemical?is?in?the?range?of?500?$/kg,?medium?value?products?100?$/kg?and?low?value?products?in?the?
range?of?1?$/kg.?From?Figure?5.2?it?can?be?seen?that?expression?achieved?with?the?CYP106A2?mutant?of?
0.05?g/g?cdw?corresponding?to?1100?nmol/L?is?definitely?in?the?low?end?of?what?is?required?to?keep?the?
production?cost?reasonable.??Further?increase?in?enzyme?expression?to?what?has?been?considered?the?
biological?limitation?of?an?overexpressed?protein?(12.5?%)?would?decrease?the?production?costs?to?half?
of?the?base?case?(480?$/kg?main?product?(MP)?instead?of?1089?$/kg?MP).?A?P450?expression?of?11?%?of?
the?cdw?has?also?been?reached?and?is?a?desirable?target?(Pflug?et?al.?2007).??????
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Figure?5.2?Influence?of?enzyme?expression?on?the?production?cost.??
5.3.1.2 Enzyme?total?turnover?
After?the?biological?limitation?of?the?enzyme?expression?has?been?reached,?the?enzyme?total?turnover?
can?be?improved?to?lower?the?production?costs.?The?conversion?to?the?desired?product?is?set?to?90?%?
and? the?base?case? is?assuming?a?substrate?conversion?of?1?g?substrate/g?enzyme?within?8?h.? In? this?
case?1?g?substrate/g?enzyme?corresponds? to?0.05?g?substrate/g?cdw?or?0.85?U/g?cdw?over?8?h.? ?An?
improvement?of?5?times?in?this?variable?would? lower?the?production?cost?from?1089?$/kg?MP?to?275?
$/kg?MP?(Figure?5.3).?This?increase?to?4.25?U/g?cdw?is?highly?realistic?also?with?respect?to?the?cofactor?
regeneration?capabilities?of?the?whole?cell,?and?could?be?increased?even?further?based?on?findings? in?
Chapter?2.?However,? this? is? calculated?over?8?h?and? stresses? the? importance?of? the? stability?of? the?
catalyst,?which?in?the?case?of?P450s?might?be?a?challenge.?Further?possible?adjustments?to?the?process?
that?would? lower? the?production?cost? that?has?not?been?considered?here,? is?an? increase? in?biomass?
concentration.??
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Figure?5.3?Influence?of?enzyme?total?turnover?on?the?production?cost.?
5.3.2 Influence?of?DSP?
In?this?chapter,?data?for?the?fermentation?and?biocatalytic?process?have?been?collected?experimentally?
on?a?2.5?L?scale.?However,?the?DSP?is?more?uncertain?and?a?liquid/liquid?extraction?has?been?assumed?
followed?by?evaporation?to?concentrate?the?product?stream.?No?significant?cost?difference?was?found?
between? recovery? by? extraction? or? adsorption? using? Amberlite? XAD?7? resin? in? the? recovery? of? 3?
fluorocatechol? from?a?biocatalytic?process?using? fluorobenzene?as? substrate? (Johnston?et?al.?1987),?
implying?that?this?alternative?also?could?be?an?option?valid? in?this?case.?The?variables?applied?for?the?
sensitivity?analysis?have?resulted? in?various?product?concentrations?summarized? in?Table?5.3.?Values?
for? the? stream? after? the? transformation? and? the? final?product? containing? stream? is?presented.?The?
resulting?various?product?concentrations?will?also? influence? the?cost?of? the? required? remaining?DSP?
operations?(Riet?1986;?Datar?1986).????
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Table?5.3?Product?concentration?in?different?cases?with?an?assumed?annual?production?of?5?
tonnes/year.?Base?case?numbers?are?represented?in?bold.?First?row?represents?base?case?numbers,?the?
following?two?rows?represent?variable?enzyme?expression?and?the?lowest?two?represent?variable?
enzyme?total?turnover.?
Enzyme?expression??
(g/g?cdw)?
Enzyme?total?turnover?
(g?s/g?cdw)?
[P]?after?
transformation?(g/L)?
[P]?after?evaporation?
(g/L)?
0.05? 1? 1.3 184
0.01? 1? 0.3 41?
0.125? 1? 3.4 387
0.05? 0.1? 0.1 21?
0.05? 5? 6.6 468
?
The?remaining?DSP?cost?will?highly?influence?the?total?production?cost,?therefore?assumptions?on?the?
remaining?cost?has?been?made.?Analyzing?an?itemized?cost?report,?in?the?base?case?it?can?be?seen?that?
the?DSP?procedures?accounted?for?here?represents?23?%?of?the?total?production?cost?(Figure?5.4).?The?
final?purification? is?highly?dependent?on?the?type?of?product?and? in?previous?published?fermentation?
processes? (although?not?biocatalytic?processes)?the?recovery?costs?was?50?%?of?the?total?costs? for?a?
penicillin?product?and?8?%?for?ethanol?(Datar?1986),? indicating?that?this?range? is?also?realistic?for?the?
products?from?P450?catalyzed?processes.?If?the?cost?for?DSP?is?doubled?or?even?increased?10?fold?the?
total?production?cost?is?considerably?increased.???
?
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Figure? 5.4? Influence?of? remaining?DSP? cost?of? the? total? production? cost.? The? distribution? between?
fermentation?combined?with?biocatalysis?and?DSP?is?also?illustrated.??
In?the?process?above,?the?product?is?assumed?to?be?localized?attached?to?the?cells,?thereby?requiring?
extraction?by?organic?solvent?prior?to?cell?separation?preventing?reusability?of?the?cell.?However,?the?
product?can?potentially?be?accumulated?inside?the?cells,?attached?to?the?cell?membrane?or?present?in?
the? aqueous? phase.? For? a? product? in? the? aqueous? phase? a? first? centrifugation? step? (using? e.g.? a?
decanter)? to? remove? the? cell?mass? is? expected? to? simplify? following? DSP? and? allow? reuse? of? the?
catalyst.?Furthermore,?extended?experimental?data?for?possibility?of?cell?recycle?and?the?consequence?
of?the?presence?of?cells?during?DSP?is?needed.??
5.3.3 Operating?mode?
The?analyses?above?have?been?made?based?on?a?resting?cell?process.?A?resting?cell?process?gives?the?
opportunity?for?more?process?optimization?compared?to?a?growing?cell?process?and?also?the?possibility?
of?cell?recycle.?However,?since?the?assumption?has?been?made?that?the?product?is?attached?to?the?cell?
membrane,? recycle? of? the? cells? is? not? possible? and? the? resting? cell? process? has? therefore? been?
compared?to?a?growing?cell?process.?The?growing?cell?process?excludes?the?diafiltration?unit?as?well?as?
the?transformation?vessel?and?the?stream?from?the?first?fermentation?vessel?is?transferred?directly?to?
the? extraction? unit.? The? fermentation? step? of? the? growing? cell? process? has? been? assumed? to? be?
identical?to?the?fermentation?process?in?the?resting?cell?process.?The?biocatalytic?reaction?is?assumed?
to?take?place?immediately?after?the?fermentation,?in?the?same?vessel,?with?carbon?source?fed?similarly?
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to? the? resting? cell? process.? The? base? case? production? cost? can? with? a? growing? cell? process? be?
decreased?from?1089?$/kg?MP?to?756?$/kg?MP?(Figure?5.5).?In?the?growing?cell?process,?only?one?of?the?
two?available?fermentation?vessels?has?been?utilized.?The?process?could?thereby?be?optimized?further,?
by?clever?scheduling?or?introduction?of?a?storage?tank?prior?to?DSP?to?decrease?costs?further.?
?
Figure?5.5?Comparison?of?resting?and?growing?cells?and?the?influence?on?the?production?cost.??
5.3.4 Best?case?scenario?
Combining?a?high?expression?and?a?high?enzyme?total?turnover?in?a?growing?cell?process?would?result?
in? a? unit? production? cost? of? 118? $/kg?MP.? In? a? similar? cost? assessment? for? the? production? of? 3?
fluoroveratrole?by?Pseudomonasi?T?12,?the?continuous?biocatalytic?route?resulted?in?a?production?cost?
of?100?200?$/kg?MP,?indicating?that?the?value?is?reasonable?(Johnston?et?al.?1987).?A?unit?production?
cost?of?118?$/kg?MP?would?require?an?enzyme?expression?of?12.5?%?of?the?cell?dry?weight?and?a?whole?
cell?activity?of?4.25?U/g?cdw?over?8?h.?Even?with?these?improvements?of?the?biocatalyst,?it?can?be?seen?
that? the? cost? falls? under? production? of? pharmaceuticals? or? high? value? chemicals,? above? 100? €/kg?
corresponding? to? around? 116? $/kg? (Lima?Ramos? et? al.? 2014).? These? combined? improvements? also?
results? in?a?final?product?concentration?after?the?combined?fermentation?and?transformation?step?of?
15?g/L,?in?the?same?order?of?magnitude?of?what?has?previously?been?presented?as?general?guidelines?
for?high?value?molecules?in?Chapter?2.???
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Conclusions?5.4
A?process?model?has?been?set?up?in?SPD?using?a?fixed?production?plant?of?two?fermenters?with?the?size?
of?50?m3?and?DSP? scaled?accordingly? including?extraction? to?an?organic? solvent?and?evaporation? to?
concentrate?the?product?stream.?The?analyses?in?this?study?show?that?with?realistic?improvements?to?
the?P450?expressing?whole?cell?catalyst,?in?terms?of?enzyme?expression?to?12.5?%?of?the?cell?dry?weight?
and?whole?cell?total?turnover?of?4.25?U/g?cdw,?production?costs?in?the?range?of?what?is?reasonable?for?
pharmaceuticals? and? high? value? chemicals? are? within? reach.? It? can? also? be? seen? that? under? the?
premises?that?the?product?is?accumulated?attached?to?the?cell?membrane,?ruling?out?recycling?of?the?
catalyst,?growing?cells?is?the?preferred?operating?mode.??????
? ?
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6 Discussion?
This? chapter?will? connect? the? findings? from? the? individual? parts? of? the? thesis,? the? initial? literature?
based?analysis?with?the?two?case?studies?presented? in?Chapters?3?and?4?together?with?the?final?cost?
assessment? in? Chapter? 5.? The? findings? will? be? discussed? in? relation? to? process? development? and?
implementation? of? P450? whole? cell? catalyzed? processes.? After? commenting? on? the? general?
methodology? and? suitable? target? products,? the? influence? on? catalyst,? reaction? and?process? related?
parameters?will?be?discussed.?Finally,?suggestions? for?successful? implementation?of?whole?cell?P450?
catalyzed?processes?are?presented.?
General?methodology?6.1
As?emphasized? repeatedly? in? scientific? literature,?P450s?perform? tempting? chemistry? to? implement?
this?group?of?enzymes?for?synthetic?production?at?industrial?scale.?The?novelty?of?this?work?has?been?
to?put?the?published?literature?in?relation?to?demands?on?an?economically?feasible?process,?something?
that? has? been?missing? in? the? field.? As? stressed? throughout? this? thesis,? there? are?many? challenges?
associated?with? the? development? of? economically? feasible? P450? catalyzed?whole? cell? processes.?A?
general?methodology?has?been?applied?to?identify?bottlenecks?in?whole?cell?catalyzed?P450?processes.?
In?the?first?part?of?the?thesis?(Chapter?2)?economic?metrics?were?applied?to?identify?challenges?within?
the?field?from? literature?data.?The? identified?challenges?have?then?been?used?as?a?basis? for?the?case?
studies?applied?in?the?thesis.?An?important?lesson?is?that?development?time?and?cost?can?be?saved?by?
in? silico? process? design,?meaning? that? it? would? be?more? efficient? to? spend? time? in? front? of? the?
computer?before?entering? the? lab.? For? this? analysis,? the?product?of? interest? should?be? the? starting?
point.?After?the?product?of?interest?has?been?identified,?the?overall?synthesis?route?should?be?selected,?
and?at? this?point?P450s?can?be?considered.?A? suitable?P450?and? substrate?can?be?determined? from?
literature? and? also? the? physical? properties? (e.g.? solubility? and? logP? guiding? the? toxicity)? can? be?
collected? from? literature.?Already?here?potential? reactor?configurations?and?process?options?can?be?
identified,? although? the? growing? or? resting? whole? cell? catalyst? in? combination? with? the? oxygen?
demand?speaks?in?favor?of?a?stirred?tank?reactor.?However,?suitable?modifications?to?this?reactor?could?
129
110?
?
be?beneficial.?Furthermore,?a?suitable?host?cell?can?be?selected?based?on?the?knowledge?gained?from?
the? in? silico? analysis.? Challenges? and? potential? limitations? for? reaching? an? economically? feasible?
process? identified? from? the? first? analysis? can?be?divided? into? catalyst? related,? reaction? related? and?
process?related?parameters.?Requirements?on?these?parameters?and?potential? improvements?to?the?
individual?parameters?were?also?identified?in?Chapter?2?and?have?then?been?the?reference?targets?for?
the?following?case?studies.?All?aspects?are?important?for?a?successful?development?of?these?processes?
and?as?stressed?in?Chapter?2?(and?Figure?2.5)?the?overall?picture?needs?to?be?considered?already?at?the?
beginning?of?the?development.??
Strategy?for?bottleneck?identification?and?ranking?6.2
Throughout? this?work? the?order? for? theoretical? and? experimental? identification?of?bottlenecks? and?
order?of? importance?have?been? attempted? to?be?determined.?However,? it?has?not? resulted? in? any?
conclusive?answer.?The? result? from? this? is? instead? that?a?whole?cell?P450?catalyst? is?a?very?complex?
machinery,? also? dependent? on? the? outer? environment? such? as? parameters? influenced? by? different?
reaction?systems?and?process?options.?Taking?biocatalyst?yield?for?a?resting?cell?process?as?an?example,?
this? is? affected? by? inhibition,? toxicity? and? specific? activity,?which? in? turn? is? dependent? on? enzyme?
expression,?enzyme?activity?and?stability?of?all?components?of?the?biocatalyst.?Enzyme?expression? is?
the? most? independent? parameter? from? the? others? that? has? a? given? target,? guided? by? biological?
limitations? for? overexpression.? All? the? other? parameters? are? correlated? and? cannot? be? completely?
separated?from?each?other.?Toxicity?and?inhibition?are?also?difficult?to?classify?as?catalyst?dependent?or?
reaction? dependent? since? they? are? dependent? on? both? mechanistic? aspects? of? the? catalyst? but?
obviously?also?dependent?of?the?molecule?of?interest.?
Suitable?target?products?6.3
Suggested? in?Chapter?2,?and?confirmed? in? the?cost?assessment? in?Chapter?5,?even? for? the?best?case?
scenario,? the?production? cost?of?118?$/kg?of?product? indicates? that? it? is?high? value?product? that? is?
suitable? for? production? by? this? type? of? catalyst? and? process.? High? value? products? include? e.g.?
pharmaceuticals?and?their?intermediates?with?a?market?value?above?100?€/kg?(Lima?Ramos,?2014).?As?
discussed?in?Chapter?2,?for?products?without?competitive?chemical?processes,?the?market?price?of?the?
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intended?products?can?be?a?challenge?to?determine.?The?fact?that?there?is?not?an?established?market?
does?not?imply?that?the?price?can?be?determined?by?the?producer,?an?indication?can?still?be?received?
from?the?market?or?application?of?the?product.??Furthermore,?for?some?types?of?products?it?might?be?a?
marketing?advantage?to?have?a?biocatalytic?production?process.?
Catalyst?related?parameters?6.4
Since?P450s?include?more?than?26?000?enzymes?from?all?kingdoms?of?life?there?is?a?huge?selection?to?
choose?from.?However,?far?from?all?of?them?are?suitable?for?overexpression?and?processes?performed?
under?economically? feasible?conditions.?When? the? final?research? target? is?process?development?and?
industrial?implementation,?realistic?improvements?utilizing?different?tools?need?to?be?put?in?relation?to?
economical? feasible? targets,? as? done? during? this? thesis,? to? rule? out? non?suitable? options? before?
exploring?the?catalyst?in?the?lab.?Enzyme?activities?above?1?s?1?and?expression?levels?around?12.5?%?of?
the?dry?cell?weight?as?well?as?a?stable?catalyst?at?relevant?conditions?are?all?parameters?to?strive?for?
already?in?lab?scale.?
6.4.1 Cytochrome?P450?monooxygenase?
In? the? first? case? study,? an? artificial? fusion? construct?was? applied? and? expressed? in? the?well?known?
laboratory? strain?E.? coli.? In? the? second? case? study,?a?multicomponent?P450?was?applied? in?a?native?
P450?expressing?host?B.?megaterium?and?finally?a?native?fusion?construct?was?applied?in?E.?coli.?In?the?
two?first?cases,?the?stability?of?the?correctly?folded?P450?was?shown?to?be?one?of?the?main?limitations?
for?an?economically?feasible?process.?The?poor?stability?of?the?enzyme?could?be?due?to?many?different?
reasons.? The? key? for? improvement? of? this? trait? is,? therefore,? to? first? identify? the? reason? for?
inactivation.?If?the?enzyme?is?worn?out?after?a?certain?number?of?catalytic?cycles,?if?certain?amino?acids?
are?sensitive?to?oxidation?or?if?poor?coupling?efficiency?producing?hydrogen?peroxide?being?harmful?to?
the?active?site?is?the?cause,?it?has?to?be?solved?using?different?approaches.???
6.4.2 Host?cell?
As? presented? in? Chapter? 2,? impressive?metabolic? engineering? work? on? entire? pathways? including?
P450s? has? previously? been? successfully? implemented? (Paddon? et? al.? 2013,? Szczebara? et? al.? 2003).?
However,?this?requires?enormous?efforts?and?overexpression?in?well?established?laboratory?strains?to?
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standardize? and? accelerate? the? development? process? of? P450? catalyzed? whole? cell? processes? is?
tempting.? It? is,?however,?not? that? straight? forward? and? the?host? cell? selection? in? a?P450? catalyzed?
whole?cell?process?is?of?major?importance?for?the?process?performance.?The?first?selection?criterion?is?
related?to?the?nature?of?the?P450,?whether?a?eukaryotic?host?cell?is?required?or?if?a?prokaryotic?host?is?
suitable.?If?the?native?P450?host?is?an?option,?this?seems?to?be?an?advantage.?The?host?is?then?capable?
of? handling? expression? of? heme?containing? proteins? (requiring? ??aminolevulinic? acid)? and? is? also?
adapted? to? cofactor? requiring? catalytic? enzymes? and? can? handle? potential? reactive? oxygen? species?
formed?in?the?catalytic?reaction.??
The?benefits?of?a?native?P450?expressing?host?were?demonstrated? in?Chapter?4?where? the?cofactor?
regeneration?by?the?resting?B.?megaterium?was?sufficient?to?support?the?catalytic?reaction.?In?contrast,?
in?Chapter?3,?where?E.?coli?was?applied,? the?catalytic? reaction?was?shown? to?be? limited?by?cofactor?
regeneration?and?could?be?improved?by?addition?of?external?NADPH.?The?overexpression?of?a?cofactor?
regenerating?dehydrogenase?also?confirms?the?indication?of?limitations?by?cofactor?regeneration?since?
lower? P450? expression,?when? the? dehydrogenase?was? expressed,? did? not? negatively? influence? the?
reaction?performance? (Appendix?1,? (Schewe?et?al.?2009)).?The?efficiency?of? the?pentose?phosphate?
pathway?for?cofactor?regeneration?of?alternative?heterologous?hosts? is?also?something?that?could?be?
considered?when?selecting?host.?However,?this?was?not?considered?in?this?thesis.?
Reaction?related?parameters?6.5
None?of?the?catalysts?applied?in?this?thesis?(the?gram?positive?B.?megaterium?or?the?gram?negative?E.?
coli)? showed? indications? of? transport? limitations? across? the? cell? membrane? for? their? respective?
substrates.?It?is?hard?to?draw?any?general?conclusions?from?this?finding?since?only?two?substrates?were?
applied? (dodecanoic? acid? and? CPA).? However,? it? has? been? demonstrated? previously? for? steroid?
substrates?like?CPA?that?the?substrate?transport?across?the?cell?membrane?has?been?a?limitation?of?a?
P450?catalyzed?reaction?performed?in?E.?coli?(Zehentgruber?et?al.?2010a).?
Another?reaction?related?challenge,?highly?relevant?for?mature?P450?catalyzed?reactions?is?the?limited?
water?solubility?of?the?substrate.?In?the?case?of?dodecanoic?acid?the?low?solubility?could?be?used?as?an?
advantage? for? the?process?as?a?way? to?keep? the?dissolved?concentrations? low?and? thereby?prevent?
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substrate?inhibition.?In?the?case?of?both?dodecanoic?acid?and?CPA,?higher?concentrations?than?applied?
in? the? studies? would? have? required? increased? DMSO? concentration? (above? 5? %).? That? would? be?
detrimental?for?the?enzyme,?as?already?indicated?at?current?conditions.?This?was?not?seen?in?the?case?
of?4?ethylphenol?but?on? the?other?hand?potential? loss?of? reactants?by?evaporation?was? introduced?
(Appendix?1).?DMSO,?or? any?other?water?miscible? co?solvent,? is? commonly? applied? in? research?but?
should?be?avoided?in?full?scale?processes?where?it?can?make?the?DSP?more?difficult.?For?the?assumed?
DSP? in?Chapter?5,?where?extraction? followed?by?evaporation? is? applied,?DMSO? is? remaining? as? the?
main?impurity?in?the?final?product?stream.??
The? other? reaction? related? parameters?mentioned? in? Chapter? 2,? inhibition? and? toxicity,? are? also?
dependent?on?the?applied?system.?For?all?case?studies? inhibition?by?either?substrate?or?product?was?
shown?to?be? limiting?when?aiming?for?high?concentrations?and?economic?feasibility.?Inhibition?of?the?
P450?was,?in?the?case?of?substrate?inhibition?by?dodecanoic?acid,?partially?circumvented?by?application?
of?solid?substrate?and?in?the?case?of?product?inhibition?by?15??OH?CPA?application?of?HP???CD?resulted?
in?a?conversion?of?98?%.?Application?of?a?second?organic?phase?previously?shown?to?be?successful?as?
substrate?reservoirs?or?to?enable? ISPR? (Schewe?et?al.?2009;?Cornelissen?et?al.?2011),?was? in?the?case?
studies? not? successfully? implemented.? In? the? case? of? CPA? conversion,? the? substrate? was? too?
hydrophobic? to?pass? from? the?organic?solvents? tested? to? the?aqueous?phase?and?enable?a? reaction.?
Different?reactor?configurations?e.g.?with?a?circulating?loop?connected?to?the?fermenter?could?enable?
several?options?for?removal?of?product.?By?retaining?the?cells?in?the?fermenter?the?biocompability?of?a?
solvent?would? be? of?minor? importance? as?well? as? the? explosion? hazards? caused? by? the? aeration.?
Furthermore,? in? combination? with? a? slow? substrate? supply? to? the? fermenter,? the? general? poor?
selectivity?of?the?solvent?between?the?substrate?and?product?would?also?have?limited?importance.????
Process?related?parameters?6.6
As?discussed?in?this?thesis,?the?requirement?of?cofactors,?redox?partners?and?relatively?low?stability?of?
P450s?makes?whole?cell?catalyst?the?preferred?catalyst?form.?To?benefit?from?cofactor?regeneration?of?
the?whole? cell? system,? two?process?operating?modes? can?be? applied,?growing? and? resting? cells.?As?
presented?in?Chapters?2?and?5,?from?an?economical?point?of?view,?P450?catalyzed?whole?cell?processes?
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are?beneficial?to?run?as?growing?cells.?What?could?influence?this?statement?is?only?if?the?catalyst?could?
be?recycled?several?times?in?a?resting?cell?process?or?if?the?operating?mode?affects?the?product?profile?
or?any?other?crucial?aspect?of?the?catalyzed?reaction.?Recycling?of?the?resting?cell?catalyst?was?shown?
not? to?be?successful? in?Chapter?4?and?does?not?oppose?the?statement.?Furthermore,?with? the?same?
model?system,?resting?cells?and?growing?cells?were?showing?similar?reaction?performance?in?terms?of?
product?profile.?The?general?differences?between?growing?and? resting?cells?would?be? interesting? to?
explore? further.? The? influence? on? the? biocatalytic? reaction? caused? by? differences? in? the?metabolic?
state?would?be?very?useful?to?establish?since?this?could?direct?research?efforts.?
The? best? case? scenario? in? Chapter? 5,? where? growing? cells? are? applied,? assumes? suggested?
improvements?to?the?catalyst?to?be?implemented?as?well?as?the?assumption?that?these?improvements?
would? not? lead? to? limitations? by? inhibition? or? toxicity.? (Alternatively,? if? new? limitations? arise,? that?
these?can?be?addressed?by?process?engineering.)?The?reasons?for?the?advantage?of?growing?cells?in?this?
assessment?are?that?the?catalyst?concentration?is?kept?identical?to?the?fermentation?in?the?resting?cell?
transformation,?the?reaction?performance?is?assumed?to?be?identical?between?the?growing?and?resting?
cell? process? and? the? cells? are? not? assumed? to? be? able? to? be? recycled.? This? leads? to? fewer? unit?
operations?and?shorter?batch?times?for?the?growing?cell?process?and?thereby?a?lower?production?cost.?
The?space?time?yield?of?the? improved?growing?cell?process? is,?over?the?48?h?process?and?despite?the?
assumed? improvements,?only?0.3?g/L/h,?which?according?to?the?defined?targets?on?this?metric? is?not?
enough?for?economic?feasibility.?This?is?due?to?the?relatively?long?time?assumed?for?the?fermentation?
process?of?40?h?followed?by?8?h?biocatalytic?reaction.?However,?even?if?this?was?modified?so?that?the?
biocatalytic? reaction?would?be?performed?during? the? first?40?h? the? space?time?yield?would?only?be?
improved?to?0.37?and?would?still?not?fulfill?the?requirement?of?2?g/L/h,?illustrating?that?this?metric?is?a?
challenge?to?fulfill?for?growing?P450?catalyzed?reactions.?To?turn?around?the?economic?advantage?of?a?
growing?cell?process,?one?or?more?of?the?assumptions?need?to?be?proven?wrong.?The?most?challenging?
metric?for?resting?cell?processes?is,?on?the?other?hand,?biocatalyst?yield,?still?assuming?no?cell?recycle?
due?to?poor?stability.?
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Another?process?related?finding,?presented?in?this?thesis,?is?the?differences?between?shake?flasks?and?
bioreactors,? stressing? the? fact? that? sufficient?mixing? and? proper? oxygen? supply? is? vital.? Sufficient?
oxygen? supply? is?of?major? importance? for?processes?where? the?biocatalytic? reaction? as?well?as? the?
catalyst? requires? oxygen.? In? practice? during? the? three? case? studies,? oxygen? supply? was? never? a?
problem? when? reactions? were? performed? in? bioreactors? and? oxygen? supplied? as? air.? However,?
increasing?catalyst?concentration?to?fulfill?e.g.?biocatalyst?yields?could?require?the?air?to?be?enriched?
with?oxygen?or?adjustment?of?the?carbon?source?feed?rate?in?a?growing?cell?process.?Regardless,?this?is?
not?considered?to?hinder?the?development?of?an?economically?feasible?process.??
Recommendations?for?implementation?6.7
The?methodological?approach?implemented?in?this?thesis?has?identified?several?bottlenecks?for?whole?
cell?P450?catalyzed?systems.?Many?of?them?are?correlated,?which?is?not?only?stressing?the?complexity?
of? these? systems,? but? also? that? several? parameters? needs? to? be? addressed? for? successful?
implementation.? The? methodology? was? proven? useful? to? identify? targets? for? improvement? and?
perhaps?most? importantly,? to? identify? suitable?products? for? this? type?of?processes.?The?approach? is?
something?that?is?recommended?to?be?applied?in?future?development?as?well.?
Except? the? scientific? advices? regarding? targets? and? tools? for? implementation? of? whole? cell? P450?
catalyzed? processes,? there? are? also? “soft”? skills? required? for? successful? implementation.? In? such? a?
complex?biocatalytic? system,?P450?experts? cannot?manage? the?development?without? support? from?
other? researchers? such? as? protein? engineers,? metabolic? engineers,? fermentation? specialists? and?
process? engineers.? Communication? between? researchers? with? the? involvement? from? interested?
companies?is?crucial?for?future?development.?Furthermore,?understanding?that?P450s?are?challenging?
catalysts?to? implement? is?also?essential?while?on?the?other?hand?the?several?“myths”?created?within?
the?P450?community?should?be?taken?with?skepticism.??
?
? ?
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7 Conclusions?
Industrial?biocatalysis? is?a?promising?alternative?and?complement?to?traditionally?chemical?catalyzed?
processes,?emphasized?by?the?increasing?number?of?implemented?processes?(Nestl?et?al.?2011).?P450s?
is?one? family?of?enzymes?with? a? lot?of?potential? for? industrial?biocatalysis.?However,? it?has?proven?
difficult?to?overcome?the?hurdles?faced?by?P450s? in?order?to?reach?an?economically? feasible?process?
and? thereby? industrial? implementation.? Based? on? this? thesis,? general? conclusions? for? successful?
implementation?of?P450?catalyzed?whole?cell?processes?can?be?drawn:??
? Not?all?potential?P450?products/processes?are?suitable? for? industrial?application.?Despite? the?
large?catalytic?potential?possessed?by? this? family?of?enzymes,?not?all?of? them?are?suitable? to?
implement? for? synthetic?production?at? industrial? scale.?Realizing? this? is?a? first? step? to?direct?
research?efforts,?which?can?be?shown?by?an?in?silico?analysis?as?done?in?Chapter?2.??
? Given? the? challenges? for? the?whole? cell? catalyst,? focus? should?be?on?high?value?products? to?
increase?the?success?rate?of?implementation.?This?was?confirmed?by?the?economic?assessment?
performed?in?Chapter?5,?where?an?improved?growing?cell?process?resulted?in?a?production?cost?
of?118?$/kg?product.?
? The?catalyst,?the?P450?and?host?cell,?needs?to?be?chosen?wisely.?Based?on?the?desired?catalytic?
reaction?the?P450?can?be?determined?followed?by?selection?of?host,?considering?demands?on?
biocatalyst?,?reaction??and?process??related?parameters?identified?from?the?in?silico?analysis.??
? Native?hosts?are?beneficial?for?catalytic?processes?performed?by?P450s,?since?they?can?handle?
cofactor?regeneration?and?expression?of?heme?proteins.?This?is?exemplified?in?Chapter?3?where?
cofactor?regeneration?of?the?heterologous?host?E.?coli?was?shown?to? limit???hydroxylation?of?
dodecanoic?acid.?Meanwhile,?in?Chapter?4,?the?15??hydroxylation?of?CPA?performed?using?the?
naturally?P450?expressing?host?B.?megaterium?was?not? shown? to?be? limited?by? the? cofactor?
regeneration?of?the?host?cell.?
? The?stability?of?the?P450?is?crucial,?as?identified?in?the?initial?literature?analysis?(Chapter?2)?and?
confirmed?by?the?case?studies? (Chapters?3?and?4).? In?Chapter?3,?50?%?of?the?correctly? folded?
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P450?were?lost?after?2?h?of?reaction.?Targets?from?the?initial?analysis?were?calculated?on?a?24?h?
process,?and?in?the?final?cost?assessment?a?8?h?process?was?assumed.?If?an?increased?stability?
cannot?be?reached,?the?specific?activity,?and?all?correlated?parameters,?needs?to?be?improved?
beyond?what?was?previously?suggested?to?compensate?for?a?shorter?process?time.??
? P450?catalyzed?reactions?suffer? from?substrate?and/or?product? inhibition.?This?was?shown? in?
the?case?studies?at?concentrations?(0.43?g/L?for???hydroxylation?of?dodecanoic?acid?and?0.23?
g/L? for? CPA? hydroxylation)? far? below? industrial? suitable? targets? of? 20? g/L,? and? needs? to? be?
circumvented?by?engineering?tools?to?enable?higher?concentrations.??
? Solid?supply?of?substrate?can?alleviate?substrate?inhibition,?as?demonstrated?in?the?dodecanoic?
acid?hydroxylation?in?Chapter?3.?This?approach?improved?the?reaction?performance?from?a?final?
product?concentration?of?0.43?g/L? to?1.2?g/L.?Apart? from? the?reduced?substrate? inhibition,? it?
also?avoids?the?negative?effects?on?the?biocatalyst?caused?by?the?co?solvent?DMSO.?
? In?situ?product?removal? is?a?promising?method?to?tackle?product? inhibition.?Chapter?4?shows?
that?application?of?derivatized? ??cyclodextrin? to? the?15??hydroxylation?of?CPA?by?CYP106A2?
expressed?in?B.?megaterium?circumvented?the?low?substrate?solubility?and?product?inhibition,?
enabling?an?increase?from?54?%?to?98?%?conversion?of?1?mM?substrate.??
? Growing?cell?processes?are?the?most?economically?suitable?operating?mode?for?whole?cell?P450?
catalyzed?processes.?In?the?economic?assessment?in?Chapter?5,?the?base?case?production?cost?
was?decreased?from?1089?$/kg?product?to?756?$/kg?product?by?changing?operating?mode?from?
resting? to? growing? cells.? Further? improvement? in? enzyme? expression? and? enzyme? total?
turnover?and?under?the?assumptions?made?in?the?analysis?resulted?in?a?production?cost?of?118?
$/kg?product?for?the?improved?growing?cell?process.?
? ?
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8 Future?work?
To? continue? exploring? the? field? of? whole?cell? P450? catalyzed? process? development? and? enable?
industrial?implementation,?suggestions?for?further?work?that?would?improve?and?expand?this?thesis?is?
presented? in? this? chapter.?Work? aiming? for? development? of? the? field? in? general? is? first? presented?
followed?by?work?recommended?specific?for?each?case?studie.??
General?for?whole?cell?P450?catalyzed?processes?8.1
8.1.1 Methodology?development??
The?methodology?used? in? the? thesis?with? identification?of?bottlenecks?divided? in?catalyst?,? reaction??
and? process?? related? parameters? could? be? expanded? and? improved.? On? the? one? hand,? the?
methodology? could? be? expanded? to? include? any? target?molecule? and? a?much? greater? selection? of?
catalysts.?On? the?other?hand,?a?methodology?more?specific? for?P450s?would?make? the? results?more?
accessible.?To?classify?both?reactants?and?P450s?into?groups,?is?one?way?to?speed?up?the?identification?
of? bottlenecks? for? P450? catalyzed? processes? and? thereby? increase? the? rate? of? industrial?
implementation.???
8.1.2 Platform?host?for?redox?catalysis?
As?stressed?in?Chapter?2?and?shown?throughout?the?thesis,?the?host?cell?should?be?selected?carefully?
since? it? plays? a? vital? role? in? the? overall? process.? As? already?mentioned,? a? platform? host? for? redox?
catalysis?and?more?specifically?P450?catalysis?would?be?truly?useful?to?speed?up?process?development.?
This? is?not?an?easy?task?and?also?difficult?to?make?general?for?P450s?considering?the?various?classes.?
However,? even? if? a? platform? host? is? not? reached,?more?widely? spread? common? laboratory? hosts?
adapted? for?cofactor?requiring?catalysis?and?synthesis?of?heme?proteins?would?be?a? first?step? in?this?
direction.???
8.1.3 P450?stability?
In?the?case?studies?in?Chapters?3?and?4,?the?stability?of?the?P450?was?shown?to?limit?the?processes.?This?
has? a? considerable? impact? on? the? potential? of? these? types? of? processes.? Therefore,? it? would? be?
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interesting?to?study?factors?influencing?the?stability?on?a?basic?research?level,?to?fully?understand?if?the?
enzyme?e.g.? is?worn?out? after? a? certain? total? turnover?number?or? if? it? is?directly? correlated? to? the?
amount? of? hydrogen? peroxide? formed? and? thereby? the? coupling? efficiency.? The? stability? could?
potentially?also?be?influenced?by?the?operating?mode,?and?a?growing?cell?could?potentially?continue?to?
synthesize?enzymes?and?thereby?keep?a?constant?level?of?active?enzymes?over?a?longer?period?of?time?
compared?to?resting?cells.??
8.1.4 Operating?mode?
From?an?economic?point?of?view,?growing?cells?have?been?shown?to?be?the?preferred?operating?mode.?
However,?a?more?detailed?comparison?of?how?factors?resulting?from?the?different?metabolic?state?of?
the? cell? influence? the? process? in? terms? of? selectivity? and? yields,? and? also? enzyme? stability? and?
inhibition?profile?using?different?systems?would?be?beneficial?for?further?comparisons.??
8.1.5 Approaches?for?substrate?supply?and?product?removal??
Rising? from? the?origin?of?enzymes?and? the? feedback? inhibition?often? involved? in?enzyme? regulation,?
product? inhibition? is? common? in?many?biocatalytic? reactions.?Cost?efficient?and?highly? specific? ISPR?
techniques?would?be?beneficial?also?for?P450?whole?cell?catalyzed?processes.?Nevertheless,?since?the?
substrate? and? product? properties? for? typical? P450? reactions? are? very? similar,? a? successful? ISPR? is?
particularly?challenging.?As?discussed?in?Chapter?6.5,?modifications?to?a?stirred?tank?reactor?with?e.g.?
an?external?loop?would?be?one?alternative?approach?to?the?commonly?used?one?pot?two?phase?system?
and?something?recommended?to?be?evaluated?further.?
Future?work?specific?to?case?studies?8.2
8.2.1 Case?study?1?
Production? of? ??hydroxylated?medium? and? long? chain? fatty? acids? by? a? biocatalytic? process? is? very?
interesting?since?the?chemical?route?suffers?from?many?drawbacks?and?the?product?has?many?areas?of?
application?including?further?functionalization.??For?demonstration?of?limitations?of?an?overexpressed?
P450? in?a?non?natural?host,? the?system?worked?well.?However,? for? this? type?of?product,? the?system?
applied? in?Chapter?3? is?perhaps?not? the?most?suitable?one.? If? the? target?product? remains? the?same,?
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taking? one? step? back? and? reconsider? catalyst? options? and? process? alternatives? is? recommended.?
Further? optimization? of? the? whole? cell? process? with? CYP52? expressed? in? Candida? tropicalis? with?
already?high?product?concentrations?achieved?is?recommended?instead?(Lu?et?al.?2010).??
8.2.2 Case?study?2?
15??hydroxylation?of?CPA?by?CYP106A2? expressing?B.?megaterium? is? a?promising?process?worth? to?
investigate? further.? The? application?of?HP???CD?was? shown? to?be? successful,?but? there? is? room? for?
improvement.?Alternative?cyclodextrins?could?also?be?considered,? since?non?derivatized?options?are?
significantly?cheaper?than?modified?ones.?Furthermore,?the?process?itself?could?be?optimized?in?terms?
of?ratio?of?HP???CD?to?CPA?and?actual?CPA?applied?to?the?reaction?as?a?complex.???
8.2.3 Cost?assessment?
Depending?on? the?purpose?with?a? further?cost?assessment,?different?approaches?can?be? taken.?The?
field?of?biocatalytic?process? evaluation? in? general?would?benefit? if? a?more? generalized? approach? is?
chosen.?From?another?perspective,?in?this?specific?case,?the?uncertainty?is?greatest?in?the?DSP?and?this?
is? something?generally?not?considered? in? research? laboratories?despite?having?a?major? influence?on?
the? overall? cost.? Therefore,? a? systematic? approach? for? potential? DSP? routes? for? different? process?
options?and?product?categories?is?recommended.?
?
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Appendix?1?Supplementary?information?for?the?cost?assessment?in?Chapter?5?
A?1.1?Material?and?methods?
A?1.1.1?Chemicals,?Bacterial?strains?and?plasmids?
All?used?chemicals?were?from?standard?sources?and?of?highest?grade?available.?Solvents?of?analytical?
grade? or? HPLC? grade? were? used? for? UPLC.? Escherichia? coli? HMS174? (DE3)? was? purchased? from?
MerckMillipore? (Schaffhausen,? Switzerland),? pET22b? used? to? insert?CYP102A1? double?mutant? from?
Novagen? (Merck,Darmstadt,? Germany)? and? plasmid? pCDF?1b? from? Novagen? (Merck,? Darmstadt,?
Germany)? for? insertion? of? cofactor? regenerating? glucose?6?phosphate? dehydrogenase? (G6PDH).?
Antibiotic?resistance?was?used?as?selective?marker,?carbenicillin?for?the?CYP102A1?double?mutant?and?
streptomycin? for? the? G6PDH.? The? antibiotics? were? applied? to? the? fermentation? broth? in? final?
concentrations?of?100?μg/mL?(carbenicillin)?and?50?μg/mL?(streptomycin).?
A?1.1.2?Fermentation?
A? seed?culture?with?LB?media? supplemented?with?antibiotics?was? inoculated? from?a? ?80? °C?glycerol?
stock?and?grown?at?37?°C,?180?rpm?until?late?exponential?phase?in?shake?flasks.?The?seed?culture?was?
used? to? inoculate? a? fermenter? with? 2.5? L? working? volume? (new? MBR,? Zürich,? Switzerland)? and?
fermentation?was?performed?by?glucose?limited?fed?batch?with?a?growth?rate?of?0.1?h?1?(Marisch?et?al.?
2013).?Set?points?controlled?during?the?fermentation?were?pH?set?to?7.2,?maintained?by?addition?of?14?
%?NH4OH?and?pO2?set?to?30?%,?controlled?by?agitation.?Feed?was? initiated?when?the?carbon?source?
from?the?batch?medium?was?depleted,? indicated?by?a?pO2?spike.?Protein?expression?was? induced?by?
0.5?μmol? IPTG?per?g?cdw?one?generation?after?feed?start?and?the?process?continued?for?3?additional?
generations.?During?the? last?generation,?the?feed?profile?was?changed?to?a? linear?feed.?Temperature?
was?decreased?at?the?time?of? induction?from?37?°C?to?30?°C.?Foam?was?controlled?by?addition?of?0.5?
mL?antifoam?204?(Sigma?Aldrich)?per?liter?media.?The?final?cell?density?reached?was?33?g?cdw/L.?
A?1.1.3?Resting?cell?transformation?
Cells?were?harvested?by?centrifugation? (6000?rpm,?40?min)? (HiCen?XL,?Herolab,?Wiesloch,?Germany)?
and?washed?with?1?L?100?mM?potassium?phosphate?buffer?(6000?rpm,?25?min)?before?the?pellet?was?
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resuspended? in?2?L?potassium?phosphate?buffer?containing?1?%?glycerol?and?20?mM?glucose.?Resting?
cell?biotransformations?were?performed? in?the?same?bioreactors?as?the?fermentation?with?a?working?
volume?of?2?L.?The?transformations?were?initiated?by?substrate?addition?from?a?1?M?stock?solution?in?
DMSO? after? initial? conditions? had? stabilized? (30? °C,? pO2? 30?%,? 1? vvm,? pH? 7.2? controlled? by? 20?%?
potassium?hydroxide?and?20?%?phosphoric?acid).?During?the?transformation,?carbon?source?was?added?
from?a?stock?mixture?containing?27?%?glycerol?and?0.67?M?glucose?and?a?suitable? linear?feeding?was?
determined?from?a?resting?cell?biotransformation?aiming?at?a?pO2?of?30?%?at?1?vvm?resulting?in?a?feed?
of?7?g/g?cdw?during?8?h.?Cell?density?applied?in?resting?cell?transformation?were?17?g?cdw/L.?
A?1.1.4?Growing?cell?transformation??
When?growing?cells?were?applied?as?operating?mode,?the?fermentation?process?was? identical?to?the?
fermentation?process? for?producing?resting?cells?and?the?substrate?(4?ethylphenol)?was?added?when?
the?linear?feed?was?initiated,?3?generations?after?feed?start.?
A?1.1.5?Analytical?methods?
Cell?dry?weight?
Samples?for?cell?dry?weight?determination?were?analyzed?using?a?halogen?moisture?balance?(HG63?P,?
Mettler?Toledo,?Greifensee,?Switzerland)?
P450?determination?
300?μL? samples?were? collected? from? fermentations?or? transformations?and?pellets?were? frozen? for?
P450?concentration?determination?by?CO?differential?spectral?assay?(Omura?and?Sato?1964).?Prior?to?
analysis,?samples?were?diluted?with?100?mM?potassium?phosphate?buffer?to?OD600?of?10.?A?spatula?tip?
sodium?hydrosulfite?was?added?to?the?samples?which?were? incubated?on? ice?for?10?min?before?they?
were?split?into?3?wells?of?a?96?well?plate,?of?which?1?was?treated?as?blank?and?2?were?treated?with?CO?
during?1?min?before?the?differential?spectra?was?measured?between?400?and?500?nm.??
UPLC?analysis?
100?μL? samples?were? taken? for?UPLC? analysis.? To? stop? the? reaction,? 10?μL?HCl?was? added? before?
diluting?the?samples?with?500?μL?solvent?A?(10?%?acetonitrile? in?0.05?%?phosphoric?acid)?and?500?μL?
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acetonitrile.? The? supernatant? was? transferred? to? a? fresh? vial? after? centrifugation.? Analysis? was?
performed?on?an?Acquity?UPLC,?with?PDA?detector,?(Waters,?Milford,?MA,?US)?using?a?reverse?phase?
Acquity?UPLC?HSS?T3?column? (1.8?μM,?2.1x100?mm)?(Waters,?Milford,?MA,?US).?An? injection?of?1?μL?
was? followed?by?a?gradient? from?10?%? to?90?%?acetonitrile? in?0.05?%?phosphoric?acid?over?2.5?min.?
After? 0.6?min? at? 90?%? acetonitrile? the? gradient?was? returned? to? initial? conditions? for? 1.7?minutes?
before?the?next?injection.?The?flow?rate?was?kept?at?0.3?mL/min?and?the?column?oven?was?set?to?40?°C.?
A?1.2?Results?and?discussion?
Resting?cell?biotransformations?were?performed?with?10?mM?substrate?concentration,? in?batch?and?
fed?batch?mode?(Figure?A.1).?The?method?of?substrate?supply?did?not?influence?the?final?result?of?the?
reaction?and?a?reaction?yield?of?21?23?%?was?achieved.?However,?according?to?the?analysis?only?54?%?
and? 69?%? of? the? calculated? added? substrate? can? be? found? as? substrate? or? product? after? 24? h? of?
reaction,?in?the?batch?and?fed?batch?mode,?respectively.?For?future?work?using?this?model?system,?the?
discrepancy? should? be? investigate? further? and? could? be? explained? by? analytical? defects? or? by?
evaporation?of?the?substrate?and/or?product.?However,?for?the?cost?assessment?a?reaction?yield?of?90?
%?has?been?assumed.??
?
??
Figure?A.1?Progress?curves?of?biocatalytic?reactions?utilizing?resting?cells.?Substrate?supplied?as?10?mM?
batch?(left)?and?10?mM?fed?batch?(right)?with?a?linear?feed?profile?over?the?initial?4?h.???
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An?evaporation? test?was?performed? to?determine?whether? this?was? the? cause? for? the? inconsistent?
mass?balances?seen? in?Figure?A.1,?using?5?mM?4?ethylphenol?and?5?mM?4?ethylcatechol? in?100?mM?
potassium?phosphate?buffer.?Conditions?during?the?evaporation?test?were?identical?to?the?resting?cell?
transformations,?except?that?no?cells?were?added.?Both?the?substrate?and?product?was?discovered?to?
decrease?over?time?(Figure?A.2),?with?70?%?of?the?calculated?value?remaining?5?min?after?substrate?and?
product?addition?and?58?%?remaining?after?24?h.?The?main?loss?was?discovered?to?be?allocated?within?5?
min?after?addition?of?the?reactants?to?the?transformation?vessel,?indicating?that?the?analytical?method?
needs?to?be?improved?or?alternatively?that?there?is?a?spontaneous?fast?reaction?taking?place.?However,?
the?decrease?between?5?minutes?and?24?h? indicates?that?evaporation? is?also?part?of?the?explanation?
and?mainly?evaporation?of?the?product?4?ethylcatechol.??
?
Figure?A.2?Progress?curve? from?evaporation?test?of?5?mM?4?Ethylphenol?and?5?mM?4?Ethylcatechol.?
Points?at?time?0?illustrates?calculated?values.?
In?an?attempt?to?increase?the?conversion?in?the?resting?cell?biotransformation,?repetitive?batch?supply?
of?the?substrate?was?applied.?Furthermore,?since?the?cofactor?regeneration?was?shown?to?be?a?limiting?
factor? in? previous? P450? catalyzed? resting? cell? processes,? glucose?6?phosphate? dehydrogenase?was?
overexpressed? together? with? the? CYP102A1? double? mutant? for? improved? cofactor? regeneration.?
Neither? the? repetitive? batch? nor? the? coexpression? of? dehydrogenase? improved? the? reaction?
performance?compared?to?the?initial?biotransformation?studies?(Figure?A.3).?Limitation?by?the?cofactor?
regeneration? of? the? host? cell? in? the? initial? resting? cell? biotransformation? was? confirmed? in? these?
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studies,? since? the?overexpression?of? the?dehydrogenase? lead? to?a?decrease? in? the?P450?expression?
without?changing?the?reaction?performance?(Figure?A.3?and?A.4).?
? ? ??
Figure?A.3?Progress?curves?of?biocatalytic? reactions?utilizing?resting?cells,?with?substrate?supplied?as?
repetitive?batch?(5+5?mM)?from?a?1?M?stock?solution?in?DMSO.?Left?graph?illustrates?E.?coli?expressing?
CYP102A1?double?mutant?and?right?graph? illustrates?E.?coli?expressing?CYP102A1?double?mutant?and?
G6PDH.?
?
Figure? A.4? Cell? dry? weight? measurements? and? P450? concentration? determination? of? biocatalytic?
resting?cell?reactions?illustrated?in?Figure?A.3.??
To? compare? the? two? operating?modes,? resting? and? growing? cells,? a? growing? cell? process?was? also?
performed.?The?repetitive?batch?supply?of?substrate?was?applied,?5?mM?substrate?was?applied?3?times.?
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The?conversion?did?not?show?any?significant?difference?compared?to?resting?cells?(Figure?A.5)?and?the?
same?assumptions?as?for?the?resting?cell?process?was?made?for?the?cost?assessment?with?90?%?reaction?
yield?over?8?h?when?applying?10?mM?substrate.?
?
Figure?A.5?Progress?curve?of?biocatalytic?growing?cell? reaction?utilizing?E.? coli?expressing?CYP102A1?
double?mutant.?Substrate?supplied?in?a?repetitive?batch?mode?(3x5?mM).?
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